P01284126A05
The/DT MMP-3/NN ,/, MMP-9/NN and/CC TIMP-1/NN stimulation/NN in/IN response/NN to/TO IL-1/NN and/CC TNF-alpha/NN treatment/NN was/VBD detected/VBN in/IN some/PRP of/IN the/DT tumor/NN cell/NN lines/NNS and/CC HUVEC/NN ./.
P01336777A04
In/IN the/DT present/JJ study/NN the/DT ability/NN of/IN human/NN osteoblasts/NNS to/TO produce/VB the/DT matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) collagenase/NN ,/, gelatinase/NN and/CC stromelysin/NN ,/, and/CC their/PRP$ specific/JJ inhibitors/NNS TIMPs-1/NN and/CC 2/CD ,/, was/VBD examined/VBN using/VBG highly/RB sensitive/JJ and/CC specific/JJ antisera/NNS and/CC by/IN zymography/NN ./.
P01339118A05
Gelatin/NN zymography/NN revealed/VBD several/JJ lysis/NN zones/NNS amongst/IN which/WDT a/DT major/JJ 92-kDa/NN band/NN shifted/VBD to/TO 83-/CD and/CC 68-kDa/NN species/NNS during/IN the/DT course/NN of/IN implantation/NN ./.
P01379048A12
The/DT active/JJ forms/NNS generated/VBN by/IN trypsin/NN were/VBD identified/VBN as/IN 80/CD kDa/NN ,/, 74/CD kDa/NN and/CC 66/CD kDa/NN by/IN their/PRP$ abilities/NNS to/TO bind/VB to/TO alpha/NN 2-macroglobulin/NN ./.
P01400481A06
The/DT proenzyme/NN is/VBZ fully/RB activated/VBN by/IN cathepsin/NN G/NN ,/, trypsin/NN ,/, alpha-chymotrypsin/NN ,/, and/CC MMP-3/NN (/( stromelysin/NN 1/CD )/) but/CC not/RB by/IN plasmin/NN ,/, leukocyte/NN elastase/NN ,/, plasma/NN kallikrein/NN ,/, thrombin/NN ,/, or/CC MMP-1/NN (/( tissue/NN collagenase/NN )/) ./.
P01480033A01
The/DT zymogens/NNS of/IN matrix/NN metalloproteinase/NN 1/CD (/( MMP-1/NN :/: tissue/NN collagenase/NN )/) ,/, MMP-2/NN (/( gelatinase/NN //SYM type/NN IV/CD collagenase/NN )/) and/CC MMP-3/NN (/( stromelysin/NN )/) were/VBD purified/VBN from/IN the/DT culture/NN medium/NN of/IN human/NN rheumatoid/JJ synovial/JJ fibroblasts/NNS and/CC the/DT mechanisms/NNS of/IN activation/NN of/IN each/DT zymogen/NN by/IN proteinases/NNS and/CC 4-aminophenylmercuric/JJ acetate/NN (/( APMA/NN )/) were/VBD studied/VBN by/IN kinetic/NN and/CC sequence/NN analyses/NNS ./.
P01645518A05
These/DT results/NNS suggest/VBP that/IN collagenolysis/NN in/IN uterine/JJ cervical/JJ fibroblasts/NNS is/VBZ negatively/RB regulated/VBN by/IN steroid/NN hormones/NNS via/IN the/DT acceleration/NN of/IN TIMP/NN production/NN and/CC the/DT suppression/NN of/IN synthesis/NN of/IN MMPs/NNS at/IN the/DT pretranslational/JJ level/NN ./.
P01653026A13
TNF/NN alpha/NN did/VBD also/RB stimulate/VBP the/DT production/NN of/IN proMMP-9/NN ,/, although/IN less/RB efficiently/RB than/IN IL1/NN ,/, but/CC it/PRP did/VBD not/RB induce/VBP ,/, or/CC very/RB poorly/RB ,/, that/PRP of/IN the/DT 55/CD kDa/NN proMMP-1/NN //SYM proMMP-3/NN activity/NN ./.
P01657905A03
IL-1/NN significantly/RB augmented/VBD the/DT production/NN of/IN proMMP-1/NN (/( vertebrate/NN procollagenase/NN )/) ,/, proMMP-3/NN (/( prostromelysin/NN )/) ,/, and/CC TIMP/NN without/IN detectable/JJ changes/NNS in/IN the/DT intracellular/JJ level/NN of/IN cAMP/NN ./.
P02166509A01
We/PRP have/VBP investigated/VBN the/DT effect/NN of/IN interleukin/NN 6/CD (/( IL-6/NN )/) on/IN the/DT synthesis/NN of/IN tissue/NN inhibitor/NN of/IN metalloproteinases/NNS (/( TIMP/NN )/) and/CC matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, collagenase/NN (/( MMP-1/NN )/) and/CC stromelysin/NN (/( MMP-3/NN )/) using/VBG human/NN skin/NN and/CC uterine/JJ cervical/JJ fibroblasts/NNS ./.
P02174435A10
In/IN contrast/NN ,/, Timp/NN gene/NN transcription/NN was/VBD reduced/VBN by/IN approximately/RB 80/CD %/SYM ,/, revealing/VBG reciprocal/JJ regulation/NN of/IN MMPs/NNS and/CC TIMP/NN during/IN the/DT induction/NN of/IN a/DT resorptive/JJ cell/NN phenotype/NN ./.
P02269296A01
Human/NN rheumatoid/JJ synovial/JJ cells/NNS in/IN culture/NN secrete/VBP at/IN least/JJS three/CD related/JJ metalloproteinases/NNS that/WDT digest/VBP extracellular/JJ matrix/NN macromolecules/NNS ./.
P07502710A12
After/IN the/DT addition/NN of/IN IL-1/NN alpha/NN ,/, a/DT very/RB rapid/JJ increase/NN in/IN MMP-1/NN and/CC MMP-3/NN mRNA/NN could/MD be/VBP observed/VBN as/RB well/RB as/IN a/DT moderate/JJ increase/NN in/IN TIMP-1/NN mRNA/NN ./.
P07512058A07
Two/CD inhibitors/NNS of/IN MMPs/NNS ,/, the/DT naturally/RB occurring/JJ tissue/NN inhibitor/NN of/IN metalloproteinases/NNS (/( TIMP/NN ;/: 10/CD micrograms/NNS //SYM ml/NN )/) and/CC the/DT synthetic/JJ ,/, peptide/NN inhibitor/NN BB-94/NN (/( 1/CD microM/NN )/) were/VBD both/PRP effective/JJ at/IN blocking/NN HUVEC-mediated/JJ collagen/NN degradation/NN ./.
P07523391A07
These/DT studies/NNS suggest/VBP that/IN MMPs/NNS ,/, beyond/IN their/PRP$ previously/RB described/JJ functions/NNS as/IN extracellular/JJ degrading/JJ enzymes/NNS ,/, may/MD also/RB exert/VBP effects/NNS on/IN cellular/JJ growth/NN and/CC proliferation/NN via/IN degradation/NN of/IN IGFBP-3/NN ,/, thus/RB enhancing/VBG IGF/NN bioavailability/NN ./.
P07533311A02
The/DT mRNA/NN levels/NNS for/IN MMP-1/NN and/CC MMP-3/NN decreased/VBD with/IN age/NN in/IN STZ-induced/JJ diabetes/NN ./.
P07540230A04
Zymography/NN of/IN medium/NN obtained/VBN from/IN cells/NNS cultured/VBN in/IN the/DT absence/NN of/IN plasminogen/NN revealed/VBD the/DT presence/NN of/IN latent/JJ matrix/NN metalloproteinase-2/NN (/( MMP-2/NN )/) which/WDT was/VBD converted/VBN to/TO a/DT lower/JJR molecular/JJ weight/NN ,/, active/JJ form/NN in/IN the/DT presence/NN of/IN mesangial/JJ cells/NNS and/CC plasminogen/NN ./.
P07543547A06
PMA/NN stimulated/VBD the/DT production/NN of/IN collagenase/NN ,/, stromelysin/NN ,/, 92-kDa/NN gelatinase/NN ,/, and/CC TIMP-1/NN in/IN both/DT endothelial/JJ cell/NN types/NNS ./.
P07547939A07
The/DT results/NNS indicate/VBP that/IN weakly/RB bound/JJ water/NN molecules/NNS are/VBP essential/JJ to/TO mediate/VB the/DT interaction/NN between/IN substrate/NN and/CC enzyme/NN ./.
P07551259A03
Neither/CC enzyme/NN nor/CC TIMP-1/NN was/VBD detected/VBN in/IN histologically/RB normal/JJ mucosa/NN ./.
P07559440A04
The/DT deduced/JJ protein/NN composed/VBN of/IN 604/CD amino/JJ acids/NNS was/VBD closely/RB related/VBN to/TO MT-MMP/NN in/IN the/DT amino/JJ acid/NN sequence/NN (/( 66/CD %/SYM homology/NN at/IN the/DT catalytic/JJ domains/NNS )/) and/CC has/VBZ a/DT potential/JJ TM/NN domain/NN at/IN the/DT C/NN terminus/NN ./.
P07563189A10
Linear/JJ regression/NN analysis/NN ,/, Student/NN 's/POS t/NN tests/NNS ,/, and/CC chi-squared/NN analysis/NN were/VBD used/VBN to/TO evaluate/VB the/DT data/NNS ./.
P07576228A05
Moreover/RB ,/, MMP/NN activity/NN is/VBZ post-transcriptionally/RB regulated/VBN by/IN proteolytic/JJ activation/NN of/IN the/DT latent/JJ proenzymes/NNS and/CC by/IN interaction/NN with/IN specific/JJ tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) ./.
P07586800A09
It/PRP appears/VBZ ,/, therefore/RB ,/, that/IN MMP-9/NN may/MD play/VBP an/DT important/JJ role/NN in/IN the/DT malignant/JJ behavior/NN of/IN GCTs/NNS and/CC suggests/VBZ a/DT potential/JJ therapeutic/JJ role/NN for/IN protease/NN inhibitors/NNS in/IN attempting/NN to/TO minimize/VB the/DT invasive/JJ behavior/NN of/IN GCTs/NNS ./.
P07589989A01
Prostaglandin/NN E2/NN (/( PGE2/NN )/) and/CC leukotriene/NN B4/NN (/( LTB4/NN )/) ,/, at/IN nanomolar/JJ to/TO micromolar/JJ concentrations/NNS ,/, elicited/VBD migration/NN of/IN human/NN blood/NN T/NN cells/NNS and/CC cultured/JJ T/NN lymphoblastoma/NN cells/NNS of/IN the/DT Tsup-1/NN line/NN through/IN a/DT layer/NN of/IN Matrigel/NN basement/NN membrane/NN matrix/NN ./.
P07591310A01
We/PRP have/VBP identified/VBN a/DT novel/JJ membrane-type/NN matrix/NN metalloproteinase/NN (/( MT-MMP/NN )/) expressed/VBN on/IN the/DT cell/NN surface/NN and/CC inducing/VBG activation/NN of/IN pro-gelatinase/NN A/NN in/FW vitro/FW ./.
P07593257A10
These/DT results/NNS suggested/VBD that/IN the/DT serum/NN induces/VBZ proliferation/NN as/RB well/RB as/IN expression/NN of/IN MMP/NN and/CC TIMP/NN in/IN HHE/NN and/CC HHF/NN cells/NNS ./.
P07601636A11
Removal/NN of/IN tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMP/NN )/) from/IN control/NN scleral/JJ extracts/NNS by/IN reduction/NN and/CC alkylation/NN resulted/VBD in/IN a/DT 222/CD %/SYM increase/NN in/IN gelatinolytic/JJ activity/NN after/IN APMA-activation/NN (/( P/NN </SYM or/CC =/SYM 0.001/CD )/) ,/, whereas/IN similar/JJ treatment/NN of/IN deprived/JJ scleral/JJ extracts/NNS resulted/VBD in/IN only/RB a/DT 76/CD %/SYM increase/NN in/IN gelatinolytic/JJ activity/NN (/( P/NN </SYM or/CC =/SYM 0.001/CD )/) ./.
P07606893A08
Schwann/NN cells/NNS immortalized/VBN by/IN protracted/JJ elevation/NN of/IN cAMP/NN ,/, as/RB well/RB as/IN a/DT schwannoma/NN cell/NN line/NN (/( D6P2T/NN )/) ,/, also/RB rapidly/RB invaded/VBD a/DT reconstituted/JJ basement/NN membrane/NN and/CC over-expressed/VBD MMP-2/NN ./.
P07613621A04
In/IN the/DT present/JJ paper/NN ,/, we/PRP have/VBP studied/VBN the/DT changes/NNS occurring/VBG in/IN human/NN primitive/JJ neuroectodermal/JJ cells/NNS following/VBG infection/NN with/IN human/NN T/NN cell/NN lymphotropic/JJ virus/NN type/NN 1/CD (/( HTLV-I/NN )/) ,/, a/DT retrovirus/NN responsible/JJ for/IN HTLV-I-associated/JJ myelopathy/NN ./.
P07615167A14
This/DT approach/NN may/MD prove/VBP generally/RB applicable/JJ for/IN the/DT detection/NN of/IN protease/NN activity/NN in/IN tissue/NN sections/NNS permitting/VBG exploration/NN of/IN the/DT roles/NNS of/IN these/DT enzymes/NNS in/IN pathobiology/NN ./.
P07616276A04
In/IN five/CD human/NN glioma/NN cell/NN lines/NNS ,/, gelatinase/NN A/NN ,/, TIMP-1/NN ,/, and/CC TIMP-2/NN genes/NNS were/VBD constitutively/RB expressed/VBN in/IN alll/DT cell/NN lines/NNS :/: the/DT matrilysin/NN gene/NN in/IN three/CD cell/NN lines/NNS ;/: the/DT stromelysin/NN gene/NN in/IN two/CD cell/NN lines/NNS ;/: and/CC the/DT interstitial/JJ collagenase/NN gene/NN in/IN one/CD cell/NN line/NN ./.
P07622455A02
We/PRP have/VBP reported/VBN that/IN a/DT catalytic/JJ amount/NN of/IN MMP-3/NN (/( stromelysin/NN 1/CD )/) activates/VBZ pro-MMP-9/NN (/( Ogata/NNP ,/, Y./NNP ,/, Enghild/NNP ,/, J./NNP J./NNP ,/, and/CC Nagase/NNP ,/, H./NNP (/( 1992/CD )/) J./NN Biol./NN Chem./NN 267/CD ,/, 3581-3584/CD )/) ./.
P07628406A12
Gelatin/NN zymography/NN of/IN follicular/JJ fluid/NN revealed/VBD bands/NNS of/IN gelatinase/NN of/IN 72/CD //SYM 67/CD kilodaltons/NNS ,/, consistent/JJ with/IN latent/JJ and/CC active/JJ MMP-2/NN ./.
P07629341A04
TMJ/NN discs/NNS were/VBD retrieved/VBN from/IN 14-week-old/JJ male/NN NZW/NN rabbits/NNS and/CC both/CC tissue-/NN and/CC disc-derived/JJ cells/NNS were/VBD cultured/VBN in/IN serum-free/JJ medium/NN ./.
P07639798A05
Radiologic/JJ and/CC functional/JJ joint/NN scores/NNS were/VBD based/VBN upon/IN Steinbrocker/NN 's/POS criteria/NNS ./.
P07669564A07
MMP-9/NN mRNA/NN positive/JJ cells/NNS were/VBD round/JJ and/CC identified/VBN as/IN macrophages/NNS by/IN immunostaining/NN with/IN an/DT anti-macrophage/NN antibody/NN (/( KP1/NN )/) ,/, while/IN TIMP-1/NN ,/, mRNA/NN was/VBD detected/VBN in/IN spindle-shaped/JJ stromal/JJ cells/NNS ./.
P07695193A07
Upon/IN stimulation/NN with/IN IL1/NN or/CC TNF/NN alpha/NN ,/, SMC/NN synthesized/VBD in/IN addition/NN 92/CD kDa/NN GL/NN ,/, stromelysin/NN ,/, and/CC interstitial/JJ collagenase/NN ,/, MMPs/NNS that/WDT together/RB can/MD degrade/VBP all/PRP of/IN the/DT ECM/NN components/NNS ./.
P07699005A08
Immunocytochemistry/NN demonstrated/VBD that/IN isolated/JJ rabbit/NN osteoclasts/NNS constitutively/RB expressed/VBD gelatinase/NN A/NN and/CC synthesized/VBD gelatinase/NN B/NN ,/, collagenase/NN and/CC stromelysin/NN ,/, as/RB well/RB as/IN the/DT tissue/NN inhibitor/NN of/IN matrix/NN metalloproteinases-1/NN (/( TIMP-1/NN )/) following/VBG IL-1/NN alpha/NN stimulation/NN ./.
P07717983A02
An/DT antiserum/NN was/VBD prepared/VBN against/IN a/DT peptide/NN conjugate/NN corresponding/VBG to/TO the/DT C-terminal/JJ sequence/NN of/IN the/DT matrix/NN metalloproteinase-generated/JJ aggrecan/NN G1/NN fragment/NN (/( Phe335-Val-Asp-Ile-Pro-Glu-Asn341/NN )/) ./.
P07734296A04
BT-20/NN cells/NNS also/RB enhanced/VBD the/DT production/NN of/IN pro-MMP-2/NN and/CC TIMP-1/NN in/IN the/DT dermal/JJ fibroblasts/NNS ,/, but/CC not/RB of/IN pro-MMP-1/NN and/CC pro-MMP-3/NN ./.
P07743917A03
Transcripts/NNS for/IN tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMP-1/NN ,/, -2/CD ,/, -3/CD )/) and/CC uPA/NN receptor/NN were/VBD detected/VBN throughout/IN pre-/JJ and/CC peri-implantation/NN development/NN whilst/IN MMP-9/NN and/CC uPA/NN mRNAs/NNS were/VBD first/RB detected/VBN in/IN peri-implantation/NN blastocysts/NNS associated/VBN with/IN the/DT invasive/JJ phase/NN of/IN implantation/NN ./.
P07772054A09
The/DT removal/NN of/IN the/DT propeptide/NN of/IN the/DT proMMP-2*/NN bound/VBN to/TO TIMP-2/NN was/VBD also/RB observed/VBN by/IN MMP-3/NN (/( stromelysin/NN 1/CD )/) ,/, but/CC not/RB by/IN MMP-1/NN (/( interstitial/JJ collagenase/NN )/) ./.
P07775665A05
DOXY/NN was/VBD added/VBN to/TO the/DT incubation/NN mixture/NN at/IN a/DT final/JJ concentration/NN of/IN 0-1000/CD microM/NN ./.
P07780609A02
Using/VBG immunohistochemistry/NN ,/, 40/CD specimens/NNS of/IN colorectal/JJ cancer/NN were/VBD examined/VBN for/IN the/DT presence/NN of/IN TIMP-1/NN and/CC the/DT MMPs/NNS ,/, stromelysin/NN ,/, gelatinases/NNS A/NN and/CC B/NN and/CC interstitial/JJ collagenase/NN ./.
P07826345A07
Thus/RB RMCP/NN II/CD activates/VBZ proMMP-1/NN via/IN a/DT mechanism/NN different/JJ from/IN that/PRP reported/VBN for/IN the/DT stepwise/JJ processing/NN by/IN combinations/NNS of/IN other/JJ trypsin-like/JJ enzymes/NNS and/CC MMP-3/NN ./.
P07836420A05
Furthermore/RB ,/, plasma/NN membrane/NN fractions/NNS from/IN these/DT cells/NNS significantly/RB enhanced/VBD the/DT rate/NN of/IN cleavage/NN of/IN [/( 14C/NN ]/) gelatin/NN I/CD substrate/NN by/IN both/CC MMP-2/NN tissue/NN inhibitor/NN of/IN metalloproteinases-2/NN (/( TIMP-2/NN )/) complex/NN (/( 2.5-8-fold/NN )/) and/CC TIMP-2-free/JJ MMP-2/NN (/( 5.9-fold/NN )/) ./.
P07840900A04
When/WRB the/DT progelatinase/NN A-TIMP-2/NN complex/NN inhibits/VBZ an/DT active/JJ matrix/NN metalloproteinase/NN ,/, a/DT ternary/JJ complex/NN is/VBZ generated/VBN ./.
P07843905A15
In/FW vivo/FW injection/NN of/IN cPAF/NN also/RB induced/VBD the/DT expression/NN of/IN MMP-9/NN ./.
P07856724A08
Western/NN blot/NN analyses/NNS demonstrated/VBD increased/JJ MMP-9/NN protein/NN in/IN amniochorion/NN extracts/NNS after/IN onset/NN of/IN labor/NN ./.
P07865092A05
Naturally/RB occurring/JJ inhibitors/NNS ,/, TIMPs/NNS (/( Tissue/NN Inhibitors/NNS of/IN MetalloProteinases/NNS )/) ,/, are/VBP important/JJ controlling/JJ factors/NNS in/IN the/DT actions/NNS of/IN MMPs/NNS ,/, and/CC tissue/NN destruction/NN in/IN disease/NN processes/NNS often/RB correlates/VBZ with/IN an/DT imbalance/NN of/IN MMPs/NNS over/IN TIMPs/NNS ./.
P07875677A04
For/IN the/DT reversibility/NN model/NN ,/, rats/NNS were/VBD treated/VBN with/IN CCl4/NN three/CD times/NNS a/DT week/NN for/IN 8/CD weeks/NNS and/CC killed/VBN at/IN 3/CD ,/, 7/CD ,/, 14/CD ,/, 28/CD ,/, or/CC 42/CD days/NNS after/IN discontinuation/NN of/IN treatment/NN ./.
P07890493A07
Gelatinase/NN B/NN is/VBZ the/DT major/JJ MMP/NN expressed/VBN by/IN corneal/JJ epithelial/JJ cells/NNS ,/, whereas/IN stromal/JJ fibroblasts/NNS produce/VBP gelatinase/NN B/NN along/JJ with/IN three/CD other/JJ MMPs/NNS :/: collagenase/NN ,/, stromelysin/NN ,/, and/CC gelatinase/NN A/NN ./.
P07890717A08
That/IN MMP-2/NN ,/, a/DT potent/JJ gelatinase/NN ,/, also/RB can/MD cleave/VBP fibrillar/JJ collagen/NN provides/VBZ an/DT alternative/NN to/TO the/DT proposal/NN that/IN two/CD enzymes/NNS ,/, an/DT interstitial/JJ collagenase/NN and/CC a/DT gelatinase/NN ,/, are/VBP required/VBN for/IN the/DT complete/JJ dissolution/NN of/IN stromal/JJ collagen/NN during/IN cellular/JJ invasion/NN ./.
P07891077A04
Enriched/JJ astrocyte/NN cultures/NNS were/VBD prepared/VBN from/IN brains/NNS of/IN 1-day-old/JJ rat/NN pups/NNS ,/, and/CC experiments/NNS were/VBD performed/VBN 13/CD days/NNS later/RB ./.
P07896811A06
On/IN the/DT other/JJ hand/NN ,/, proMMP-1/NN is/VBZ activated/VBN by/IN MMP-7/NN to/TO an/DT activity/NN similar/JJ to/TO that/PRP obtained/VBN by/IN APMA/NN and/CC the/DT activation/NN by/IN MMP-7/NN is/VBZ enhanced/VBN up/IN to/TO approximately/RB 6.5/CD fold/NN in/IN the/DT presence/NN of/IN APMA/NN ./.
P07923181A06
In/IN the/DT presence/NN of/IN this/DT matrix/NN ,/, M24net/NN cells/NNS assume/VBP a/DT differentiated/JJ morphology/NN and/CC have/VBP a/DT reduced/JJ growth/NN rate/NN ./.
P07927938A01
The/DT 72-kDa/NN (/( MMP-2/NN ,/, gelatinase/NN A/NN )/) and/CC the/DT 92-kDa/NN (/( MMP-9/NN ,/, gelatinase/NN B/NN )/) matrix/NN metalloproteinases/NNS have/VBP been/VBN associated/VBN with/IN tumor/NN cell/NN invasion/NN and/CC metastasis/NN ./.
P07944383A02
Using/VBG this/DT assay/NN we/PRP were/VBD able/JJ to/TO compare/VB the/DT native/JJ MMPs/NNS with/IN the/DT respective/JJ catalytic/JJ domains/NNS in/IN terms/NNS of/IN inhibitor/NN affinities/NNS and/CC peptide/NN hydrolysis/NN ./.
P07945177A02
In/IN particular/NN ,/, the/DT role/NN of/IN the/DT matrix/NN degrading/JJ metalloproteinase/NN (/( MMP/NN )/) family/NN is/VBZ discussed/VBN ./.
P07989608A07
All/DT plaque/NN extracts/NNS contained/VBD activated/JJ forms/NNS of/IN gelatinases/NNS determined/VBN zymographically/RB and/CC by/IN degradation/NN of/IN 3H-collagen/NN type/NN IV/CD ./.
P08006459A08
Concomitantly/RB ,/, catheptic/JJ collagenolytic/JJ activity/NN decreased/VBD in/IN fibrotic/JJ fibroblast/NN extracts/NNS compared/VBN to/TO controls/NNS ./.
P08013077A09
Moreover/RB ,/, since/IN these/DT mediators/NNS augment/VBP the/DT production/NN of/IN MMPs/NNS without/IN appreciably/RB affecting/NN the/DT synthesis/NN of/IN TIMPs/NNS ,/, locally/RB secreted/JJ cytokines/NNS may/MD tip/VBP the/DT regional/JJ balance/NN of/IN MMP/NN activity/NN in/IN favor/NN of/IN vascular/JJ matrix/NN degradation/NN ./.
P08014015A06
Nor/CC was/VBD there/EX any/DT association/NN between/IN amount/NN of/IN TNF/NN mRNA/NN and/CC levels/NNS of/IN MMP/NN enzymes/NNS ./.
P08015284A11
However/WRB ,/, the/DT PA22-2-mediated/JJ increase/NN in/IN type/NN IV/CD collagenolytic/JJ activity/NN of/IN the/DT A-2058/NN melanoma/NN line/NN remains/VBZ to/TO be/VB elucidated/VBN ./.
P08019900A02
The/DT structures/NNS and/CC specificities/NNS of/IN TIMP1/NN and/CC TIMP2/NN are/VBP described/VBN ./.
P08032535A01
We/PRP have/VBP examined/VBN the/DT correlation/NN between/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) expression/NN and/CC metastatic/JJ properties/NNS of/IN a/DT low/JJ metastatic/JJ osteosarcoma/NN cell/NN line/NN ,/, osteosarcoma/NN takase/NN (/( OST/NN )/) ,/, under/IN stimulation/NN by/IN tumour/NN necrosis/NN factor/NN alpha/NN (/( TNF/NN alpha/NN )/) ./.
P08040944A02
METHODS/NNS :/: We/PRP measured/VBD MMP/NN expression/NN (/( gelatin/NN ,/, casein/NN ,/, and/CC elastin/NN zymography/NN )/) by/IN vascular/JJ wall/NN cells/NNS in/IN balloon-injured/JJ carotid/JJ artery/NN during/IN the/DT period/NN of/IN medial/JJ SMC/NN proliferation/NN ,/, migration/NN of/IN SMC/NN from/IN the/DT media/NN to/TO the/DT intima/NN ,/, and/CC subsequent/JJ intimal/JJ SMC/NN proliferation/NN ./.
P08063713A08
Unfortunately/RB ,/, NFF-2/NN showed/VBD little/DT discrimination/NN between/IN MMP-3/NN ,/, MMP-2/NN (/( kcat/NN //SYM Km/NN =/SYM 54,000/CD s-1/NN M-1/NN )/) ,/, and/CC MMP-9/NN (/( kcat/NN //SYM Km/NN =/SYM 55,300/CD s-1/NN M-1/NN )/) ./.
P08083435A12
Periodontal/JJ treatment/NN reduced/VBD the/DT amount/NN of/IN gelatinases/NNS dramatically/RB ./.
P08107689A07
Incubation/NN of/IN the/DT extract/NN with/IN both/CC serine/NN protease/NN and/CC GSSG/NN increased/VBD the/DT rate/NN of/IN activation/NN 30-fold/NN ./.
P08129038A02
We/PRP investigated/VBD levels/NNS and/CC cellular/JJ sites/NNS of/IN gene/NN expression/NN of/IN two/CD major/JJ collagen-degrading/JJ enzymes/NNS ,/, matrix-metalloproteinase/NN (/( MMP/NN )/) -1/CD (/( fibroblast/NN type-interstitial/JJ collagenase/NN )/) and/CC MMP-2/NN (/( 72-kd/NN gelatinase/NN ,/, type/NN IV/CD collagenase/NN )/) in/IN five/CD normal/JJ and/CC 18/CD fibrotic/JJ human/NN livers/NNS as/RB well/RB as/IN in/IN cultured/JJ human/NN hepatic/JJ fat-storing/JJ cells/NNS by/IN Northern/NN blot/NN analysis/NN and/CC in/FW situ/FW hybridization/NN ./.
P08132824A05
Interestingly/RB ,/, in/IN ulcerative/JJ colitis/NN ,/, another/DT inflammatory/JJ bowel/NN disease/NN ,/, stromelysin/NN was/VBD localised/VBN in/IN the/DT lamina/NN propria/NN in/IN regions/NNS of/IN mucosal/JJ loss/NN ./.
P08156782A05
Basal/JJ levels/NNS of/IN gelatinolytic/JJ activity/NN in/IN keratoconus/NN culture/NN media/NN (/( no/DT reduction/NN ,/, alkylation/NN ,/, or/CC APMA/NN treatment/NN )/) ,/, determined/VBN by/IN two/CD different/JJ assay/NN methods/NNS ,/, tended/VBD to/TO be/VB about/RB twice/RB that/PRP of/IN normal/JJ cell/NN cultures/NNS ./.
P08158500A03
MMPs/NNS were/VBD observed/VBN in/IN connective/JJ tissues/NNS at/IN sites/NNS that/WDT histologically/RB showed/VBD signs/NNS of/IN remodelling/NN ./.
P08166290A05
24/CD h/NN after/IN instillation/NN ,/, a/DT BAL/NN was/VBD performed/VBN ,/, the/DT BAL/NN fluid/NN was/VBD separated/VBN from/IN the/DT cells/NNS by/IN centrifugation/NN ,/, and/CC AMACs/NNS and/CC PMNs/NNS were/VBD separately/RB cultured/VBN for/IN 24/CD h/NN ./.
P08175780A05
MMP/NN inhibitors/NNS (/( MMPI/NN )/) were/VBD also/RB present/JJ in/IN these/DT CM/NN and/CC were/VBD separated/VBN by/IN gel/NN filtration/NN ./.
P08179336A04
Additionally/RB ,/, the/DT indomethacin-mediated/JJ suppression/NN of/IN Con/NN A-induced/JJ monocyte/NN interstitial/JJ collagenase/NN and/CC 92-kDa/NN type/NN IV/CD collagenase/NN //SYM gelatinase/NN production/NN could/MD be/VBP reversed/VBN by/IN CT/NN ./.
P08219937A01
Tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) play/VBP an/DT important/JJ role/NN in/IN the/DT regulation/NN of/IN the/DT activity/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) such/JJ as/IN collagenase/NN ,/, stromelysin/NN and/CC gelatinase/NN ./.
P08225873A04
METHODS/NNS ./.
P08280080A11
In/IN human/NN vein/NN endothelial/JJ cells/NNS it/PRP enhanced/VBD the/DT PMA-mediated/JJ induction/NN of/IN MMP-9/NN ,/, whereas/IN it/PRP suppressed/VBD this/DT induction/NN in/IN human/NN microvascular/JJ endothelial/JJ cells/NNS and/CC in/IN synovial/JJ fibroblasts/NNS ./.
P08311464A02
In/IN this/DT paper/NN ,/, we/PRP report/VBP that/IN both/DT peptides/NNS are/VBP efficiently/RB hydrolyzed/VBN not/RB only/RB by/IN SLN/NN but/CC also/RB by/IN two/CD other/JJ matrix/NN metalloproteinases/NNS ,/, collagenase/NN and/CC gelatinase/NN ,/, and/CC by/IN the/DT bacterial/JJ metalloproteinase/NN thermolysin/NN ./.
P08314305A05
Tera/NN 2/CD cells/NNS can/MD be/VBP induced/VBN by/IN retinoic/JJ acid/NN to/TO differentiate/VB into/IN quiescent/JJ cells/NNS ,/, of/IN which/WDT many/PRP express/VBP neuronal/JJ characteristics/NNS ./.
P08369572A07
Stromelysins/NNS 1/CD and/CC 3/CD mRNAs/NNS were/VBD not/RB detected/VBN in/IN any/PRP of/IN the/DT tumors/NNS studied/VBN ./.
P08384126A01
A/DT proform/NN of/IN high/JJ molecular/JJ weight/NN type/NN IV/CD collagenase/NN was/VBD isolated/VBN and/CC purified/VBN 1230-fold/NN from/IN human/NN metastatic/JJ carcinoma/NN tissue/NN ./.
P08411260A02
However/WRB ,/, the/DT abundance/NN of/IN this/DT latent/JJ proenzyme/NN in/IN normal/JJ tissues/NNS and/CC fluids/NNS suggests/VBZ that/IN MMP-2/NN proenzyme/NN utilization/NN is/VBZ limited/VBN by/IN its/PRP$ physiological/JJ activation/NN rather/RB than/IN expression/NN alone/JJ ./.
P08425205A08
We/PRP present/VBP evidence/NN which/WDT suggests/VBZ that/IN this/DT temporal/JJ relationship/NN is/VBZ imposed/VBN by/IN the/DT structural/JJ architecture/NN of/IN the/DT matrix/NN such/JJ that/IN matrix/NN glycoprotein/NN serves/VBZ to/TO protect/VB associated/JJ collagen/NN from/IN MMP-dependent/JJ degradation/NN ./.
P08521614A08
Isolated/JJ THP-1/NN M/NN phi/NN s/NN produced/VBD basal/JJ levels/NNS of/IN both/CC MMP-2/NN and/CC MMP-9/NN ./.
P08521615A03
Using/VBG gelatin/NN zymography/NN ,/, densitometry/NN ,/, and/CC an/DT enzyme-linked/JJ immunosorbent/JJ assay/NN for/IN the/DT quantitative/JJ determination/NN of/IN the/DT MMP-2/NN ,/, we/PRP found/VBD that/IN the/DT enzyme/NN 's/POS activity/NN was/VBD significantly/RB elevated/VBN in/IN malignant/JJ astrocytomas/NNS ,/, especially/RB in/IN glioblastoma/NN multiforme/NN ,/, compared/VBN to/TO low-grade/NN glioma/NN and/CC normal/JJ brain/NN tissues/NNS ./.
P08531210A01
Fibrillar/JJ collagens/NNS ,/, essential/JJ for/IN maintaining/NN the/DT structural/JJ integrity/NN of/IN the/DT myocardium/NN ,/, are/VBP degraded/VBN by/IN matrix/NN metalloproteinase/NN (/( MMP-1/NN )/) ./.
P08542596A16
Altered/JJ MT-MMP/NN expression/NN might/MD contribute/VBP ,/, in/IN part/NN ,/, to/TO gelatinase/NN A/NN activation/NN ,/, which/WDT in/IN turn/NN facilitates/VBZ invasion/NN of/IN these/DT tumors/NNS ./.
P08558853A13
Sandwich/NN enzyme/NN immunoassays/NNS showed/VBD that/IN MMP-9/NN levels/NNS are/VBP significantly/RB higher/JJR in/IN both/CC homogenates/NNS and/CC culture/NN media/NN of/IN the/DT cup/NN and/CC stem/NN interface/NN membranes/NNS than/IN the/DT control/NN pseudocapsule/NN ./.
P08567965A07
The/DT increase/NN of/IN MMP-2/NN induced/VBN by/IN P/NN withdrawal/NN was/VBD associated/VBN with/IN the/DT metalloproteinase-dependent/JJ breakdown/NN of/IN stromal/JJ cultures/NNS ,/, involving/VBG dissolution/NN of/IN extracellular/JJ matrix/NN and/CC dissociation/NN of/IN stromal/JJ cells/NNS ./.
P08576934A08
The/DT results/NNS indicated/VBD that/IN MMP/NN activity/NN was/VBD co-eluted/VBN with/IN TIMP/NN activity/NN ./.
P08579123A09
These/DT results/NNS indicate/VBP the/DT production/NN of/IN MMP-9/NN by/IN multinucleated/JJ giant/JJ cells/NNS and/CC suggest/VBP that/IN the/DT metalloproteinase/NN may/MD contribute/VBP to/TO proteolysis/NN associated/VBN with/IN vascular/JJ invasion/NN and/CC local/JJ bone/NN resorption/NN in/IN human/NN GCT/NN ./.
P08583501A04
Thus/RB ,/, it/PRP was/VBD of/IN interest/NN to/TO determine/VB whether/IN activated/JJ microglia/NNS secrete/VBP MMPs/NNS ./.
P08594211A11
Potential/JJ treatments/NNS possible/JJ in/IN this/DT second/JJ therapeutic/JJ window/NN include/VBP interfering/NN with/IN the/DT genes/NNS that/WDT produce/VBP the/DT MMPs/NNS or/CC inhibiting/NN the/DT action/NN of/IN the/DT gene/NN products/NNS ./.
P08594658A09
In/IN addition/NN ,/, osteoclasts/NNS in/IN rheumatoid/JJ subchondral/JJ bone/NN were/VBD intensively/RB stained/VBN ./.
P08600068A07
Using/VBG gelatin/NN zymography/NN ,/, active/JJ forms/NNS of/IN MMP-2/NN and/CC MMP-9/NN were/VBD more/RB frequently/RB detected/VBN in/IN carcinoma/NN tissue/NN ,/, and/CC the/DT activation/NN rate/NN of/IN the/DT zymogen/NN of/IN MMP-2/NN (/( proMMP-2/NN )/) ,/, but/CC not/RB that/PRP of/IN proMMP-9/NN ,/, correlated/VBD well/RB with/IN degree/NN of/IN local/JJ invasion/NN and/CC lymphatic/JJ permeation/NN ./.
P08608454A06
TIMP/NN levels/NNS were/VBD found/VBN to/TO be/VB increased/VBN in/IN restenotic/JJ lesions/NNS (/( 0.38/CD +/-/SYM 0.04/CD ng/NN //SYM mL/NN )/) compared/VBN with/IN normal/JJ arterial/JJ tissue/NN (/( 0.27/CD +/-/SYM 0.05/CD ng/NN //SYM mL/NN )/) and/CC with/IN tissue/NN derived/VBN from/IN de/FW novo/FW (/( 0.30/CD +/-/SYM 0.02/CD ng/NN //SYM mL/NN atherosclerotic/JJ lesions/NNS ./.
P08608561A14
The/DT average/JJ intensities/NNS of/IN the/DT amplified/JJ gene/NN fragments/NNS from/IN K-neo/NN cells/NNS ,/, KTCL-1/NN cells/NNS ,/, and/CC KTCL-14/NN cells/NNS in/IN Week/NN 4/CD after/IN transplantation/NN were/VBD 100/CD %/SYM ,/, 45/CD %/SYM ,/, and/CC 18/CD %/SYM ,/, respectively/RB ,/, of/IN the/DT parenteral/JJ KKLS/NN cells/NNS ./.
P08611162A03
The/DT binding/NN of/IN each/DT individual/JJ domain/NN to/TO TIMP-2/NN ,/, however/WRB ,/, was/VBD weak/JJ enough/RB that/IN either/DT domain/NN could/MD be/VBP fully/RB replaced/VBN by/IN proMMP-2/NN through/IN the/DT same/JJ binding/JJ sites/NNS as/IN does/VBZ proMMP-2/NN ,/, and/CC also/RB that/IN the/DT high-order/NN structure/NN of/IN proMMP-2/NN allows/VBZ a/DT more/RB stable/JJ binding/NN to/TO TIMP-2/NN ./.
P08611170A05
In/IN this/DT manner/NN ,/, TIMP-2/NN may/MD assume/VBP a/DT bifunctional/JJ role/NN causing/NN :/: (/( i/CD )/) inhibition/NN of/IN gelatinase/NN A/NN in/IN the/DT extracellular/JJ compartment/NN ;/: and/CC (/( ii/CD )/) guiding/NN gelatinase/NN A/NN to/TO activation/NN through/IN a/DT membrane/NN association/NN with/IN MT-MMP/NN ./.
P08625086A12
CONCLUSIONS/NNS ./.
P08625169A04
After/IN local/JJ secretion/NN ,/, MMPs/NNS and/CC their/PRP$ complexes/NNS with/IN TIMPs/NNS leach/VBP into/IN the/DT blood/NN stream/NN where/WRB their/PRP$ concentration/NN can/MD be/VBP measured/VBN ,/, thereby/RB serving/VBG as/IN surrogate/JJ markers/NNS of/IN disease/NN ./.
P08631880A08
However/WRB ,/, the/DT SH/NN group/NN of/IN Cys75/NN of/IN the/DT intermediates/NNS was/VBD not/RB modified/VBN by/IN SH-reagents/NNS ,/, indicating/VBG that/IN the/DT enzymatic/JJ activity/NN generated/VBN by/IN SH-reagents/NNS resulted/VBN from/IN molecular/JJ perturbation/NN of/IN the/DT enzyme/NN rather/RB than/IN their/PRP$ interaction/NN with/IN Cys75/NN ./.
P08641841A15
In/IN fact/NN ,/, active/JJ (/( and/CC latent/JJ )/) MMP-2/NN levels/NNS were/VBD reduced/VBN in/IN recovering/JJ eyes/NNS even/RB below/IN the/DT levels/NNS found/VBN in/IN their/PRP$ contralateral/JJ control/NN eyes/NNS ./.
P08645587A09
Our/PRP$ data/NNS therefore/RB argue/VBP that/IN there/EX are/VBP remarkably/RB similar/JJ patterns/NNS of/IN specific/JJ functions/NNS involved/VBN in/IN ECM/NN remodelling/NN that/WDT correlate/VBP with/IN malignancy/NN in/IN different/JJ human/NN tumours/NNS of/IN different/JJ histogenesis/NN ./.
P08646367A01
Immunolocalization/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN matrix/NN metalloproteinases/NNS (/( TIMPs/NNS )/) in/IN periarticular/JJ tissues/NNS of/IN beta/NN 2-microglobulin/NN amyloidosis/NN patients/NNS was/VBD investigated/VBN ./.
P08649561A06
Patients/NNS (/( n/NN =/SYM 7/CD )/) given/VBN steroids/NNS to/TO treat/VB an/DT acute/JJ episode/NN of/IN MS/NN had/VBD CSF/NN sampled/VBN before/IN and/CC after/IN 3/CD days/NNS of/IN methylprednisolone/NN (/( 1/CD g/NN //SYM day/NN )/) ./.
P08651985A11
The/DT combination/NN of/IN antiinflammatory/JJ and/CC MMP-regulating/JJ properties/NNS of/IN adenosine/NN or/CC adenosine-regulating/JJ agents/NNS suggest/VBP that/IN treatment/NN based/VBN on/IN this/DT approach/NN might/MD be/VBP useful/JJ in/IN rheumatoid/JJ arthritis/NN ./.
P08655631A07
IL-1/NN beta/NN ,/, IL-6/NN and/CC TGF-beta/NN did/VBD not/RB affect/VBP TIMP-2/NN expression/NN but/CC TGF-beta/NN induced/VBD TIMP-1/NN mRNA/NN in/IN human/NN OA/NN chondrocytes/NNS ./.
P08663061A06
Zymography/NN showed/VBD that/IN exposure/NN of/IN HBECs/NNS to/TO LPS/NN induced/VBD 2-/CD and/CC 20-fold/NN increases/NNS in/IN 92-kDa/NN gelatinase/NN production/NN and/CC activation/NN ,/, respectively/RB ,/, as/RB well/RB as/IN a/DT smaller/JJR increase/NN in/IN activated/JJ 68-kDa/NN gelatinase/NN ./.
P08665498A02
delta/NN MT1/NN ,/, but/CC not/RB mutant/JJ delta/NN MT1/NN ,/, was/VBD processed/VBN to/TO an/DT active/JJ form/NN and/CC exhibited/VBD gelatinolytic/JJ activity/NN as/IN seen/VBN using/VBG gelatin/NN zymography/NN ./.
P08666998A04
Although/IN a/DT significant/JJ decrease/NN in/IN MMP-2/NN activity/NN was/VBD noticed/VBN in/IN the/DT ALS/NN motor/NN cortex/NN ,/, statistically/RB significant/JJ increases/NNS in/IN MMP-9/NN (/( 100-kDa/NN )/) activity/NN were/VBD observed/VBN in/IN ALS/NN frontal/JJ and/CC occipital/JJ cortices/NNS (/( BA10/NN and/CC 17/CD )/) and/CC all/DT three/CD spinal/JJ cord/NN regions/NNS when/WRB compared/VBN with/IN control/NN specimens/NNS ./.
P08674412A09
We/PRP conclude/VBP that/IN administration/NN of/IN MMP/NN inhibitors/NNS retards/VBZ decidual/JJ remodeling/NN and/CC growth/NN ,/, and/CC we/PRP suggest/VBP that/IN the/DT MMPs/NNS expressed/VBN in/IN precursor/NN stromal/JJ cells/NNS promote/VBP their/PRP$ differentiation/NN and/CC expansion/NN ./.
P08675803A08
Dexamethasone/RB markedly/RB decreased/VBD the/DT amount/NN of/IN MMP-2/NN mRNA/NN in/IN the/DT GFs/NNS ./.
P08690299A04
MMP/NN species/NNS identical/JJ to/TO those/PRP secreted/VBN from/IN several/JJ well-characterized/JJ ovarian/JJ adenocarcinoma/NN cell/NN lines/NNS were/VBD found/VBN in/IN the/DT majority/NN of/IN ascites/NNS :/: MMP-2-like/JJ gelatinase/NN (/( 23/CD of/IN 23/CD cases/NNS )/) and/CC MMP-9-like/JJ gelatinase/NN (/( 18/CD of/IN 23/CD cases/NNS )/) ,/, suggesting/VBG a/DT prevalence/NN of/IN these/DT species/NNS in/IN the/DT ovarian/JJ carcinoma/NN microenvironment/NN and/CC their/PRP$ availability/NN for/IN tumor-associated/JJ proteolysis/NN ./.
P08691532A09
From/IN these/DT data/NNS ,/, we/PRP suggest/VBP SMCs/NNS may/MD be/VBP involved/VBN in/IN the/DT abnormal/JJ degradation/NN of/IN the/DT aortic/JJ wall/NN in/IN AAA/NN through/IN the/DT excessive/JJ metalloproteinase/NN activity/NN produced/VBN by/IN SMCs/NNS ./.
P08698836A04
RT-PCR/NN permitted/VBD us/PRP to/TO confirm/VB the/DT observation/NN that/IN MMP-9/NN is/VBZ activated/VBN following/VBG transformation/NN and/CC also/RB to/TO observe/VB the/DT previously/RB unreported/JJ activation/NN of/IN MMP-7/NN in/IN SV40-transformed/JJ cells/NNS ./.
P08706790A01
The/DT balance/NN between/IN the/DT activities/NNS of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC the/DT tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) is/VBZ an/DT important/JJ control/NN point/NN in/IN tissue/NN remodeling/NN ./.
P08706864A02
Until/IN now/RB ,/, no/DT convenient/JJ and/CC sensitive/JJ MMP-activity/NN assay/NN in/IN crude/JJ media/NN like/IN synovial/JJ fluid/NN has/VBZ been/VBN available/JJ ./.
P08717434A09
Thus/RB ,/, in/IN dilated/JJ failing/JJ human/NN hearts/NNS secondary/JJ to/TO previous/JJ MI/NN or/CC DCM/NN ,/, MMP/NN activity/NN is/VBZ increased/VBN ./.
P08719871A07
The/DT migration/NN of/IN TRAP+/NN cells/NNS is/VBZ completely/RB prevented/VBN by/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) inhibitors/NNS ,/, but/CC not/RB by/IN a/DT cysteine/NN proteinase/NN inhibitor/NN ,/, an/DT inhibitor/NN of/IN carbonic/JJ anhydrase/NN ,/, or/CC a/DT bisphosphonate/NN ./.
P08726363A15
In/IN transformed/JJ cells/NNS reducing/JJ agents/NNS inhibit/VBP MMP/NN expression/NN and/CC increase/VBP TIMP/NN levels/NNS ,/, which/WDT suggests/VBZ a/DT role/NN of/IN antioxidants/NNS in/IN preventing/NN tumorigenesis/NN ./.
P08738566A03
Based/VBN on/IN this/DT background/NN ,/, we/PRP raised/VBD monoclonal/JJ antibodies/NNS against/IN human/NN gelatinase/NN (/( MMP-9/NN )/) and/CC human/NN recombinant/JJ TIMP/NN (/( TIMP-1/NN )/) ,/, and/CC immunostained/VBD these/DT two/CD components/NNS in/IN skin/NN from/IN patients/NNS with/IN squamous/JJ cell/NN carcinoma/NN (/( SCC/NN )/) ,/, Bowen/NN 's/POS disease/NN (/( BD/NN )/) and/CC keratoacanthoma/NN (/( KA/NN )/) ./.
P08743942A08
The/DT activation/NN rate/NN of/IN proMMP-2/NN was/VBD proportional/JJ to/TO the/DT expression/NN of/IN MMP-2/NN and/CC MT-MMP/NN ./.
P08744792A08
Preliminary/JJ findings/NNS show/VBP TIMP-1/NN mediated/VBD changes/NNS in/IN morphology/NN and/CC downregulation/NN of/IN MMP/NN activity/NN ./.
P08751977A06
Similar/JJ results/NNS were/VBD obtained/VBN by/IN immunoprecipitation/NN ./.
P08753775A05
Moreover/RB ,/, tissue/NN inhibitor/NN of/IN metalloproteinases-1/NN had/VBD at/IN most/RBS a/DT partial/JJ effect/NN on/IN the/DT in/FW vivo/FW release/NN of/IN the/DT cytokine/NN in/IN mice/NNS ./.
P08760357A01
Endothelial-cell-stimulating/JJ angiogenesis/NN factor/NN (/( ESAF/NN )/) has/VBZ been/VBN shown/VBN to/TO activate/VB procollagenase/NN and/CC reactivate/VBP complexes/NNS of/IN collagenase/NN and/CC gelatinase/NN A/NN with/IN tissue/NN inhibitor/NN of/IN metallo-proteinase/NN (/( TIMP/NN )/) -1/CD ./.
P08761942A13
This/PRP suggests/VBZ that/IN ,/, in/IN addition/NN to/TO the/DT well-known/JJ activators/NNS and/CC inhibitors/NNS of/IN MMP/NN activity/NN in/IN the/DT matrix/NN ,/, differential/JJ membrane/NN distribution/NN may/MD enable/VBP more/RB precise/JJ control/NN over/IN the/DT site/NN ,/, rate/NN ,/, and/CC extent/NN of/IN matrix/NN degradation/NN by/IN the/DT cell/NN ./.
P08771322A03
Cells/NNS of/IN the/DT disc/NN synthesised/VBD all/DT three/CD classes/NNS of/IN MMPs/NNS as/RB well/RB as/IN TIMP-1/NN in/IN all/DT regions/NNS of/IN the/DT disc/NN at/IN all/DT stages/NNS examined/VBN ./.
P08779137A02
It/PRP was/VBD hypothesised/VBN that/IN tuberculous/JJ lung/NN destruction/NN is/VBZ mediated/VBN ,/, at/IN least/JJS in/IN part/NN ,/, by/IN the/DT participation/NN of/IN matrix/NN metalloproteinases/NNS released/VBN by/IN mononuclear/JJ phagocytes/NNS ./.
P08780160A03
A/DT synthetic/JJ ,/, biotinylated/JJ inhibitor/NN specific/JJ for/IN activated/JJ MMP-2/NN in/IN solution/NN phase/NN ,/, and/CC immunohistochemistry/NN were/VBD used/VBN to/TO detect/VB MMP-2/NN and/CC TIMP-2/NN expression/NN in/IN cell/NN lines/NNS and/CC ovarian/JJ tumors/NNS and/CC to/TO analyze/VB the/DT surface-binding/JJ capacity/NN of/IN the/DT inhibitors/NNS ,/, which/WDT are/VBP potential/JJ therapeutic/JJ agents/NNS ./.
P08780171A05
The/DT physiologic/JJ mechanism/NN of/IN this/DT activation/NN is/VBZ not/RB well/RB understood/VBN ./.
P08783637A04
A/DT tissue-specific/JJ inhibitor/NN of/IN matrix/NN metalloproteinases/NNS (/( TIMP-1/NN )/) and/CC a/DT plasma/NN proteinase/NN inhibitor/NN ,/, alpha2-macroglobulin/NN (/( alpha2M/NN )/) ,/, were/VBD used/VBN to/TO block/VB the/DT activity/NN of/IN MMPs/NNS ./.
P08806767A05
Our/PRP$ data/NNS demonstrate/VBP that/IN fluorescence/NN quenching/NN of/IN the/DT proMMP-2/NN //SYM TIMP-2/NN complex/NN by/IN either/CC acrylamide/NN or/CC iodide/NN is/VBZ significantly/RB increased/VBN following/VBG mercurial/JJ activation/NN ./.
P08808829A06
Tissues/NNS were/VBD obtained/VBN at/IN operation/NN after/IN informed/JJ consent/NN was/VBD got/VBN from/IN each/DT patient/NN ./.
P08808829A21
The/DT major/JJ gelatinases/NNS were/VBD those/PRP with/IN molecular/JJ weight/NN of/IN 92/CD and/CC 72kD/NN ,/, which/WDT corresponded/VBD to/TO MMP-9/NN and/CC MMP-2/NN ,/, respectively/RB ./.
P08814070A05
Immunolocalization/NN of/IN MMP-9/NN in/IN RA/NN ,/, OA/NN ,/, and/CC normal/JJ synovium/NN was/VBD investigated/VBN using/VBG MMP-9-specific/JJ antisera/NNS ./.
P08817668A08
Together/RB ,/, these/DT studies/NNS suggest/VBP that/IN MMPs/NNS ,/, beyond/IN their/PRP$ previously/RB described/JJ roles/NNS as/IN extracellular/JJ matrix/NN degrading/JJ enzymes/NNS ,/, may/MD also/RB exert/VBP effects/NNS on/IN cellular/JJ growth/NN and/CC differentiation/NN via/IN degradation/NN of/IN IGFBPs/NNS ./.
P08831505A04
To/TO test/VB this/DT hypothesis/NN ,/, we/PRP developed/VBD clones/NNS of/IN rat/NN SMCs/NNS that/WDT overexpress/VBP baboon/NN tissue/NN inhibitor/NN of/IN matrix/NN metalloproteinase-I/NN (/( TIMP-1/NN )/) ,/, using/VBG retrovirally/RB mediated/JJ gene/NN transfer/NN ,/, and/CC characterized/VBD the/DT functional/JJ capacity/NN of/IN these/DT cells/NNS in/FW vitro/FW and/CC in/FW vivo/FW ./.
P08841929A11
2D-zymographic/JJ analysis/NN suggested/VBD that/IN the/DT lytic/JJ band/NN at/IN 66/CD kDa/NN was/VBD a/DT mixture/NN of/IN two/CD neutral/JJ proteinases/NNS with/IN different/JJ isoelectric/JJ point/NN ./.
P08851335A02
Cancer/NN cells/NNS are/VBP known/VBN to/TO produce/VB various/JJ ECM-degrading/JJ enzymes/NNS including/VBG matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, serine/NN proteinases/NNS and/CC cathepsins/NNS ./.
P08856511A10
The/DT same/JJ stromal/JJ cells/NNS could/MD synthesize/VBP MMP-1/NN ,/, MMP-2/NN (/( gelatinase/NN A/NN )/) and/CC MMP-3/NN (/( stromelysin-1/NN )/) ,/, as/RB well/RB as/IN laminin/NN ,/, and/CC did/VBD not/RB correspond/VBP to/TO macrophages/NNS ./.
P08863676A01
Delayed/JJ re-epithelialization/NN of/IN the/DT cornea/NN after/IN injury/NN usually/RB precedes/VBZ stromal/JJ ulceration/NN ./.
P08867813A13
It/PRP may/MD also/RB provide/VBP potential/JJ intervention/NN sites/NNS for/IN the/DT therapeutic/JJ use/NN of/IN inhibitors/NNS of/IN aberrant/JJ MMP/NN activities/NNS which/WDT characterize/VBP chronic/JJ wounds/NNS ./.
P08872958A06
The/DT conditioned/JJ medium/NN from/IN the/DT cystic/JJ tubules/NNS contained/VBD higher/JJR than/IN normal/JJ levels/NNS of/IN MMP-9/NN ,/, MMP-2/NN ,/, and/CC MMP-3/NN as/RB well/RB as/IN TIMP-1/NN and/CC TIMP-2/NN ./.
P08875960A10
The/DT presence/NN of/IN excessive/JJ levels/NNS of/IN activated/JJ forms/NNS of/IN matrix-degrading/JJ enzymes/NNS at/IN the/DT wound/NN surface/NN of/IN pressure/NN ulcers/NNS may/MD impede/VBP the/DT healing/NN of/IN these/DT wounds/NNS and/CC may/MD be/VBP relevant/JJ to/TO the/DT development/NN of/IN new/JJ rationales/NNS for/IN treatment/NN ./.
P08882290A05
Matrix/NN metalloproteinase-9/NN was/VBD the/DT predominant/JJ gelatinase/NN in/IN freshly/RB prepared/JJ granulosa/NN cells/NNS and/CC in/IN culture/NN media/NN ,/, and/CC also/RB represented/VBD a/DT major/JJ metalloproteinase/NN component/NN in/IN homogenates/NNS of/IN early/JJ and/CC mid-luteal/JJ phase/NN samples/NNS of/IN corpora/NNS lutea/NN ./.
P08884145A02
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC their/PRP$ inhibitors/NNS like/IN tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) have/VBP been/VBN thought/VBN to/TO play/VB major/JJ roles/NNS in/IN the/DT tissue/NN metabolism/NN ./.
P08895151A03
TIMP-1/NN mRNA/NN expression/NN was/VBD analyzed/VBN by/IN Northern/NN blotting/NN using/VBG a/DT 0.6/CD kb/NN cDNA/NN probe/NN for/IN human/NN TIMP-1/NN ./.
P08911730A10
In/IN RA/NN ,/, the/DT levels/NNS of/IN MMP/NN and/CC TIMP/NN mRNA/NN were/VBD high/JJ ./.
P08912869A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) have/VBP been/VBN implicated/VBN in/IN tumor/NN progression/NN ,/, but/CC the/DT exact/JJ roles/NNS that/WDT each/DT member/NN of/IN this/DT family/NN may/MD play/VBP in/IN contributing/NN to/TO the/DT behavior/NN of/IN malignant/JJ tumors/NNS are/VBP only/RB beginning/VBG to/TO be/VB understood/VBN ./.
P08913840A07
Previous/JJ studies/NNS in/IN patients/NNS with/IN malignant/JJ ascites/NN have/VBP shown/VBN no/DT major/JJ toxicities/NNS at/IN doses/NNS as/RB high/JJ as/IN 1350/CD mg/NN //SYM m2/NN ./.
P08918435A05
From/IN tubular/JJ adenomas/NNS to/TO villous/JJ adenomas/NNS ,/, immunolocalization/NN of/IN gelatinases/NNS and/CC TIMPs/NNS showed/VBD increasing/VBG gradually/RB ,/, and/CC in/FW situ/FW carcinomas/NNS showed/VBD a/DT definite/JJ positive/JJ ,/, immunolocalization/NN of/IN gelatinases/NNS and/CC TIMPs/NNS ./.
P08920930A06
Thus/RB ,/, in/IN common/JJ with/IN several/JJ other/JJ MMPs/NNS ,/, macrophage/NN metalloelastase/NN has/VBZ a/DT broad/JJ substrate/NN range/NN which/WDT extends/VBZ beyond/IN that/PRP of/IN elastin/NN alone/JJ ./.
P08921246A13
The/DT induction/NN of/IN gelatinase/NN activity/NN in/IN rabbit/NN AH/NN preceded/VBD the/DT increase/NN in/IN cell/NN number/NN during/IN the/DT inflammatory/JJ process/NN in/IN the/DT anterior/JJ chamber/NN ./.
P08939968A03
In/IN this/DT report/NN ,/, we/PRP investigated/VBD whether/IN the/DT cleavage/NN of/IN the/DT RRKR/NN motif/NN of/IN MT-MMP1/NN by/IN Golgi-associated/JJ furin/NN is/VBZ analogous/JJ to/TO a/DT similar/JJ enzyme/NN activation/NN mechanism/NN observed/VBN with/IN stromelysin-3/NN ./.
P08941646A08
aggrecanase/NN site/NN ./.
P08953151A03
The/DT preoperative/JJ serial/JJ radiographic/JJ examinations/NNS revealed/VBD an/DT apparent/JJ clear/JJ zone/NN around/IN all/DT implants/NNS ./.
P08955363A05
Our/PRP$ kinetic/JJ data/NNS demonstrate/VBP that/IN TIMP-2/NN is/VBZ a/DT potent/JJ inhibitor/NN for/IN the/DT recombinant/JJ enzyme/NN ./.
P08956284A04
Using/VBG in/FW situ/FW hybridization/NN ,/, transcripts/NNS for/IN MMP-9/NN were/VBD detected/VBN in/IN trophoblast/NN cells/NNS of/IN the/DT embryo/NN from/IN the/DT earliest/JJS stage/NN of/IN decidual/JJ formation/NN (/( day/NN 6.0/CD )/) examined/VBN ./.
P08957940A11
From/IN many/DT recent/JJ studies/NNS it/PRP seems/VBZ that/IN tissue/NN destruction/NN ,/, both/CC physiological/JJ and/CC pathological/JJ ,/, is/VBZ correlated/VBN with/IN an/DT imbalance/NN of/IN inhibitors/NNS over/IN proteinases/NNS ./.
P08960389A06
To/TO further/RB identify/VB the/DT type/NN of/IN MMP/NN ,/, tissue/NN homogenates/NNS were/VBD prepared/VBN from/IN collateral/JJ and/CC LAD/NN vessels/NNS and/CC analyzed/VBN by/IN SDS-PAGE/NN zymography/NN ./.
P08970581A02
We/PRP measured/VBD the/DT activity/NN of/IN MMP-2/NN from/IN 28/CD normal/JJ ,/, 12/CD benign/JJ and/CC 126/CD breast/NN cancer/NN tissues/NNS using/VBG gelatin/NN zymography/NN ./.
P08978831A07
These/DT results/NNS provide/VBP direct/JJ evidence/NN for/IN cleavage/NN of/IN an/DT extracellular/JJ matrix/NN molecule/NN by/IN an/DT MMP/NN in/FW vivo/FW ./.
P08988738A06
Increased/JJ expression/NN of/IN the/DT MT1-MMP/NN mRNA/NN transcript/NN was/VBD also/RB detected/VBN in/IN eight/CD of/IN eight/CD of/IN these/DT tissues/NNS ./.
P08994438A12
CONCLUSIONS/NNS :/: MMP/NN expression/NN is/VBZ markedly/RB increased/VBN in/IN AOD/NN and/CC AAA/NN samples/NNS ,/, and/CC an/DT imbalance/NN between/IN MMPs/NNS and/CC their/PRP$ inhibitors/NNS results/VBZ in/IN similar/JJ proteolytic/JJ activity/NN ./.
P08997658A08
Elevated/JJ levels/NNS of/IN MMP-8/NN were/VBD further/RB detected/VBN in/IN saliva/NN of/IN AP/NN compared/VBN to/TO LJP/NN and/CC the/DT controls/NNS ./.
P09003362A02
The/DT results/NNS indicate/VBP that/IN hyperglycaemic/JJ conditions/NNS modulate/VBP the/DT potential/JJ proteolytic/JJ activity/NN of/IN the/DT enzymes/NNS secreted/VBN by/IN confluent/JJ cultures/NNS of/IN these/DT cells/NNS ./.
P09008612A06
RESULTS/NNS :/: In/IN cultures/NNS of/IN nasal/JJ cartilage/NN with/IN IL-1/NN alpha/NN ,/, almost/RB all/PDT the/DT proteoglycan/NN was/VBD released/VBN within/IN the/DT first/JJ week/NN ,/, whereas/IN there/EX was/VBD no/DT detectable/JJ release/NN of/IN type/NN II/CD collagen/NN for/IN the/DT first/JJ 2/CD weeks/NNS of/IN culture/NN ./.
P09009103A08
Fluorometric/JJ methods/NNS represent/VBP a/DT good/JJ alternative/NN for/IN MMP/NN activity/NN measurement/NN ,/, especially/RB when/WRB a/DT large/JJ number/NN of/IN samples/NNS must/MD be/VBP processed/VBN ./.
P09021326A09
However/WRB ,/, the/DT possibility/NN remains/VBZ that/IN MMP-8/NN plays/VBZ an/DT important/JJ role/NN in/IN periodontal/JJ tissue/NN destruction/NN ,/, since/IN the/DT mRNA/NN abundance/NN and/CC not/RB the/DT enzyme/NN activity/NN was/VBD assessed/VBN ./.
P09033278A08
By/IN contrast/NN ,/, these/DT cytokines/NNS induced/VBD a/DT sevenfold/NN increase/NN in/IN the/DT steady-state/NN levels/NNS of/IN stromelysin/NN mRNA/NN ./.
P09038230A06
In/IN contrast/NN ,/, Serratia/NN 56-kDa/NN proteinase/NN and/CC Pseudomonas/NN alkaline/JJ proteinase/NN ,/, both/PRP of/IN which/WDT are/VBP classified/VBN as/IN members/NNS of/IN the/DT serralysin/NN subfamily/NN of/IN zinc/NN metalloproteinases/NNS (/( family/NN M10/NN )/) ,/, and/CC Serratia/NN 73-kDa/NN thiol/NN proteinase/NN did/VBD not/RB evidence/VBP proteolytic/JJ processing/NN or/CC activation/NN of/IN proMMP-1/NN ,/, -8/CD ,/, and/CC -9/CD under/IN these/DT experimental/JJ conditions/NNS ./.
P09040053A03
Cholesterol/NN is/VBZ required/VBN for/IN receptor/NN signaling/NN in/IN the/DT plasma/NN membrane/NN ,/, but/CC a/DT role/NN of/IN MMPs/NNS for/IN cholesterol/NN in/IN ECM/NN remodeling/NN has/VBZ not/RB yet/RB been/VBN shown/VBN ./.
P09043823A07
Inclusion/NN of/IN gelatin/NN affinity/NN chromatography/NN did/VBD not/RB totally/RB remove/VBP the/DT gelatinases/NNS ./.
P09049977A06
High/JJ level/NN expression/NN is/VBZ driven/VBN by/IN the/DT cytomegalovirus/NN major/JJ immediate/JJ early/JJ promoter/NN (/( CMV/NN IEP/NN )/) ./.
P09057654A01
We/PRP have/VBP studied/VBN the/DT expression/NN of/IN gelatinase/NN A/NN ,/, gelatinase/NN B/NN ,/, interstitial/JJ collagenase/NN ,/, tissue/NN inhibitor/NN of/IN metalloproteinase/NN (/( TIMP/NN )/) -1/CD and/CC TIMP-2/NN in/IN reactive/JJ lymphoid/JJ cells/NNS ,/, as/RB well/RB as/IN in/IN a/DT series/NN of/IN cell/NN lines/NNS derived/VBN from/IN neoplasms/NNS of/IN B-/NN and/CC T-cell/NN lineage/NN ./.
P09070604A09
These/DT findings/NNS suggest/VBP the/DT overexpression/NN of/IN MMP-9/NN by/IN eosinophils/NNS in/IN bronchial/JJ tissues/NNS of/IN asthmatic/JJ individuals/NNS ,/, and/CC the/DT participation/NN of/IN MMPs/NNS in/IN the/DT pathologic/JJ changes/NNS in/IN asthmatic/JJ airways/NNS ./.
P09074710A02
Surgical/JJ preparative/JJ injury/NN is/VBZ an/DT important/JJ determinant/NN of/IN neointimal/JJ thickening/NN in/IN human/NN saphenous/JJ vein/NN bypass/NN grafts/NNS ./.
P09075665A08
The/DT ratios/NNS of/IN serum/NN MMP-2/NN to/TO TIMP-1/NN levels/NNS were/VBD significantly/RB higher/JJR in/IN transient/JJ responders/NNS and/CC non-responders/NNS than/IN in/IN sustained/JJ responders/NNS (/( p/NN </SYM 0.001/CD ,/, respectively/RB )/) even/RB when/WRB HCV/NN RNA/NN levels/NNS were/VBD low/JJ in/IN patients/NNS with/IN HCV/NN genome/NN subtype/NN 1b/NN or/CC when/WRB the/DT HCV/NN genome/NN subtype/NN was/VBD 2a/NN or/CC 2b/NN ./.
P09083057A09
A/DT similar/JJ activation/NN may/MD also/RB occur/VBP in/FW situ/FW as/IN indicated/VBN previously/RB for/IN tissue-derived/JJ BM-40/NN ./.
P09084432A03
Using/VBG quantitative/JJ zymography/NN ,/, three/CD major/JJ neutral/JJ proteinases/NNS with/IN molecular/JJ masses/NNS of/IN 60/CD ,/, 95/CD ,/, and/CC 280/CD kDa/NN were/VBD readily/RB detected/VBN ./.
P09084672A07
Gelatinolytic/JJ activity/NN ,/, at/IN low/JJ levels/NNS ,/, was/VBD also/RB found/VBN in/IN MVs/NNS ,/, but/CC not/RB PMs/NNS or/CC conditioned/JJ media/NN ./.
P09086544A02
The/DT current/JJ study/NN analyzed/VBD the/DT expression/NN of/IN MMP-2/NN and/CC MMP-9/NN in/IN pancreatic/JJ cancer/NN tissues/NNS ./.
P09092941A01
The/DT osteoclasts/NNS are/VBP the/DT cells/NNS responsible/JJ for/IN bone/NN resorption/NN ./.
P09096655A02
These/DT polypeptides/NNS regulate/VBP proliferation/NN in/IN breast/NN cancer/NN cells/NNS through/IN interaction/NN with/IN membrane/NN receptors/NNS ./.
P09102166A12
Our/PRP$ results/NNS suggest/VBP that/IN at/IN sites/NNS of/IN vascular/JJ injury/NN ,/, thrombin/NN may/MD activate/VBP locally/RB produced/JJ MMP-2/NN and/CC thereby/RB facilitate/VBP cell/NN migration/NN and/CC proliferation/NN ./.
P09108368A06
Culture/NN of/IN day/NN 10/CD mandibular/JJ explants/NNS with/IN a/DT hydroxamic/JJ acid/NN metalloproteinase/NN inhibitor/NN ,/, but/CC not/RB with/IN inhibitors/NNS of/IN metalloendopeptidases/NNS (/( thiorphan/NN and/CC phosphoramidon/NN )/) ,/, serine/NN proteinases/NNS (/( aprotinin/NN )/) ,/, cysteine/NN proteinases/NNS (/( leupeptin/NN )/) and/CC urokinase/NN (/( amiloride/NN )/) ,/, altered/VBD mandibular/JJ morphogenesis/NN dramatically/RB ./.
P09113512A10
Inhibitor/NN studies/NNS and/CC gelatin/NN zymograms/NNS indicated/VBD that/IN the/DT membrane-associated/JJ MT-MMP/NN expressed/VBN on/IN the/DT HT/NN 1080/CD cells/NNS played/VBD an/DT important/JJ role/NN in/IN cleavage/NN activation/NN of/IN the/DT vector/NN ./.
P09119036A01
Membrane-type-1/NN matrix/NN metalloproteinase/NN has/VBZ been/VBN identified/VBN as/IN an/DT activator/NN of/IN the/DT matrix/NN metalloproteinase/NN progelatinase/NN A/NN at/IN cell/NN surfaces/NNS ./.
P09119983A10
Of/IN the/DT other/JJ six/CD MMPs/NNS detected/VBN ,/, 92/CD kDa/NN gelatinase/NN showed/VBD a/DT modest/JJ 5/CD fold/NN increase/NN which/WDT peaked/VBN at/IN the/DT onset/NN of/IN clinical/JJ signs/NNS and/CC then/RB declined/VBN during/IN the/DT most/RBS severe/JJ phase/NN of/IN the/DT disease/NN ./.
P09131273A03
ProMMP-9/NN was/VBD expressed/VBN in/IN 17.5/CD %/SYM of/IN the/DT cancer/NN patients/NNS compared/VBN to/TO 2.5/CD %/SYM in/IN 40/CD non-cancerous/JJ tissues/NNS (/( p/NN =/SYM 0.014/CD )/) ./.
P09141525A08
Expression/NN of/IN the/DT messenger/NN RNA/NN for/IN TIMP-1/NN or/CC TIMP-2/NN also/RB was/VBD not/RB changed/VBN by/IN P/NN withdrawal/NN ./.
P09158005A10
Activation/NN of/IN proMMP-2/NN was/VBD significantly/RB higher/JJR in/IN the/DT carcinoma/NN samples/NNS with/IN lymph/NN node/NN or/CC distant/JJ metastasis/NN compared/VBN to/TO carcinoma/NN without/IN metastasis/NN ,/, normal/JJ control/NN ,/, or/CC fibrocystic/JJ disease/NN (/( P/NN </SYM 0.05/CD )/) ./.
P09158711A11
The/DT aggressive/JJ clinical/JJ behavior/NN of/IN small/JJ cell/NN carcinoma/NN may/MD be/VBP attributable/JJ ,/, at/IN least/JJS in/IN part/NN ,/, to/TO a/DT loss/NN of/IN the/DT inhibitory/JJ effect/NN of/IN TIMP-2/NN ,/, as/IN a/DT significant/JJ proportion/NN of/IN these/DT tumors/NNS showed/VBD negative/JJ or/CC low/JJ levels/NNS of/IN TIMP-2/NN expression/NN ./.
P09168808A08
Both/CC mRNA/NN and/CC immunodetectable/JJ protein/NN of/IN MT-MMP1/NN are/VBP increased/VBN with/IN monensin/NN treatment/NN while/IN message/NN for/IN the/DT protein/NN inhibitor/NN of/IN gelatinase/NN A/NN ,/, TIMP-2/NN ,/, is/VBZ unchanged/VBN ./.
P09169591A06
With/IN the/DT aid/NN of/IN protein/NN engineering/NN ,/, a/DT modified/JJ pro-urokinase/NN has/VBZ been/VBN prepared/VBN in/IN which/WDT the/DT activation/NN sequence/NN normally/RB recognized/VBN by/IN plasmin/NN (/( Pro-Arg-Phe-Lys/NN upward/JJ arrowIle-Ile-Gly-Gly/NN )/) has/VBZ been/VBN replaced/VBN by/IN a/DT sequence/NN expected/VBN to/TO be/VB recognized/VBN and/CC hydrolysed/VBN by/IN many/DT MMPs/NNS (/( Arg-Pro-Leu-Gly/NN upward/JJ arrowIle-Ile-Gly-Gly/NN )/) ./.
P09170840A01
The/DT matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC the/DT tissue/NN inhibitor/NN of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) regulate/VBP the/DT extracellular/JJ matrix/NN and/CC are/VBP important/JJ in/IN the/DT process/NN of/IN connective/JJ tissue/NN remodeling/NN ./.
P09171509A03
Matrix/NN metalloproteinases/NNS seem/VBP to/TO play/VB a/DT key/JJ role/NN in/IN physiological/JJ periodontal/JJ remodelling/NN and/CC pathological/JJ tissue/NN destruction/NN ./.
P09175201A05
To/TO examine/VB whether/IN changes/NNS in/IN the/DT ulcer/NN formation/NN and/CC healing/JJ phase/NN correlate/VBP with/IN MMP/NN activity/NN ,/, Triton/NN X-100/NN //SYM CaCl2/NN and/CC Tris/NN //SYM CaCl2/NN (/( 60/CD degrees/NNS C/NN )/) extracts/NNS of/IN stomachs/NNS were/VBD prepared/VBN from/IN controls/NNS and/CC animals/NNS killed/VBN 24/CD h/NN (/( formation/NN phase/NN )/) and/CC 7/CD days/NNS (/( healing/JJ phase/NN )/) after/IN acetic/JJ acid/NN administration/NN ./.
P09177919A01
OBJECTIVE/NN :/: To/TO clarify/VB whether/IN gelatinases/NNS in/IN the/DT synovial/JJ fluid/NN are/VBP related/VBN to/TO rheumatoid/JJ arthritis/NN (/( RA/NN )/) ./.
P09180929A04
MXT/NN clones/NNS and/CC variants/NNS were/VBD selected/VBN by/IN either/CC in/FW vitro/FW or/CC in/FW vivo/FW procedures/NNS ,/, and/CC they/PRP differ/VBP in/IN metastatic/JJ ability/NN and/CC 17/CD beta-estradiol/NN dependency/NN for/IN tumor/NN growth/NN ./.
P09182725A01
The/DT active/JJ forms/NNS of/IN all/PRP of/IN the/DT matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP inhibited/VBN by/IN a/DT family/NN of/IN specific/JJ inhibitors/NNS ,/, the/DT tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) ./.
P09186550A07
In/IN addition/NN ,/, interaction/NN of/IN MMP-2/NN with/IN the/DT ovarian/JJ carcinoma/NN cell/NN surface/NN resulted/VBD in/IN a/DT 2.5-/CD to/TO 5-fold/NN increase/NN in/IN invasiveness/NN ./.
P09188064A06
Lastly/RB ,/, this/DT report/NN examines/VBZ structure-function/NN relationships/NNS of/IN TIMPs/NNS ./.
P09195290A12
Batimastat/NN (/( BB-94/NN )/) and/CC marimastat/NN (/( BB-2516/NN )/) are/VBP synthetic/JJ ,/, low-molecular/JJ weight/NN MMP/NN inhibitors/NNS ./.
P09198203A03
Thus/RB ,/, this/DT progelatinase/NN A/NN activator/NN was/VBD named/VBN membrane-type/NN matrix/NN metalloproteinase/NN (/( MT1-MMP/NN )/) ./.
P09202045A01
Membrane/NN vesicles/NNS are/VBP shed/VBN by/IN tumor/NN cells/NNS both/CC in/FW vivo/FW and/CC in/FW vitro/FW ./.
P09212749A10
Plasma/NN membranes/NNS prepared/VBN from/IN cultured/JJ chondrocytes/NNS with/IN MT1-MMP/NN expression/NN and/CC those/PRP directly/RB isolated/VBN from/IN OA/NN cartilage/NN could/MD activate/VBP pro-MMP-2/NN ./.
P09219724A06
However/WRB ,/, no/DT significant/JJ changes/NNS of/IN MMP-2/NN levels/NNS were/VBD noted/VBN in/IN BCNU-treated/JJ cells/NNS ./.
P09219732A07
The/DT enzyme/NN activity/NN from/IN MDA/NN cells/NNS was/VBD not/RB influenced/VBN by/IN treatment/NN with/IN any/PRP of/IN the/DT antiestrogens/NNS ,/, whereas/IN ,/, in/IN MCF/NN cells/NNS ,/, ICI/NN produced/VBD the/DT greatest/JJS enzyme/NN inhibition/NN (/( 47.93/CD %/SYM )/) ,/, followed/VBN by/IN AII/NN (/( 36.51/CD %/SYM )/) and/CC TAM/NN (/( 24.05/CD %/SYM )/) ./.
P09224642A04
This/PRP resulted/VBD from/IN cleavage/NN of/IN the/DT Val69-Cys70/NN bond/NN ./.
P09230755A03
Release/NN of/IN these/DT MMPs/NNS into/IN the/DT culture/NN medium/NN and/CC secretion/NN of/IN neutrophil/NN elastaselike/JJ activity/NN was/VBD also/RB assessed/VBN ./.
P09232430A06
However/WRB ,/, RASI-1/NN expression/NN can/MD also/RB be/VBP found/VBN in/IN non-inflamed/JJ blood/NN vessels/NNS of/IN uterine/JJ ligaments/NNS and/CC skin/NN ./.
P09234385A01
The/DT expression/NN of/IN matrix/NN metalloproteinase-2/NN (/( MMP-2/NN ;/: 72/CD kDa/NN type/NN IV/CD collagenase/NN //SYM gelatinase/NN A/NN )/) and/CC MMP-9/NN (/( 92/CD kDa/NN type/NN IV/CD collagenase/NN //SYM gelatinase/NN B/NN )/) was/VBD immunohistochemically/RB investigated/VBN in/IN 79/CD T1/NN adenocarcinomas/NNS of/IN the/DT lung/NN using/VBG non-commercial/JJ polyclonal/JJ anti-MMP-2/NN and/CC -9/CD antibodies/NNS ./.
P09236138A08
Although/IN 2-week/NN losartan/NN treatment/NN of/IN 65/CD ,/, 120/CD and/CC 200/CD day/NN experimental/JJ groups/NNS had/VBD no/DT significant/JJ effect/NN on/IN left/JJ ventricular/JJ fibrillar/JJ collagen/NN concentration/NN or/CC collagen/NN mRNA/NN abundance/NN when/WRB compared/VBN to/TO vehicle-infused/JJ CMP/NN hamsters/NNS ,/, AT1/NN receptor/NN blockade/NN was/VBD associated/VBN with/IN complete/JJ regression/NN of/IN cardiac/JJ hypertrophy/NN ./.
P09238653A04
Analysis/NN of/IN culture/NN medium/NN by/IN zymography/NN using/VBG gelatin/NN as/IN substrate/NN demonstrated/VBD the/DT presence/NN of/IN metalloproteinases/NNS (/( MMP/NN )/) ,/, MMP-9/NN (/( gelatinase/NN B/NN )/) appearing/VBG as/IN the/DT predominant/JJ band/NN ./.
P09260202A03
To/TO study/VB the/DT involvement/NN of/IN the/DT ECM/NN degrading/JJ proteases/NNS (/( matrix/NN metalloproteinases/NNS ;/: MMPs/NNS )/) and/CC their/PRP$ specific/JJ inhibitors/NNS in/IN the/DT process/NN of/IN pancreatic/JJ regeneration/NN ,/, we/PRP examined/VBD the/DT expression/NN of/IN these/DT genes/NNS on/IN the/DT transcript/NN level/NN and/CC the/DT activation/NN of/IN the/DT corresponding/JJ enzymes/NNS by/IN use/NN of/IN zymographies/NNS ./.
P09260879A04
However/WRB ,/, large/JJ changes/NNS in/IN cell/NN morphology/NN ,/, viability/NN and/CC expression/NN of/IN MMPs/NNS and/CC MMP/NN inhibitors/NNS occurred/VBD when/WRB fibroblasts/NNS were/VBD treated/VBN with/IN 10/CD (/( -4/CD )/) or/CC 10/CD (/( -3/CD )/) M/NN c3Ado/NN ./.
P09268350A07
The/DT reactive/JJ site/NN identified/VBN by/IN these/DT studies/NNS is/VBZ a/DT structurally/RB constrained/JJ but/CC elongated/JJ region/NN of/IN TIMP/NN that/WDT can/MD fit/VBP the/DT matrix/NN metalloproteinase/NN substrate-binding/JJ site/NN ./.
P09269785A09
We/PRP conclude/VBP that/IN the/DT increase/NN of/IN MMP/NN activity/NN produced/VBN or/CC induced/VBN by/IN myeloma/NN cells/NNS in/IN these/DT cocultures/NNS could/MD favor/VBP bone/NN resorption/NN and/CC tumor/NN invasion/NN ./.
P09269815A02
This/DT family/NN of/IN enzymes/NNS degrades/VBZ all/DT components/NNS of/IN connective/JJ tissue/NN and/CC has/VBZ been/VBN implicated/VBN as/IN a/DT cause/NN of/IN anastomotic/JJ dehiscence/NN ./.
P09276670A05
In/IN addition/NN ,/, plasminogen/NN converted/VBD the/DT pro/JJ form/NN of/IN MMPs/NNS into/IN the/DT active/JJ form/NN ./.
P09279657A07
Intense/JJ gelatinase/NN B/NN expression/NN was/VBD observed/VBN at/IN sites/NNS of/IN bone/NN resorption/NN in/IN osteoclasts/NNS and/CC mononuclear/JJ cells/NNS ./.
P09284814A03
We/PRP studied/VBD the/DT distribution/NN of/IN 92-kd/NN gelatinase/NN B/NN (/( MMP-9/NN )/) and/CC of/IN EMMPRIN/NN in/IN 33/CD benign/JJ and/CC 41/CD malignant/JJ ,/, paraffin-embedded/JJ pigment/NN cell/NN lesions/NNS using/VBG immunohistochemistry/NN and/CC monoclonal/JJ antibodies/NNS ./.
P09285647A05
We/PRP report/VBP here/RB that/IN stimulated/JJ human/NN T/NN lymphocytes/NNS induced/VBD the/DT expression/NN of/IN the/DT matrix-degrading/JJ enzymes/NNS ,/, ie/IN ,/, interstitial/JJ collagenase/NN (/( MMP-1/NN )/) ,/, stromelysin/NN (/( MMP-3/NN )/) ,/, gelatinase/NN B/NN (/( MMP-9/NN )/) ,/, and/CC activated/JJ gelatinase/NN A/NN (/( MMP-2/NN )/) ,/, in/IN human/NN vascular/JJ SMCs/NNS by/IN cell/NN contact/NN via/IN CD40/NN ligation/NN ,/, as/IN demonstrated/VBN by/IN Western/NN blot/NN analysis/NN ,/, zymography/NN ,/, and/CC antibody/NN neutralization/NN ./.
P09288131A03
This/DT study/NN proposes/VBZ to/TO quantify/VB relative/JJ mRNA/NN levels/NNS for/IN interstitial/JJ collagenase/NN (/( MMP-1/NN )/) ,/, 72/CD kd/NN type/NN IV/CD collagenase/NN (/( MMP-2/NN )/) ,/, 92/CD kd/NN type/NN IV/CD collagenase/NN (/( MMP-9/NN )/) ,/, TIMP-1/NN ,/, and/CC TIMP-2/NN in/IN normal/JJ aorta/NN (/( NA/NN )/) and/CC AAA/NN to/TO provide/VB insight/NN as/IN to/TO the/DT relative/JJ importance/NN of/IN each/PRP in/IN aneurysm/NN formation/NN ./.
P09291433A02
Since/IN the/DT liver/NN is/VBZ a/DT main/JJ target/NN for/IN metastases/NNS from/IN gastrointestinal/JJ adenocarcinoma/NN ,/, we/PRP have/VBP investigated/VBN MMP2/NN and/CC TIMP2/NN expression/NN by/IN RT-PCR/NN ,/, in/FW situ/FW hybridization/NN and/CC zymography/NN in/IN the/DT liver/NN of/IN patients/NNS with/IN gastrointestinal/JJ adenocarcinomas/NNS and/CC no/DT detectable/JJ hepatic/JJ metastasis/NN (/( n/NN =/SYM 12/CD )/) ,/, in/IN tumoral/JJ and/CC nontumoral/JJ liver/NN from/IN patients/NNS with/IN hepatic/JJ metastasis/NN (/( n/NN =/SYM 9/CD )/) and/CC in/IN control/NN liver/NN (/( n/NN =/SYM 4/CD )/) ./.
P09291579A08
Signals/NNS for/IN MMP-9/NN mRNA/NN were/VBD first/RB detected/VBN in/IN a/DT small/JJ population/NN of/IN stromal/JJ cells/NNS exclusively/RB at/IN the/DT site/NN of/IN implantation/NN on/IN day/NN 5/CD at/IN the/DT antimesometrial/JJ pole/NN ./.
P09292803A05
Amounts/NNS of/IN MMP-3/NN and/CC TIMP-1/NN mRNA/NN were/VBD measured/VBN by/IN Northern/NN blot/NN analysis/NN ./.
P09297576A01
OBJECTIVE/NN AND/CC DESIGN/NN :/: To/TO determine/VB whether/IN an/DT inhibitor/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, administered/VBN to/TO human/NN subjects/NNS in/IN a/DT dental/JJ school/NN research/NN clinic/NN ,/, can/MD reduce/VBP bone-type/NN collagen/NN degradation/NN fragments/NNS in/IN oral/JJ inflammatory/JJ exudates/NNS containing/VBG excessive/JJ levels/NNS of/IN collagenase/NN ./.
P09300240A02
The/DT present/JJ study/NN addressed/VBD the/DT question/NN as/IN to/TO whether/IN glomerular/JJ sclerosis/NN was/VBD associated/VBN with/IN alterations/NNS in/IN the/DT degradation/NN of/IN matrix/NN components/NNS ./.
P09301473A12
These/DT data/NNS suggest/VBP that/IN the/DT integrity/NN of/IN Bruch/NN 's/POS membrane/NN may/MD serve/VBP to/TO regulate/VB RPE/NN functions/NNS in/IN MMP/NN and/CC TIMP/NN secretion/NN and/CC that/IN extracellular/JJ matrices/NNS contain/VBP signals/NNS that/WDT regulate/VBP MMP/NN and/CC TIMP/NN synthesis/NN and/or/CC secretion/NN by/IN the/DT RPE/NN ./.
P09306059A05
Potential/JJ MMP-2/NN &/CC MMP-9/NN monomer/NN enzyme/NN activities/NNS were/VBD significantly/RB elevated/VBN in/IN both/CC septic/JJ and/CC aseptic/JJ joint/NN disease/NN synovial/JJ fluids/NNS in/IN comparison/NN to/TO fluids/NNS from/IN normal/JJ joints/NNS ./.
P09310250A10
Exploration/NN of/IN TIMP-2/NN expression/NN is/VBZ valuable/JJ for/IN the/DT discrimination/NN between/IN macroscopically/RB localized/JJ and/CC metastatic/JJ colorectal/JJ cancer/NN ,/, but/CC it/PRP can/MD not/RB predict/VBP which/PRP of/IN the/DT potentially/RB cured/JJ patients/NNS are/VBP likely/RB to/TO have/VB micrometastases/NNS ./.
P09310982A05
METHODS/NNS :/: The/DT aneurysm/NN wall/NN was/VBD excised/VBN from/IN three/CD of/IN six/CD patients/NNS undergoing/VBG craniotomies/NNS for/IN aneurysm/NN clipping/NN ./.
P09316744A05
Since/IN all/DT three/CD analytes/NNS were/VBD lower/JJR in/IN heparin/NN plasma/NN than/IN in/IN serum/NN or/CC EDTA/NN plasma/NN ,/, heparin/NN plasma/NN was/VBD selected/VBN as/IN the/DT specimen/NN of/IN choice/NN ./.
P09325265A08
They/PRP are/VBP co-expressed/VBN during/IN vascular/JJ and/CC urogenital/JJ development/NN and/CC during/IN the/DT development/NN of/IN osteocartilaginous/JJ and/CC musculotendinous/JJ structures/NNS ./.
P09327785A04
After/IN injury/NN ,/, MMP-2/NN mRNA/NN levels/NNS fell/VBP compared/VBN with/IN the/DT uninjured/JJ arteries/NNS ;/: by/IN 24/CD hours/NNS ,/, levels/NNS had/VBD increased/VBN 2-fold/NN ./.
P09328314A04
Effluents/NNS were/VBD also/RB collected/VBN from/IN 17/CD human/NN donor/NN livers/NNS stored/VBN in/IN UW/NN solution/NN ./.
P09328562A08
This/DT change/NN was/VBD most/RBS pronounced/VBN in/IN the/DT spleen/NN ,/, while/IN liver/NN ,/, kidney/NN and/CC brain/NN showed/VBD minor/JJ or/CC no/DT changes/NNS in/IN MMP/NN expression/NN ./.
P09334934A08
The/DT method/NN developed/VBN here/RB was/VBD capable/JJ of/IN recovering/NN gelatinase/NN activities/NNS from/IN rat/NN brain/NN tissue/NN over/IN a/DT 4-10-fold/NN range/NN using/VBG gelatin/NN zymography/NN for/IN the/DT measurement/NN of/IN activity/NN ./.
P09338470A08
Production/NN of/IN u-PA/NN by/IN OVET/NN and/CC OVEM/NN cells/NNS was/VBD regulated/VBN by/IN adhesive/JJ substratum/NN ./.
P09344045A06
There/EX was/VBD a/DT significant/JJ difference/NN in/IN the/DT increase/NN of/IN MMP-2/NN and/CC MMP-9/NN (/( 2.46-fold/NN and/CC 7.14-fold/NN ,/, respectively/RB ,/, at/IN 0.4/CD mg/NN //SYM ml/NN protein/NN ;/: P/NN </SYM 0.005/CD )/) ./.
P09344465A05
Pregnancy/NN zone/NN protein/NN was/VBD cleaved/VBN at/IN Thr693-Tyr694/NN and/CC alpha2-macroglobulin/NN at/IN Gly679-Leu680/NN and/CC Arg696-Leu697/NN by/IN matrix/NN metalloproteinase-2/NN ./.
P09348221A02
In/IN wild-type/NN animals/NNS ,/, MAT/NN ,/, STR-1/NN ,/, STR-2/NN ,/, STR-3/NN ,/, and/CC gelatinase/NN A/NN were/VBD consistently/RB expressed/VBN during/IN the/DT most/RBS active/JJ phases/NNS of/IN the/DT estrous/JJ cycle/NN ,/, estrus/NN and/CC proestrus/NN ./.
P09352216A02
TIMP-1/NN and/CC TIMP-2/NN are/VBP capable/JJ of/IN inhibiting/NN the/DT activities/NNS of/IN all/DT known/JJ matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC as/IN such/PRP play/VBP a/DT key/JJ role/NN in/IN maintaining/NN the/DT balance/NN between/IN extracellular/JJ matrix/NN (/( ECM/NN )/) deposition/NN and/CC degradation/NN in/IN different/JJ physiological/JJ processes/NNS ./.
P09352227A04
Substance/NN P/NN in/IN synovial/JJ fibroblasts/NNS induced/VBD an/DT increase/NN in/IN the/DT overall/JJ matrix/NN metalloproteinase/NN activity/NN towards/IN the/DT dinitrophenyl-labelled/JJ peptide/NN by/IN 85/CD %/SYM ,/, against/IN an/DT increase/NN of/IN 124/CD %/SYM after/IN stimulation/NN with/IN IL-1/NN beta/NN ./.
P09364466A09
Gelatinase-B/NN was/VBD strongly/RB expressed/VBN by/IN neutrophils/NNS in/IN tissue/NN from/IN patients/NNS up/IN to/TO 1/CD week/NN after/IN an/DT infarct/NN ,/, whereas/IN gelatinase-A/NN and/CC matrilysin/NN staining/NN was/VBD much/RB less/RB marked/VBN ./.
P09369533A04
Distinct/JJ spatial/JJ localisations/NNS for/IN each/DT MMP/NN were/VBD observed/VBN :/: MMP-2/NN was/VBD found/VBN in/IN epidermal/JJ structures/NNS ;/: MMP-9/NN was/VBD observed/VBN in/IN inflammatory/JJ cells/NNS up/IN to/TO day/NN 21/CD ;/: MMP-1/NN was/VBD localised/VBN to/TO keratinocytes/NNS at/IN the/DT wound/NN margin/NN ./.
P09369811A05
Release/NN of/IN gelatinases/NNS from/IN the/DT membranes/NNS was/VBD studied/VBN with/IN gelatin/NN zymography/NN ./.
P09389796A08
Endothelial/JJ cells/NNS constitutively/RB expressed/VBD gelatinases/NNS at/IN Mr/NN 96,000/CD and/CC 72,000/CD ,/, consistent/JJ with/IN MMP-9/NN and/CC inactive/JJ MMP-2/NN ./.
P09390324A01
It/PRP is/VBZ important/JJ to/TO monitor/VB the/DT early/JJ stages/NNS of/IN postoperative/JJ wound/NN repair/NN in/IN order/NN to/TO identify/VB those/DT problems/NNS associated/VBN with/IN impaired/JJ healing/NN ./.
P09393778A09
Further/JJ studies/NNS with/IN PLE/NN revealed/VBD that/IN MMP-9/NN induction/NN by/IN PLC/NN progressively/RB increased/VBD with/IN the/DT length/NN of/IN cell/NN culture/NN time/NN in/IN the/DT absence/NN of/IN serum/NN ./.
P09394051A05
We/PRP have/VBP studied/VBN the/DT distribution/NN patterns/NNS of/IN matrix/NN metalloproteinases-1/NN ,/, -2/CD ,/, -3/CD ,/, and/CC -9/CD and/CC their/PRP$ inhibitors/NNS TIMP-1/NN and/CC TIMP-2/NN as/IN compared/VBN to/TO the/DT distribution/NN of/IN their/PRP$ substrates/NNS along/IN the/DT invasive/JJ pathway/NN of/IN extravillous/JJ trophoblast/NN of/IN 1st/JJ ,/, 2nd/JJ ,/, and/CC 3rd/JJ trimester/NN placentas/NNS by/IN means/NNS of/IN light/NN microscopy/NN on/IN paraffin/NN and/CC cryostat/NN sections/NNS as/RB well/RB as/IN at/IN the/DT ultrastructural/JJ level/NN (/( only/RB 3rd/JJ trimester/NN placenta/NN )/) ./.
P09395517A11
The/DT C-terminal/JJ portion/NN of/IN the/DT cleaved/JJ HB-EGF/NN JM-AP/NN that/WDT remained/VBD attached/VBN to/TO the/DT anti-AP/NN beads/NNS was/VBD N-terminally/RB sequenced/VBN and/CC the/DT MMP-3/NN cleavage/NN site/NN was/VBD determined/VBN to/TO be/VB Glu151-Asn152/NN ,/, a/DT site/NN within/IN the/DT JM/NN domain/NN ./.
P09396371A14
Those/DT evidence/NN suggest/VBP that/IN MMP-2/NN and/CC MMP-9/NN share/VBP very/RB important/JJ role/NN in/IN the/DT destructive/JJ mechanism/NN of/IN RDC/NN ,/, possibly/RB under/IN imbalance/NN between/IN TIMPs/NNS ./.
P09396633A02
SM3/NN had/VBD a/DT novel/JJ sequence/NN consisting/VBG of/IN 50/CD amino/JJ acids/NNS after/IN Lys407/NN instead/RB of/IN amino/JJ acids/NNS containing/VBG the/DT transmembrane/JJ domain/NN of/IN MT3-MMP/NN ./.
P09397993A10
Increased/JJ expression/NN of/IN MMP-2/NN and/CC MT1-MMP/NN was/VBD detected/VBN in/IN CH/NN and/CC LC/NN ,/, while/IN dual/JJ over-expression/NN was/VBD found/VBN in/IN stellate/JJ cells/NNS and/CC fibroblasts/NNS ,/, possibly/RB resulting/VBG in/IN the/DT increase/NN of/IN active/JJ MMP-2/NN in/IN and/CC around/IN these/DT cells/NNS ./.
P09407317A03
To/TO study/VB the/DT potential/JJ involvement/NN of/IN MMPs/NNS in/IN retinoic/JJ acid/NN (/( RA/NN )/) regulation/NN of/IN skeletal/JJ development/NN ,/, we/PRP studied/VBD the/DT effect/NN of/IN all-trans-RA/NN on/IN MMPs/NNS levels/NNS in/IN mineralizing/JJ chicken/NN epiphyseal/JJ chondrocyte/NN primary/JJ cultures/NNS ./.
P09409309A15
These/DT results/NNS correlate/VBP with/IN the/DT MT-MMP1/NN protein/NN level/NN ,/, negatively/RB modified/VBN after/IN FK/NN treatment/NN ./.
P09412577A05
Expression/NN of/IN STR-3/NN and/CC TIMP-2/NN was/VBD also/RB assessed/VBN immunohistochemically/RB with/IN the/DT avidin-biotin-complex/NN (/( ABC/NN )/) technique/NN ./.
P09412584A06
In/IN contrast/NN ,/, analyses/NNS of/IN gelatinase-B/NN (/( MMP-9/NN )/) demonstrated/VBD a/DT specific/JJ expression/NN pattern/NN ,/, with/IN high/JJ expression/NN in/IN exudates/NNS and/CC lack/NN of/IN expression/NN in/IN transudates/NNS ./.
P09417058A06
Both/CC the/DT vitronectin-induced/JJ MMP-2/NN production/NN and/CC vitronectin-enhanced/JJ invasion/NN were/VBD blocked/VBN by/IN the/DT peptide/NN ligand/NN Arg-Gly-Asp-Ser/NN (/( RGDS/NN )/) ./.
P09418730A08
Substitution/NN of/IN EDTA/NN for/IN calcium/NN and/CC zinc/NN in/IN the/DT development/NN solution/NN eliminated/VBD the/DT appearance/NN of/IN these/DT bands/NNS ,/, indicating/VBG that/IN they/PRP reflect/VBP MMP/NN activity/NN ./.
P09422789A04
Specific/JJ receptors/NNS for/IN TIMP-2/NN were/VBD identified/VBN on/IN COS-1/NN cells/NNS transfected/VBN with/IN MT1-MMP/NN cDNA/NN ,/, but/CC not/RB on/IN vector-transfected/JJ cells/NNS ./.
P09433928A04
Reverse/JJ transcription-polymerase/NN chain/NN reaction/NN (/( RT-PCR/NN )/) and/CC restriction/NN enzyme/NN analysis/NN revealed/VBD that/IN leiomyomata/NN and/CC myometrium/NN expressed/VBD MMP-1/NN ,/, -2/CD ,/, -3/CD and/CC -9/CD ,/, as/RB well/RB as/IN TIMP-1/NN and/CC -2/CD mRNA/NN ./.
P09438380A11
However/WRB ,/, there/EX was/VBD a/DT dramatic/JJ difference/NN in/IN level/NN of/IN response/NN by/IN the/DT two/CD cell/NN types/NNS with/IN FSE/NN secreting/NN substantially/RB more/DT TIMP1/NN and/CC MMP9/NN compared/VBN to/TO HUVE/NN ./.
P09462388A02
The/DT strength/NN of/IN an/DT anastomosis/NN is/VBZ dependent/JJ on/IN collagen/NN ,/, which/WDT is/VBZ degraded/VBN by/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ./.
P09464653A05
Using/VBG gelatin/NN zymography/NN ,/, we/PRP have/VBP compared/VBN activities/NNS of/IN these/DT MMPs/NNS in/IN infarcted/JJ and/CC matched/JJ non-infarcted/JJ cerebral/JJ tissue/NN from/IN eight/CD subjects/NNS dying/VBG at/IN intervals/NNS of/IN less/RB than/IN 2/CD h/NN to/TO several/JJ years/NNS after/IN a/DT stroke/NN ./.
P09465944A08
The/DT increased/JJ ratio/NN of/IN MMP/NN //SYM TIMP-1/NN can/MD be/VBP interpreted/VBN as/IN an/DT indicator/NN of/IN the/DT imbalance/NN between/IN MMP/NN and/CC TIMP/NN ,/, characteristic/JJ of/IN prostate/NN carcinoma/NN tissue/NN ./.
P09466528A07
This/DT pattern/NN of/IN CSF/NN gelatinase/NN activity/NN may/MD be/VBP a/DT useful/JJ marker/NN for/IN neuroborreliosis/NN ./.
P09473407A02
Treatment/NN of/IN cultures/NNS with/IN 10/CD ng/NN //SYM ml/NN or/CC more/PRP of/IN VEGF/NN significantly/RB increased/VBD cell/NN proliferation/NN ./.
P09477095A11
CONCLUSIONS/NNS :/: The/DT results/NNS of/IN the/DT current/JJ study/NN indicate/VBP that/IN MMP-2/NN activation/NN plays/VBZ a/DT significant/JJ role/NN in/IN tumor/NN invasion/NN and/CC metastasis/NN in/IN pancreatic/JJ carcinoma/NN ./.
P09482695A01
Smooth/JJ muscle/NN cell/NN (/( SMC/NN )/) phenotypic/JJ alteration/NN ,/, followed/VBN by/IN migration/NN and/CC proliferation/NN ,/, is/VBZ a/DT prominent/JJ feature/NN of/IN atherogenesis/NN and/CC vascular/JJ neointimal/JJ formation/NN ./.
P09482695A16
These/DT data/NNS verify/VBP the/DT expression/NN of/IN MT-MMP-1/NN in/IN arterial/JJ SMC/NN and/CC suggest/VBP its/PRP$ importance/NN in/IN MMP-2/NN activation/NN after/IN balloon/NN catheter/NN de-endothelialization/NN ./.
P09486583A07
RESULTS/NNS :/: CSF/NN from/IN all/DT patients/NNS with/IN malignant/JJ astrocytomas/NNS or/CC brain/NN metastases/NNS contained/VBD precursor/NN gelatinase/NN A/NN (/( pMMP2/NN )/) and/CC precursor/NN gelatinase/NN B/NN (/( pMMP9/NN )/) ,/, whereas/IN control/NN CSF/NN contained/VBD only/RB pMMP2/NN ./.
P09492070A11
These/DT results/NNS demonstrate/VBP that/IN the/DT potency/NN of/IN induction/NN of/IN MMPs/NNS by/IN IL-1/NN and/CC IL-6/NN is/VBZ closely/RB linked/VBN to/TO the/DT respective/JJ bone-resorbing/JJ activity/NN ,/, suggesting/VBG that/IN MMP-dependent/JJ degradation/NN of/IN bone/NN matrix/NN plays/VBZ a/DT key/JJ role/NN in/IN bone/NN resorption/NN induced/VBN by/IN these/DT cytokines/NNS ./.
P09495249A11
We/PRP propose/VBP that/IN an/DT early/JJ step/NN in/IN tumor/NN angiogenesis/NN involves/VBZ VEGF-induced/JJ thrombin/NN generation/NN and/CC increased/JJ MMP/NN production/NN with/IN subsequent/JJ activation/NN of/IN endothelial/JJ progelatinase/NN A/NN and/CC degradation/NN of/IN the/DT underlying/JJ basement/NN membrane/NN ./.
P09499937A01
We/PRP investigated/VBD whether/IN PF4/NN could/MD regulate/VBP the/DT constitutive/JJ and/CC thrombin-stimulated/JJ expression/NN of/IN metalloproteinases/NNS (/( MMPs/NNS )/) in/IN endothelial/JJ cells/NNS (/( EC/NN )/) ./.
P09502424A06
Timp2/NN and/CC Timp3/NN ,/, the/DT murine/JJ homologues/NNS of/IN the/DT respective/JJ TIMP/NN genes/NNS ,/, were/VBD constitutively/RB expressed/VBN ,/, whereas/IN Timp1/NN was/VBD markedly/RB up-regulated/VBN during/IN fibrosis/NN ./.
P09502791A06
TIMP-3/NN overexpression/NN induced/VBD DNA/NN synthesis/NN ,/, and/CC promoted/VBD SMC/NN death/NN by/IN apoptosis/NN ,/, a/DT phenotype/NN reproduced/VBN by/IN adding/NN TIMP-3/NN to/TO uninfected/JJ cells/NNS ,/, but/CC not/RB by/IN a/DT synthetic/JJ MMP/NN inhibitor/NN ./.
P09504769A02
We/PRP investigated/VBD the/DT immunolocalization/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) in/IN rabbit/NN carotid/JJ arteries/NNS after/IN balloon/NN denudation/NN ./.
P09504860A08
These/DT data/NNS suggest/VBP that/IN besides/IN increased/JJ TIMP-1/NN activity/NN ,/, altered/JJ MMP/NN expression/NN may/MD also/RB play/VBP a/DT part/NN in/IN fibroproliferation/NN in/IN liver/NN disease/NN ./.
P09506709A03
The/DT matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) have/VBP been/VBN demonstrated/VBN to/TO play/VB a/DT significant/JJ role/NN in/IN tissue/NN remodeling/NN in/IN a/DT number/NN of/IN pathological/JJ processes/NNS ./.
P09510201A07
Together/RB ,/, these/DT results/NNS demonstrate/VBP that/IN firm/JJ adhesion/NN of/IN T/NN lymphoma/NN cells/NNS to/TO endothelial/JJ cells/NNS participates/VBZ in/IN the/DT production/NN of/IN MMP-9/NN in/IN both/DT cell/NN types/NNS through/IN bi-directional/JJ signaling/JJ pathways/NNS ,/, and/CC identify/VBP intercellular/JJ adhesion/NN molecule-1/NN //SYM LFA-1/NN as/IN a/DT key/JJ interaction/NN in/IN the/DT up-regulation/NN of/IN MMP-9/NN in/IN T/NN lymphoma/NN cells/NNS ./.
P09510291A06
At/IN the/DT termination/NN of/IN culture/NN ,/, MMPs/NNS were/VBD extracted/VBN from/IN the/DT tissue/NN and/CC quantified/VBN by/IN a/DT combination/NN of/IN substrate/NN gel/NN enzymography/NN and/CC immunoblotting/NN ./.
P09513609A12
In/IN the/DT 16/CD fluids/NNS from/IN rheumatoid/JJ arthritis/NN patients/NNS ,/, levels/NNS of/IN MMP-9/NN and/CC TIMP-1/NN were/VBD closely/RB correlated/VBN with/IN serum/NN C-reactive/JJ protein/NN levels/NNS ./.
P09514050A04
This/DT model/NN is/VBZ composed/VBN of/IN the/DT parental/JJ immortalized/JJ non-tumorigenic/JJ human/NN keratinocyte/NN line/NN (/( HaCaT/NN )/) ,/, and/CC three/CD activated/JJ c-Harvey-ras-oncogene/NN transfected/JJ variants/NNS (/( A-4/NN ,/, I-7/NN and/CC II-4/NN )/) ./.
P09528836A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP zinc/NN dependent/JJ endopeptidases/NNS implicated/VBN in/IN cancer/NN invasion/NN and/CC metastasis/NN ./.
P09529001A02
Immunohistochemical/JJ ,/, immunoblotting/JJ ,/, zymographical/JJ ,/, and/or/CC Northern/NN blot/NN analyses/NNS showed/VBD that/IN MMP-2/NN and/CC -9/CD levels/NNS were/VBD much/RB higher/JJR in/IN the/DT growth/NN plate/NN than/IN in/IN permanent/JJ cartilage/NN in/FW vivo/FW ./.
P09531484A08
This/DT cascade/NN was/VBD effectively/RB inhibited/VBN by/IN tissue/NN inhibitors/NNS of/IN metalloproteinases-2/NN and/CC -3/CD ./.
P09534207A07
In/FW situ/FW hybridization/NN revealed/VBD intense/JJ positive/JJ staining/NN for/IN TIMPs/NNS in/IN GCA/NN despite/IN weak/JJ immunocytochemical/JJ staining/NN for/IN TIMPs/NNS ./.
P09536819A05
By/IN contrast/NN ,/, the/DT three/CD MMPs/NNS showed/VBD variable/JJ values/NNS between/IN experiments/NNS in/IN response/NN to/TO MC/NN activation/NN ;/: no/DT reproducible/JJ trend/NN of/IN either/CC an/DT increased/JJ or/CC decreased/JJ production/NN of/IN each/DT MMP/NN over/IN control/NN values/NNS was/VBD evident/JJ ./.
P09538225A02
To/TO clarify/VB the/DT mechanism/NN of/IN the/DT IL-1-induced/JJ bFGF/NN release/NN ,/, we/PRP investigated/VBD the/DT production/NN and/CC gene/NN expression/NN of/IN bFGF/NN ,/, matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, syndecan/NN 3/CD ,/, and/CC inducible/JJ NO/NN synthase/NN (/( iNOS/NN )/) by/IN IL-1-treated/JJ rabbit/NN articular/JJ chondrocytes/NNS ./.
P09538475A02
These/DT interactions/NNS are/VBP characterized/VBN by/IN cell/NN adhesion/NN and/CC migration/NN ./.
P09543631A08
Stromal/JJ scars/NNS of/IN keratoconus/NN corneas/NNS also/RB had/VBD increased/VBN staining/NN with/IN TIMP-1/NN and/CC TIMP-2/NN antibodies/NNS ./.
P09545106A09
The/DT highest/JJS MMP-2/NN mRNA/NN levels/NNS were/VBD determined/VBN in/IN thyroid-derived/JJ fibroblasts/NNS and/CC HTh/NN 74/CD cells/NNS ./.
P09546322A10
These/DT findings/NNS indicate/VBP that/IN 92-kd/NN gelatinase/NN and/CC matrilysin/NN are/VBP selectively/RB up-regulated/VBN during/IN EAN/NN and/CC expressed/VBN in/IN nerves/NNS of/IN GBS/NN patients/NNS and/CC thus/RB may/MD contribute/VBP to/TO the/DT pathogenesis/NN of/IN inflammatory/JJ demyelination/NN of/IN the/DT peripheral/JJ nervous/JJ system/NN ./.
P09546361A05
The/DT colitis/NN types/NNS studied/VBN did/VBD not/RB essentially/RB differ/VBP in/IN their/PRP$ MMP/NN expression/NN ./.
P09549496A10
Our/PRP$ findings/NNS indicate/VBP that/IN 92-kDa/NN gelatinase/NN and/CC matrilysin/NN are/VBP selectively/RB upregulated/VBN during/IN AT-EAE/NN and/CC thus/RB may/MD contribute/VBP to/TO the/DT pathogenesis/NN of/IN inflammatory/JJ diseases/NNS of/IN the/DT CNS/NN ./.
P09549524A11
Prominent/JJ infiltration/NN of/IN inflammatory/JJ cells/NNS into/IN the/DT sciatic/JJ nerve/NN was/VBD concordant/JJ with/IN a/DT significant/JJ increase/NN in/IN the/DT expression/NN levels/NNS of/IN matrilysin/NN and/CC macrophage/NN metalloelastase/NN ./.
P09550215A04
The/DT attenuated/JJ Ta-Ode/NN cells/NNS were/VBD found/VBN to/TO disseminate/VB very/RB poorly/RB compared/VBN to/TO their/PRP$ virulent/JJ progenitors/NNS ,/, which/WDT correlates/VBZ with/IN a/DT marked/JJ reduction/NN in/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) expression/NN ./.
P09553130A02
Previously/RB ,/, we/PRP showed/VBD the/DT surface/NN association/NN of/IN pro-MMP-9/NN in/IN human/NN breast/NN epithelial/JJ MCF10A/NN cells/NNS ./.
P09558121A08
These/DT results/NNS suggest/VBP that/IN one/CD of/IN the/DT ways/NNS in/IN which/WDT TNF-alpha/NN causes/VBZ tissue/NN injury/NN in/IN the/DT gut/NN is/VBZ by/IN stimulating/NN mucosal/JJ mesenchymal/JJ cell/NN to/TO secrete/VB matrix-degrading/JJ metalloproteinases/NNS ./.
P09560329A05
MMP/NN activities/NNS are/VBP regulated/VBN by/IN their/PRP$ transition/NN from/IN latent/JJ to/TO activated/JJ forms/NNS ,/, as/RB well/RB as/IN by/IN the/DT presence/NN of/IN tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) ./.
P09561025A01
The/DT molecular/JJ mechanism/NN by/IN which/WDT IL-10/NN inhibits/VBZ metastases/NNS was/VBD examined/VBN using/VBG a/DT SCID/NN mouse/NN model/NN ./.
P09570393A07
The/DT high/JJ level/NN of/IN TIMP-1/NN appeared/VBD to/TO be/VB related/VBN to/TO malignant/JJ phenotype/NN in/IN ovaries/NNS as/RB well/RB as/IN the/DT high/JJ level/NN of/IN MMP-9/NN ./.
P09578462A07
ProMMP-9/NN (/( progelatinase/NN B/NN )/) is/VBZ activated/VBN by/IN MMP-10/NN to/TO its/PRP$ full/JJ activity/NN and/CC processed/VBN to/TO the/DT low-Mr/NN species/NNS of/IN Mr/NN 81,000/CD ,/, 65,000/CD ,/, 57,000/CD and/CC 55,000/CD ,/, the/DT former/JJ two/CD of/IN which/WDT show/VBP proteolytic/JJ activity/NN on/IN a/DT gelatin/NN zymography/NN ./.
P09579471A07
Gelatinase/NN A/NN was/VBD immunolocalized/VBN to/TO the/DT epithelium/NN and/CC stroma/NN of/IN normal/JJ corneas/NNS and/CC was/VBD predominant/JJ in/IN the/DT basal/JJ epithelium/NN and/CC superficial/JJ stroma/NN at/IN 3/CD and/CC 7/CD days/NNS after/IN wounding/NN ./.
P09588507A14
This/DT enhanced/JJ MMP-9/NN activity/NN could/MD then/RB result/VBP in/IN degradation/NN of/IN the/DT ECM/NN ,/, leading/VBG to/TO aneurysmal/JJ dilatation/NN ./.
P09591765A01
BACKGROUND/NN :/: One/CD of/IN the/DT hallmarks/NNS of/IN dilated/JJ cardiomyopathy/NN (/( DCM/NN )/) is/VBZ left/JJ ventricular/JJ (/( LV/NN )/) remodeling/NN ./.
P09596253A04
After/IN focal/JJ stroke/NN ,/, there/EX is/VBZ a/DT breakdown/NN of/IN the/DT BBB/NN with/IN an/DT associated/JJ increase/NN in/IN vascular/JJ permeability/NN ,/, inflammatory/JJ cell/NN influx/NN ,/, and/CC neuronal/JJ cell/NN death/NN ./.
P09598840A01
We/PRP have/VBP recently/RB demonstrated/VBD that/IN the/DT blockade/NN of/IN matrix/NN metalloproteinases/NNS by/IN local/JJ overexpression/NN of/IN the/DT intrinsic/JJ inhibitor/NN tissue/NN inhibitor/NN of/IN matrix/NN metalloproteinase-1/NN (/( TIMP-1/NN )/) reduces/VBZ intimal/JJ hyperplasia/NN ./.
P09604716A04
No/DT MMP-2/NN binding/NN to/TO fibrin/NN occurred/VBD ./.
P09605768A06
Immunohistochemical/JJ analysis/NN of/IN tumor/NN tissue/NN samples/NNS indicated/VBD that/IN MMP-2/NN was/VBD present/JJ in/IN both/CC tumor/NN cells/NNS and/CC stromal/JJ cells/NNS ./.
P09610608A01
OBJECTIVES/NNS :/: To/TO elucidate/VB the/DT role/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) in/IN human/NN urothelial/JJ cancers/NNS ,/, we/PRP studied/VBD gene/NN expressions/NNS of/IN MMPs/NNS ,/, TIMPs/NNS ,/, and/CC membrane-type/NN 1/CD matrix/NN metalloproteinase/NN (/( MT1-MMP/NN )/) in/IN noninvasive/JJ or/CC invasive/JJ tumor/NN lines/NNS transplanted/VBN in/IN mice/NNS with/IN severe/JJ combined/JJ immunodeficiency/NN (/( SCID/NN )/) ./.
P09610697A02
Recently/RB ,/, GM-CSF/NN has/VBZ been/VBN demonstrated/VBN to/TO be/VB produced/VBN by/IN several/JJ tumor/NN cells/NNS and/CC also/RB to/TO be/VB associated/VBN with/IN tumor/NN growth/NN and/CC metastasis/NN ./.
P09612358A13
These/DT findings/NNS demonstrate/VBP that/IN pacing-induced/JJ CHF/NN leads/VBZ to/TO changes/NNS in/IN myocardial/JJ MMP/NN activity/NN and/CC expression/NN that/WDT may/MD be/VBP responsible/JJ for/IN LV/NN remodeling/NN in/IN CHF/NN ./.
P09620087A02
METHODS/NNS :/: Forty-two/CD vitreous/JJ samples/NNS were/VBD collected/VBN at/IN the/DT time/NN of/IN pars/NN plana/NN vitrectomy/NN ./.
P09627804A05
Since/RB little/PRP is/VBZ known/VBN about/IN the/DT actual/JJ mechanism/NN (/( s/NNS )/) involved/VBN ./.
P09639398A02
Activation/NN of/IN MMP-2/NN is/VBZ RGD/NN sequence/NN dependent/JJ ,/, possibly/RB involves/VBZ anti-alphaVbeta3/NN integrins/NNS ,/, is/VBZ preceded/VBN by/IN a/DT change/NN from/IN spread/JJ to/TO rounded/JJ cell/NN morphology/NN and/CC is/VBZ mimicked/VBN by/IN the/DT actin/NN depolymerising/JJ agent/NN cytochalasin/NN B/NN ./.
P09639575A02
For/IN these/DT studies/NNS we/PRP used/VBD rAgg1mut/NN ,/, a/DT mutated/JJ form/NN of/IN the/DT recombinant/JJ fusion/NN protein/NN (/( rAgg1/NN )/) that/WDT has/VBZ been/VBN used/VBN as/IN a/DT substrate/NN to/TO monitor/VB '/`` aggrecanase/NN '/'' catabolism/NN in/FW vitro/FW [/( Hughes/NNP ,/, Buttner/NNP ,/, Eidenmuller/NNP ,/, Caterson/NNP and/CC Bartnik/NNP (/( 1997/CD )/) J./NN Biol./NN Chem./NN 272/CD ,/, 20269-20274/CD ]/) ./.
P09640131A08
RESULTS/NNS :/: There/EX was/VBD little/DT difference/NN between/IN the/DT amounts/NNS of/IN MMP2/NN secreted/VBN by/IN any/PRP of/IN the/DT cell/NN lines/NNS ./.
P09642234A02
Wild/JJ type/NN TIMP-3/CD was/VBD entirely/RB localized/VBN to/TO the/DT ECM/NN in/IN both/CC its/PRP$ glycosylated/JJ (/( 27/CD kDa/NN )/) and/CC unglycosylated/JJ (/( 24/CD kDa/NN )/) forms/NNS ./.
P09644306A02
These/DT enzymes/NNS are/VBP capable/JJ of/IN degrading/NN the/DT extracellular/JJ matrix/NN ,/, including/VBG collagens/NNS ,/, laminin/NN ,/, proteoglycan/NN and/CC fibronectin/NN ./.
P09645358A04
In/IN the/DT present/JJ study/NN we/PRP investigated/VBD whether/IN plasma/NN cells/NNS could/MD contribute/VBP to/TO matrix/NN degradation/NN by/IN their/PRP$ expression/NN of/IN MMP/. In/FW situ/FW hybridization/NN and/CC immunohistochemical/JJ analyses/NNS on/IN diseased/JJ synovial/JJ and/CC scleral/JJ tissue/NN demonstrated/VBD the/DT expression/NN of/IN stromelysin-1/NN (/( MMP-3/NN )/) and/CC gelatinase/NN B/NN (/( MMP-9/NN )/) ,/, but/CC little/DT or/CC no/DT tissue/NN inhibitor/NN of/IN matrix/NN metalloproteinase/NN 1/CD (/( TIMP-1/NN )/) mRNA/NN ,/, by/IN IgG-positive/JJ plasma/NN cells/NNS ./.
P09645454A01
The/DT enhanced/JJ expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMP/NN )/) ,/, especially/RB gelatinases/NNS MMP-2/NN and/CC MMP-9/NN ,/, has/VBZ been/VBN associated/VBN with/IN the/DT invasive/JJ behavior/NN of/IN tumor/NN cells/NNS ./.
P09645759A04
Western/NN blotting/NN of/IN lung/NN tissue/NN homogenates/NNS was/VBD performed/VBN for/IN MMP-2/NN and/CC MMP-9/NN ./.
P09645764A01
The/DT aim/NN of/IN the/DT present/JJ study/NN was/VBD to/TO investigate/VB the/DT proteolytic/JJ potential/NN and/CC localization/NN of/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) -2/CD in/IN relation/NN to/TO its/PRP$ regulatory/JJ protein/NN ,/, membrane-type-MMP/NN (/( MT1-MMP/NN )/) ,/, and/CC tissue/NN inhibitor/NN of/IN metalloproteinase-2/NN (/( TIMP-2/NN )/) ,/, as/RB well/RB as/IN to/TO clarify/VB an/DT important/JJ step/NN in/IN the/DT cascade/NN of/IN periprosthetic/JJ connective-tissue/NN remodeling/NN in/IN loose/JJ total-hip/NN prostheses/NNS ./.
P09648071A05
The/DT role/NN of/IN MT-1-MMP/NN in/IN renal/JJ development/NN is/VBZ unknown/VBN ./.
P09648925A09
The/DT MT-MMP/NN and/CC tPA/NN activities/NNS of/IN cytosol/NN and/CC membrane/NN fractions/NNS were/VBD measured/VBN by/IN gelatin-/NN and/CC plasminogen-zymography/NN ,/, respectively/RB ./.
P09649139A07
TIMP-1/NN mRNA/NN was/VBD detected/VBN in/IN some/DT stromal/JJ cells/NNS surrounding/VBG the/DT neoplastic/JJ islands/NNS ,/, whereas/IN the/DT mRNA/NN expression/NN for/IN TIMP-2/NN was/VBD negligible/JJ ./.
P09660504A05
We/PRP have/VBP investigated/VBN the/DT presence/NN of/IN MMPs/NNS in/IN the/DT vitreous/NN of/IN patients/NNS with/IN retinal/JJ detachment/NN and/CC the/DT predictive/JJ value/NN of/IN MMPs/NNS for/IN the/DT future/JJ development/NN of/IN PVR/NN ./.
P09661630A03
Corpora/NNS lutea/NN (/( n/NN =/SYM 9/CD )/) were/VBD collected/VBN at/IN hysterectomy/NN and/CC were/VBD dated/VBN by/IN serial/JJ urinary/JJ LH/NN estimation/NN ./.
P09665201A02
Dissemination/NN of/IN malignant/JJ cells/NNS in/IN acute/JJ myeloid/NN leukemia/NN (/( AML/NN )/) may/MD be/VBP mediated/VBN by/IN similar/JJ mechanisms/NNS ./.
P09666818A06
On/IN gelatin/NN zymographic/JJ analysis/NN ,/, the/DT gelatinolytic/JJ activities/NNS of/IN MMP-9/NN but/CC not/RB of/IN MMP-2/NN were/VBD increased/VBN (/( 2.2-fold/NN )/) ./.
P09672063A10
Thus/RB ,/, the/DT unaltered/JJ ratios/NNS of/IN active/JJ and/CC latent/JJ MMP-2/NN suggest/VBP that/IN proMMP-2/NN activation/NN may/MD occur/VBP in/IN the/DT absence/NN of/IN tPA/NN ,/, uPA/NN ,/, or/CC Plg/NN ,/, whereas/IN no/DT active/JJ MMP-9/NN was/VBD detected/VBN in/IN the/DT absence/NN of/IN Plg/NN ./.
P09678429A05
Inhibitor/NN studies/NNS showed/VBD that/IN MMPs/NNS were/VBD responsible/JJ for/IN 72.2/CD %/SYM of/IN the/DT degradation/NN ./.
P09679762A07
The/DT TNF/NN alpha-induced/JJ degradation/NN of/IN IkappaB/NN alpha/NN was/VBD also/RB suppressed/VBN by/IN ALLN/NN treatment/NN ,/, thus/RB implying/VBG that/IN the/DT molecule/NN linking/VBG proteasome/NN to/TO MMP-9/NN production/NN should/MD be/VBP IkappaB/NN alpha/NN ./.
P09681807A04
MMP-2/NN and/CC MMP-9/NN were/VBD expressed/VBN in/IN neoplastic/JJ cell/NN plasma/NN membrane/NN in/IN 83.3/CD %/SYM and/CC 88/CD %/SYM of/IN cases/NNS of/IN AGC/NN ,/, respectively/RB with/IN inter-tumoral/JJ variability/NN of/IN staining/JJ intensity/NN ./.
P09685743A02
MT1-MMP/NN mRNA/NN was/VBD expressed/VBN in/IN 8/CD cell/NN lines/NNS ,/, while/IN MT2-MMP/NN and/CC MT3-MMP/NN mRNAs/NNS were/VBD expressed/VBN in/IN fewer/JJR cell/NN lines/NNS ./.
P09687303A04
Here/RB we/PRP report/VBP a/DT new/JJ effect/NN of/IN ascorbic/JJ acid/NN acting/VBG as/IN a/DT modulator/NN of/IN the/DT 72-kDa/NN type/NN IV/CD collagenase/NN (/( matrix/NN metalloproteinase-2/NN ;/: MMP-2/NN )/) ./.
P09688221A02
In/IN periodontal/JJ diseases/NNS ,/, matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) may/MD play/VBP key/JJ roles/NNS in/IN the/DT extracellular/JJ matrix/NN ,/, basement/NN membrane/NN ,/, serpin/NN degradation/NN ,/, and/CC modification/NN of/IN cytokine/NN action/NN ./.
P09695737A08
Acetate/NN did/VBD not/RB modulate/VBP MMPs/NNS ,/, TIMP-1/NN ,/, or/CC uPA/NN ,/, but/CC stimulated/VBD TIMP-2/NN ./.
P09695744A14
ProMMP-2/NN activation/NN by/IN PMN-conditioned/JJ medium/NN is/VBZ not/RB blocked/VBN by/IN inhibitors/NNS of/IN plasmin/NN ,/, cysteine-/NN ,/, acid-/NN ,/, or/CC metalloproteinases/NNS ./.
P09703281A10
Our/PRP$ observation/NN of/IN the/DT unique/JJ presence/NN of/IN the/DT active/JJ form/NN of/IN MMP-9/NN within/IN liver/NN metastasis/NN suggests/VBZ that/IN proMMP-9/NN activation/NN may/MD be/VBP a/DT pivotal/JJ event/NN during/IN CRC/NN liver/NN metastasis/NN formation/NN ./.
P09703333A10
Competition-based/JJ reverse/JJ transcription-polymerase/NN chain/NN reaction/NN revealed/VBD that/IN nondiabetic/JJ and/CC diabetic/JJ HRECs/NNS expressed/VBD constitutively/RB mRNA/NN for/IN MMP-2/NN ,/, MMP-9/NN ,/, tissue/NN inhibitor/NN of/IN metalloproteinase/NN (/( TIMP/NN )/) -1/CD ,/, TIMP-2/NN ,/, and/CC fibronectin/NN ./.
P09706130A02
This/DT study/NN assessed/VBD the/DT feasibility/NN of/IN modulating/NN MMP/NN activity/NN in/IN hSVGs/NNS by/IN adenovirus-mediated/JJ gene/NN transfer/NN ./.
P09706143A05
The/DT culture/NN supernatants/NNS were/VBD analyzed/VBN by/IN gelatin/NN zymography/NN ./.
P09707196A11
Pretreatment/NN of/IN the/DT serum/NN by/IN APMA/NN (/( n/NN =/SYM 60/CD )/) lowered/VBD the/DT molecular/JJ weight/NN of/IN the/DT band/NN to/TO 66/CD kDa/NN ./.
P09708803A06
Moreover/RB ,/, substrate/NN gel/NN electrophoresis/NN showed/VBD that/IN the/DT activated/JJ forms/NNS of/IN gelatinases/NNS A/NN and/CC B/NN were/VBD present/JJ in/IN glioblastomas/NNS and/CC medulloblastomas/NNS ./.
P09710119A02
The/DT balance/NN between/IN degradation/NN by/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) may/MD regulate/VBP plaque/NN stability/NN ./.
P09710383A06
TIMP-3/NN was/VBD abundantly/RB expressed/VBN in/IN stromal/JJ fibroblast-/NN and/CC macrophage-like/JJ cells/NNS surrounding/VBG vessels/NNS and/CC sweat/NN glands/NNS in/IN both/DT types/NNS of/IN wounds/NNS ./.
P09711934A13
Both/CC C/NN pneumoniae/NN and/CC recombinant/JJ chlamydial/JJ HSP/NN 60/CD induced/VBD TNF-alpha/NN production/NN by/IN mouse/NN macrophages/NNS in/IN a/DT concentration-/NN and/CC time-dependent/JJ fashion/NN ./.
P09714179A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) play/VBP critical/JJ roles/NNS in/IN tissue/NN remodeling/NN under/IN various/JJ physiologic/JJ and/CC pathologic/JJ conditions/NNS ./.
P09716571A03
We/PRP have/VBP examined/VBN the/DT interaction/NN between/IN human/NN mast/JJ cells/NNS and/CC endometrial/JJ stromal/JJ cells/NNS with/IN regard/NN to/TO MMP/NN production/NN and/CC activation/NN ./.
P09718371A05
HT1080/NN cells/NNS cultured/VBN on/IN immobilised/JJ antibodies/NNS to/TO the/DT alpha5/NN and/CC beta1/NN integrin/NN subunits/NNS secreted/VBD levels/NNS of/IN active/JJ MMP-2/NN similar/JJ to/TO those/PRP observed/VBN for/IN full/JJ length/NN fibronectin/NN ,/, whereas/IN cells/NNS cultured/VBN on/IN an/DT antibody/NN to/TO the/DT alpha6/NN integrin/NN subunit/NN secreted/VBD mainly/RB proMMP-2/NN ./.
P09719036A03
We/PRP performed/VBD Western/NN blot/NN analyses/NNS using/VBG MMP-specific/JJ antibodies/NNS to/TO identify/VB MMPs/NNS in/IN human/NN dental/JJ caries/NN lesions/NNS ./.
P09721888A01
We/PRP assessed/VBD the/DT functional/JJ significance/NN of/IN tumor/NN cell-associated/JJ matrix/NN metalloproteinase/NN (/( MMP/NN )/) -2/CD in/IN extracellular/JJ matrix/NN remodeling/NN compared/VBN with/IN that/PRP of/IN the/DT soluble/JJ enzyme/NN by/IN evaluating/NN the/DT contraction/NN of/IN three-dimensional/JJ collagen/NN lattices/NNS by/IN human/NN glioma/NN U251.3/NN and/CC fibrosarcoma/NN HT-1080/NN cell/NN lines/NNS ./.
P09722003A05
RESULTS/NNS :/: MMP-2/NN and/CC MMP-9/NN were/VBD coexpressed/VBN in/IN neuroblastoma/NN and/CC exhibited/VBD an/DT intratumor/JJ variability/NN of/IN staining/JJ intensity/NN ./.
P09727371A05
Such/PRP results/NNS demonstrate/VBP an/DT independent/JJ and/CC opposite/JJ regulation/NN of/IN the/DT enzymes/NNS and/CC their/PRP$ inhibitors/NNS ./.
P09731514A10
Modulation/NN of/IN TNFalpha/NN receptor/NN shedding/NN by/IN TIMP-2/NN could/MD have/VBP important/JJ implications/NNS for/IN the/DT pleiotropic/JJ effects/NNS of/IN TNFalpha/NN in/IN both/CC normal/JJ and/CC malignant/JJ cells/NNS and/CC for/IN the/DT pharmacological/JJ activity/NN of/IN synthetic/JJ MMPIs/NNS ./.
P09732233A04
The/DT use/NN of/IN organomercurials/NNS revealed/VBD the/DT presence/NN of/IN latent/JJ enzyme/NN in/IN all/DT cases/NNS ./.
P09733107A01
The/DT roles/NNS of/IN the/DT matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC their/PRP$ specific/JJ inhibitors/NNS ,/, the/DT tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMP/NN )/) ,/, in/IN embryologic/JJ development/NN in/IN general/NN ,/, and/CC in/IN nephrogenesis/NN in/IN particular/NN ,/, have/VBP not/RB been/VBN fully/RB elucidated/VBN ./.
P09736032A04
Lung/NN mRNAs/NNS assayed/VBN by/IN Northern/NN and/CC in/FW situ/FW hybridization/NN showed/VBD an/DT up-regulation/NN of/IN lung/NN gelatinases/NNS A/NN and/CC B/NN from/IN the/DT 3rd/JJ day/NN on/RB ./.
P09736043A06
MT2-MMP/NN mRNA/NN was/VBD rather/RB stable/JJ in/IN the/DT different/JJ groups/NNS ./.
P09736919A02
Dysregulated/JJ activity/NN has/VBZ long/RB been/VBN implicated/VBN in/IN the/DT pathologies/NNS of/IN cancer/NN and/CC arthritis/NN ,/, and/CC the/DT number/NN of/IN diseases/NNS more/RB recently/RB associated/VBN with/IN these/DT enzymes/NNS has/VBZ been/VBN increasing/VBG ./.
P09743373A06
Cytokine/NN stimulation/NN of/IN MMP-1/NN was/VBD due/JJ ,/, at/IN least/JJS in/IN part/NN ,/, to/TO an/DT increase/NN in/IN the/DT release/NN of/IN arachidonic/JJ acid/NN and/CC PG/NN E2/NN (/( PGE2/NN )/) ,/, because/IN inhibition/NN of/IN MMP-1/NN by/IN indomethacin/NN could/MD be/VBP reversed/VBN by/IN exogenous/JJ PGE2/NN ./.
P09748137A04
A/DT 20/CD %/SYM risk/NN also/RB resulted/VBD from/IN a/DT 1-unit/NN increment/NN in/IN the/DT MT1-MMP/NN :/: MMP-2/NN ratio/NN ,/, which/WDT showed/VBD differences/NNS of/IN up/IN to/TO 15-fold/NN ./.
P09756602A15
Treatment/NN with/IN BB-1101/NN reduced/VBD BBB/NN opening/NN at/IN 3/CD hours/NNS and/CC brain/NN edema/NN at/IN 24/CD hours/NNS ,/, but/CC neither/PRP was/VBD affected/VBN at/IN 48/CD hours/NNS ./.
P09758100A10
Reverse/JJ zymography/NN of/IN culture/NN supernatants/NNS of/IN synovial/JJ fibroblasts/NNS and/CC chondrocytes/NNS gave/VBD similar/JJ results/NNS whereas/IN the/DT culture/NN supernatants/NNS from/IN PMNs/NNS and/CC PBMs/NNS showed/VBD the/DT presence/NN of/IN only/RB the/DT 28/CD kDa/NN protein/NN ./.
P09759652A08
In/IN addition/NN to/TO the/DT presence/NN of/IN mRNA/NN levels/NNS ,/, the/DT level/NN of/IN MT1-MMP/NN according/VBG to/TO immunoblot/NN analysis/NN increased/VBD in/IN the/DT emphysematous/JJ samples/NNS ./.
P09759850A08
In/IN contrast/NN ,/, gelatinase/NN B/NN processed/VBD pIL-1/NN beta/NN within/IN minutes/NNS ,/, resulting/VBG in/IN immunoreactive/JJ products/NNS as/RB well/RB as/IN biologic/JJ activity/NN stable/JJ for/IN 72/CD h/NN ./.
P09761302A08
MMP-2/NN ,/, TIMP-1/NN ,/, and/CC TIMP-2/NN mRNA/NN had/VBD a/DT similar/JJ overall/JJ distribution/NN that/WDT was/VBD relatively/RB uniform/JJ within/IN the/DT vascularized/JJ membrane/NN stroma/NN ./.
P09763536A03
Quantitative/JJ competitive/JJ reverse/JJ transcription-polymerase/NN chain/NN reaction/NN and/CC gelatin/NN zymography/NN showed/VBD increased/JJ MMP-9/NN mRNA/NN and/CC protein/NN in/IN both/CC AAA/NN and/CC AOD/NN tissues/NNS compared/VBN with/IN those/PRP in/IN control/NN tissue/NN ,/, but/CC there/EX was/VBD no/DT significant/JJ difference/NN between/IN AAA/NN and/CC AOD/NN ./.
P09771466A02
Immature/JJ female/NN Long-Evans/NN rats/NNS were/VBD primed/VBN with/IN 15/CD IU/NN pregnant/JJ mare/NN 's/POS serum/NN gonadotropin/NN (/( PMSG/NN )/) in/IN 100/CD microliters/NNS PBS/NN ./.
P09775397A05
Results/NNS show/VBP that/IN in/IN normal/JJ mouse/NN muscles/NNS MMP-2/NN and/CC MMP-9/NN are/VBP localized/VBN at/IN the/DT neuromuscular/JJ junctions/NNS ,/, in/IN Schwann/NN cells/NNS and/CC the/DT perineurium/NN of/IN the/DT intramuscular/JJ nerves/NNS ./.
P09776730A01
Vascular/JJ endothelial/JJ growth/NN factor/NN (/( VEGF/NN )/) is/VBZ a/DT critical/JJ regulator/NN of/IN angiogenesis/NN that/WDT stimulates/VBZ proliferation/NN ,/, migration/NN ,/, and/CC proteolytic/JJ activity/NN of/IN endothelial/JJ cells/NNS ./.
P09776730A16
These/DT data/NNS are/VBP the/DT first/PRP to/TO show/VB a/DT direct/JJ effect/NN of/IN VEGF/NN on/IN SMCs/NNS ./.
P09778117A05
There/EX was/VBD more/DT (/( P/NN </SYM 0.001/CD )/) MMP-2/NN activity/NN in/IN the/DT caruncle/NN versus/CC intercaruncle/NN and/CC intercotyledon/NN ,/, and/CC all/PRP had/VBD greater/JJR MMP-2/NN activity/NN (/( P/NN </SYM 0.001/CD )/) than/IN the/DT cotyledon/NN ./.
P09778216A02
METHODS/NNS :/: Dermal/JJ fibroblasts/NNS and/CC fibroblast-like/JJ synovial/JJ cells/NNS (/( synoviocytes/NNS )/) were/VBD cultured/VBN with/IN fixed/JJ T/NN cells/NNS ,/, isolated/JJ plasma/NN membranes/NNS from/IN T/NN cells/NNS ,/, interleukin-1beta/NN (/( IL-1beta/NN ;/: 250/CD pg/NN //SYM ml/NN )/) ,/, or/CC transforming/JJ growth/NN factor/NN beta/NN (/( TGFbeta/NN ;/: 5/CD ng/NN //SYM ml/NN )/) ./.
P09785129A04
Eighteen/CD cervical/JJ adenocarcinomas/NNS and/CC 5/CD controls/NNS were/VBD immunohistochemically/RB analyzed/VBN for/IN the/DT expression/NN of/IN MMP-2/NN ,/, MMP-3/NN ,/, MMP-9/NN ,/, and/CC their/PRP$ inhibitors/NNS ,/, TIMP-1/NN and/CC TIMP-2/NN ,/, in/IN tumor/NN cells/NNS and/CC peritumoral/JJ stromal/JJ cells/NNS ./.
P09786263A13
CONCLUSION/NN :/: A/DT decrease/NN in/IN proteolytic/JJ activity/NN may/MD be/VBP responsible/JJ for/IN the/DT histological/JJ and/CC structural/JJ alterations/NNS leading/VBG to/TO varicose/JJ degeneration/NN of/IN superficial/JJ lower/JJR extremity/NN veins/NNS ./.
P09790969A04
The/DT addition/NN of/IN specific/JJ MMP/NN inhibitor/NN BB-94/NN and/CC tissue/NN inhibitor/NN MMP/NN (/( TIMP/NN )/) -2/CD but/CC not/RB TIMP-1/NN to/TO such/DT collagen/NN gel/NN cultures/NNS reduced/VBD the/DT formation/NN of/IN branching/JJ tubules/NNS induced/VBN by/IN HGF/NN ./.
P09791731A02
The/DT proteinase/NN is/VBZ secreted/VBN from/IN the/DT cell/NN as/IN an/DT inactive/JJ zymogen/NN ./.
P09804345A02
To/TO better/RBR understand/VB the/DT pathogenesis/NN of/IN ulcer/NN formation/NN we/PRP investigated/VBD the/DT expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMP/NN )/) and/CC tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMP/NN )/) in/IN lipodermatosclerosis/NN ./.
P09804828A01
The/DT release/NN of/IN aggrecan/NN catabolites/NNS from/IN cartilage/NN is/VBZ an/DT early/JJ event/NN in/IN the/DT pathogenesis/NN of/IN degenerative/JJ joint/NN diseases/NNS ./.
P09808534A03
To/TO address/VB the/DT contribution/NN of/IN MMP/NN activity/NN to/TO the/DT development/NN of/IN intestinal/JJ adenomas/NNS ,/, we/PRP administered/VBD the/DT synthetic/JJ MMP/NN inhibitor/NN batimastat/NN and/CC expressed/VBD the/DT tissue/NN inhibitor/NN of/IN metalloproteinases-1/NN (/( TIMP-1/NN )/) in/IN the/DT gastrointestinal/JJ tract/NN of/IN Min/NN mice/NNS ,/, which/WDT spontaneously/RB develop/VBP pre-malignant/JJ small/JJ and/CC large/JJ intestinal/JJ tumors/NNS ./.
P09819295A01
BACKGROUND/NN :/: Bronchial/JJ asthma/NN is/VBZ characterized/VBN by/IN airway/NN structural/JJ changes/NNS ,/, including/VBG mucosal/JJ inflammation/NN and/CC subepithelial/JJ collagen/NN deposition/NN ./.
P09821179A03
Therefore/RB we/PRP investigated/VBD the/DT expression/NN of/IN several/JJ MMPs/NNS and/CC of/IN two/CD of/IN their/PRP$ tissue/NN inhibitors/NNS (/( TIMPs/NNS )/) in/IN rat/NN pancreatic/JJ islets/NNS ./.
P09822200A07
Interestingly/RB ,/, proteolytically/RB processed/JJ MMP-9/NN was/VBD found/VBN in/IN saliva/NN (/( vide/NN supra/NN )/) ,/, and/CC in/FW vivo/FW activated/JJ MMP-9/NN was/VBD significantly/RB higher/JJR in/IN SS/NN than/IN in/IN controls/NNS (/( p=0.002/NN )/) ./.
P09823336A07
These/DT data/NNS demonstrate/VBP that/IN MMPs/NNS ,/, but/CC not/RB the/DT plasminogen/NN activator-plasmin/NN system/NN ,/, can/MD directly/RB regulate/VBP the/DT ability/NN of/IN either/CC EGF-/NN or/CC SF-stimulated/JJ tumor/NN cells/NNS to/TO invade/VB interstitial/JJ matrix/NN barriers/NNS ./.
P09828178A07
Menstruation/NN and/CC MMP/NN expression/NN after/IN P4/NN withdrawal/NN were/VBD similar/JJ in/IN both/CC the/DT presence/NN and/CC absence/NN of/IN estradiol/NN ./.
P09846979A09
This/PRP appears/VBZ to/TO result/VB from/IN the/DT formation/NN of/IN TIMP/NN //SYM MMP/NN complexes/NNS ./.
P09847290A07
MMP-9/NN and/CC TIMP-1/NN concentrations/NNS were/VBD greater/JJR in/IN sputum/NN of/IN patients/NNS with/IN asthma/NN and/CC chronic/JJ bronchitis/NN than/IN in/IN control/NN subjects/NNS ./.
P09852923A03
All/DT TAAs/NNS showed/VBD cystic/JJ medial/JJ necrosis/NN (/( CMN/NN )/) ,/, with/IN loss/NN of/IN elastic/JJ fibers/NNS and/CC smooth/JJ muscle/NN cells/NNS ./.
P09856774A05
Kinetic/JJ inhibition/NN analysis/NN was/VBD conducted/VBN for/IN stromelysin/NN ,/, gelatinase/NN A/NN ,/, and/CC gelatinase/NN B/NN with/IN the/DT various/JJ inhibitors/NNS ./.
P09858432A04
METHODS/NNS :/: NOD/NN ,/, immunodeficient/JJ NOD-scid/NN ,/, and/CC nondiabetic/JJ NOD.B10.H2b/NN mice/NNS were/VBD evaluated/VBN for/IN MMP/NN activity/NN in/IN their/PRP$ saliva/NN and/CC exocrine/JJ gland/NN lysates/NNS by/IN gelatin/NN zymography/NN and/CC reverse/JJ transcriptase-polymerase/NN chain/NN reaction/NN (/( RT-PCR/NN )/) ./.
P09858504A07
We/PRP conclude/VBP that/IN ,/, like/IN mammalian/JJ fetal/JJ membranes/NNS ,/, chick/NN embryonic/JJ membranes/NNS undergo/VBP terminal/JJ remodeling/NN before/IN hatching/NN ,/, in/IN part/NN as/IN a/DT result/NN of/IN increased/JJ MMP/NN activity/NN ./.
P09862695A10
These/DT results/NNS raise/VBP the/DT possibility/NN that/IN TNF-alpha/NN and/CC IFN-gamma/NN may/MD have/VBP beneficial/JJ effects/NNS in/IN attenuating/NN astroglioma/NN invasive/JJ properties/NNS ./.
P09872414A06
Taken/VBN together/RB ,/, we/PRP propose/VBP a/DT novel/JJ function/NN for/IN BCL-2/NN in/IN the/DT malignant/JJ phenotype/NN of/IN glioma/NN cells/NNS ,/, that/WDT is/VBZ ,/, to/TO enhance/VB migration/NN and/CC invasion/NN by/IN altering/NN the/DT expression/NN of/IN a/DT set/NN of/IN metalloproteinases/NNS and/CC their/PRP$ inhibitors/NNS ./.
P09872597A03
Furthermore/RB ,/, treatment/NN of/IN cells/NNS with/IN lactose/NN (/( 30/CD mM/NN )/) ,/, which/WDT dissociated/VBD 67-kDa/NN elastin/NN binding/JJ protein/NN (/( EBP/NN )/) from/IN cell/NN surfaces/NNS ,/, completely/RB abolished/VBD this/DT effect/NN ,/, suggesting/VBG that/IN the/DT elastin/NN receptor/NN could/MD mediate/VBP such/PDT a/DT response/NN ./.
P09876398A01
OBJECTIVE/NN :/: The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO define/VB the/DT relative/JJ regulation/NN of/IN matrix/NN metalloproteinase-3/NN (/( MMP-3/NN )/) ,/, and/CC tissue/NN inhibitor/NN of/IN metalloproteinases-1/NN (/( TIMP-1/NN )/) ,/, in/IN chondrocytes/NNS and/CC synovium/NN in/IN experimental/JJ osteoarthritis/NN (/( EOA/NN )/) ./.
P09881602A04
A/DT porcine/JJ MT1-MMP/NN cDNA/NN composed/VBN of/IN 3284/CD bp/NN was/VBD isolated/VBN from/IN an/DT enamel/NN organ-specific/JJ cDNA/NN library/NN ./.
P09882504A14
By/IN in/FW situ/FW hybridization/NN we/PRP localized/VBD MMP-9/NN mRNA/NN in/IN inflammatory/JJ cells/NNS and/CC putative/JJ activated/JJ satellite/NN cells/NNS in/IN injured/JJ muscles/NNS ./.
P09889060A11
Active/JJ MMP-2/NN was/VBD present/JJ in/IN both/DT groups/NNS but/CC significantly/RB decreased/VBN in/IN animals/NNS treated/VBN with/IN BB-94/NN ./.
P09890433A05
Furthermore/RB ,/, it/PRP was/VBD demonstrated/VBN that/IN a/DT synthetic/JJ furin/NN convertase/NN inhibitor/NN ,/, decanoyl-Arg-Val-Lys-Arg-chloromethylketone/NN ,/, decreased/VBD the/DT production/NN of/IN A/NN beta-induced/JJ active/JJ MMP-2/NN in/IN U87/NN cells/NNS ./.
P09892093A06
In/IN addition/NN ,/, a/DT possible/JJ relation/NN between/IN exposure/NN of/IN glioma/NN cells/NNS to/TO IL-10/NN and/CC invasiveness/NN of/IN these/DT cells/NNS due/JJ to/TO MMP/NN expression/NN was/VBD analyzed/VBN ./.
P09918213A01
Elevated/JJ expression/NN levels/NNS of/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) -2/CD and/CC MMP-9/NN have/VBP been/VBN implicated/VBN as/IN playing/NN important/JJ roles/NNS in/IN tumor/NN invasion/NN and/CC metastasis/NN in/IN various/JJ tissues/NNS ./.
P09918237A02
METHODS/NNS :/: Enzyme/NN linked/JJ immunoassays/NNS and/CC high/JJ performance/NN liquid/NN chromatography/NN were/VBD used/VBN ./.
P09918530A08
Indeed/RB ,/, IL-8/NN (/( 2.5/CD ng/NN //SYM mL/NN )/) induced/VBD maximal/JJ inhibition/NN of/IN TIMP-1/NN accumulation/NN (/( 30/CD %/SYM of/IN control/NN )/) in/IN 4/CD of/IN 6/CD cell/NN preparations/NNS ./.
P09920023A11
Production/NN of/IN TIMPs/NNS appears/VBZ to/TO be/VB individually/RB linked/VBN to/TO the/DT synthesis/NN of/IN specific/JJ cartilage/NN molecules/NNS ./.
P09920024A04
MMP/NN activity/NN in/IN the/DT medium/NN was/VBD determined/VBN using/VBG a/DT quenched/JJ fluorescent/JJ substrate/NN assay/NN ,/, while/IN specific/JJ collagenases/NNS were/VBD identified/VBN by/IN Western/NN immunoblotting/NN ./.
P09923652A07
These/DT results/NNS indicate/VBP that/IN components/NNS of/IN the/DT ternary/JJ MT1-MMP/NN //SYM TIMP-2/NN //SYM MMP-2/NN complex/NN are/VBP coexpressed/VBN in/IN the/DT normal/JJ synovial/JJ lining/NN and/CC in/IN its/PRP$ pathological/JJ extension/NN on/IN the/DT hyaline/NN articular/JJ cartilage/NN ./.
P09927064A11
These/DT results/NNS suggest/VBP for/IN the/DT first/JJ time/NN that/IN among/IN seven/CD different/JJ MMPs/NNS ,/, the/DT production/NN of/IN proMMP-2/NN and/CC its/PRP$ MT1-MMP-mediated/JJ activation/NN in/IN the/DT carcinoma/NN cell/NN nests/NNS play/VBP an/DT important/JJ role/NN in/IN the/DT lymph/NN node/NN metastasis/NN of/IN human/NN invasive/JJ papillary/JJ thyroid/NN carcinomas/NNS ./.
P09927150A10
The/DT cytokine-specific/JJ regulation/NN of/IN MMP/NN //SYM TIMP/NN expression/NN in/IN hepatic/JJ stellate/JJ cells/NNS suggests/VBZ that/IN the/DT initial/JJ matrix/NN breakdown/NN following/VBG liver/NN injury/NN might/MD be/VBP enhanced/VBN by/IN TNF-alpha/NN ,/, while/IN diminished/JJ matrix/NN degradation/NN during/IN chronic/JJ tissue/NN injury/NN might/MD be/VBP due/JJ to/TO the/DT action/NN of/IN TGF-beta1/NN through/IN TIMP/NN induction/NN ./.
P09927378A11
The/DT low/JJ MMP-9/NN :/: TIMP-1/NN ratio/NN observed/VBN in/IN subjects/NNS with/IN little/DT or/CC no/DT FEV1/NN improvement/NN with/IN CS/NN supports/VBZ the/DT hypothesis/NN that/IN ,/, in/IN these/DT asthmatic/JJ subjects/NNS ,/, bronchial/JJ fibrogenesis/NN predominates/VBZ over/IN inflammation/NN ./.
P09930309A06
Neointima/NN formation/NN and/CC neointimal/JJ cell/NN numbers/NNS were/VBD reduced/VBN 79/CD %/SYM and/CC 71/CD %/SYM ,/, respectively/RB (/( P/NN </SYM 0.05/CD ;/: n/NN =/SYM 8/CD )/) ./.
P09932102A03
However/WRB ,/, when/WRB cultured/VBN in/IN the/DT presence/NN of/IN the/DT matrix/NN metalloproteinase/NN (/( MMP/NN )/) activator/NN aminophenylmercuric/JJ acetate/NN (/( APMA/NN )/) ,/, the/DT lamellae/NNS separated/VBD when/WRB tension/NN was/VBD applied/VBN by/IN pulling/NN the/DT hoof/NN wall/NN in/IN an/DT opposite/JJ direction/NN to/TO the/DT connective/JJ tissue/NN ./.
P09933437A05
We/PRP show/VBP that/IN CD40/NN ligation/NN on/IN gingival/JJ fibroblasts/NNS resulted/VBD in/IN a/DT decrease/NN of/IN their/PRP$ MMP-1/NN and/CC MMP-3/NN production/NN ,/, while/IN MMP-2/NN and/CC TIMP-1/NN production/NN were/VBD unaffected/VBN as/IN determined/VBN by/IN Western/NN blot/NN ./.
P09933484A09
Thus/RB ,/, this/DT study/NN demonstrated/VBD that/IN gelatinase/NN A/NN and/CC its/PRP$ activator/NN might/MD contribute/VBP to/TO the/DT aseptic/JJ loosening/NN of/IN polyethylene/NN prostheses/NNS ./.
P09933646A06
A/DT triple/JJ mutation/NN ,/, K566A/NN //SYM K568A/NN //SYM K575A/NN ,/, having/VBG TIMP-2/NN binding/NN indistinguishable/JJ from/IN the/DT wild-type/NN C/NN domain/NN (/( Kd/NN 3.0/CD x/SYM 10/CD (/( -8/CD )/) M/NN )/) ,/, showed/VBD that/IN simple/JJ reduction/NN of/IN net/JJ positive/JJ charge/NN does/VBZ not/RB reduce/VBP TIMP-2/NN affinity/NN ./.
P09933692A07
Fourteen/CD tumors/NNS (/( 11/CD cancers/NNS ,/, 3/CD adenomas/NNS )/) were/VBD also/RB analyzed/VBN for/IN collagenase-3/NN mRNA/NN ,/, but/CC no/DT expression/NN was/VBD detected/VBN ./.
P09935179A07
These/DT findings/NNS have/VBP several/JJ implications/NNS for/IN investigations/NNS into/IN tumor/NN metastasis/NN ,/, development/NN ,/, and/CC lymphocyte/NN function/NN ./.
P09952109A05
We/PRP now/RB report/VBP on/IN the/DT expression/NN of/IN TIMP-1/NN ,/, the/DT inhibitor/NN of/IN MMP-9/NN ,/, and/CC compare/VBP the/DT levels/NNS and/CC the/DT regulation/NN by/IN cytokines/NNS of/IN both/CC MMP-9/NN and/CC TIMP-1/NN ./.
P09974405A06
Zymography/NN revealed/VBD that/IN TIMP-1/NN was/VBD the/DT most/RBS abundant/JJ TIMP/NN secreted/VBN and/CC that/IN its/PRP$ secretion/NN increased/VBD dramatically/RB between/IN 0/CD to/TO 2/CD and/CC 12/CD to/TO 14/CD days/NNS of/IN culture/NN ./.
P09986746A07
TIMP-2/NN positive/JJ cells/NNS were/VBD observed/VBN within/IN the/DT inner/JJ and/CC outer/JJ nuclear/JJ cell/NN layers/NNS of/IN normal/JJ retina/NN ./.
P09988231A06
We/PRP conclude/VBP that/IN in/IN human/NN breast/NN cancer/NN ,/, endogenous/JJ TIMP-1/NN does/VBZ not/RB inhibit/VBP tumor/NN progression/NN but/CC may/MD enhance/VBP the/DT process/NN ./.
P10022430A01
Early/JJ human/NN trophoblast/NN shows/VBZ dramatic/JJ invasive/JJ properties/NNS during/IN early/JJ pregnancy/NN ./.
P10023324A04
The/DT purpose/NN of/IN this/DT study/NN was/VBD to/TO determine/VB whether/IN MMPs/NNS play/VBP a/DT role/NN in/IN aggrecan/NN catabolism/NN in/IN cartilage/NN tumours/NNS ./.
P10027404A06
However/WRB ,/, subcutaneous/JJ injection/NN of/IN the/DT alphaPI-C-secreting/JJ clones/NNS resulted/VBD in/IN tumors/NNS that/WDT were/VBD 1.5/CD to/TO 3-fold/NN larger/JJR than/IN those/PRP of/IN control/NN clones/NNS with/IN an/DT increased/JJ tendency/NN to/TO invasiveness/NN and/CC lymph/NN node/NN metastasis/NN ./.
P10029294A08
As/IN serum/NN MMP-1/NN level/NN was/VBD closely/RB associated/VBN with/IN the/DT histological/JJ degree/NN of/IN necroinflammation/NN ,/, we/PRP examined/VBD the/DT ability/NN of/IN the/DT serum/NN MMP-1/NN test/NN to/TO differentiate/VB active/JJ and/CC inactive/JJ forms/NNS of/IN hepatitis/NN with/IN a/DT receiver/NN operating/JJ curve/NN ./.
P10048978A01
Invasiveness/NN and/CC metastatic/JJ capacity/NN of/IN tumor/NN cells/NNS have/VBP been/VBN related/VBN to/TO increased/JJ expression/NN and/CC activation/NN of/IN gelatinase-A/NN (/( MMP-2/NN )/) ./.
P10051290A05
Exposure/NN to/TO ox-LDL/NN (/( 10/CD to/TO 50/CD microg/NN //SYM mL/NN )/) increased/VBD MMP-9/NN mRNA/NN expression/NN as/IN analyzed/VBN by/IN Northern/NN blot/NN ,/, protein/NN expression/NN as/IN measured/VBN by/IN ELISA/NN and/CC Western/NN blot/NN ,/, and/CC gelatinolytic/JJ activity/NN as/IN determined/VBN by/IN zymography/NN ./.
P10067990A09
In/IN addition/NN ,/, the/DT active/JJ forms/NNS of/IN these/DT enzymes/NNS were/VBD present/JJ in/IN the/DT membranes/NNS ,/, whereas/IN there/EX was/VBD no/DT detectable/JJ level/NN of/IN the/DT active/JJ forms/NNS in/IN normal/JJ retinas/NNS ./.
P10068210A08
These/DT data/NNS indicate/VBP that/IN TIMP-1/NN inhibits/VBZ TAg-induced/JJ hepatocarcinogenesis/NN by/IN altering/NN hepatocellular/JJ proliferation/NN and/CC tumor/NN vascularization/NN ,/, without/IN any/DT effect/NN on/IN hepatocyte/NN apoptosis/NN and/CC stromal/JJ composition/NN ./.
P10071915A08
In/IN heterotopic/JJ bone/NN only/RB occasional/JJ low/JJ level/NN TIMP-1/NN expression/NN was/VBD detected/VBN in/IN chondrocytes/NNS and/CC osteoblasts/NNS ./.
P10076570A01
We/PRP recently/RB established/VBD a/DT metallothionein-I/NN (/( MT/NN )/) //SYM RET/NN transgenic/JJ mouse/NN line/NN in/IN which/WDT skin/NN melanosis/NN ,/, benign/JJ melanocytic/JJ tumor/NN and/CC malignant/JJ melanoma/NN develop/VBP stepwise/RB ./.
P10080160A10
Neither/CC plasma/NN MMP-2/NN or/CC serum/NN ALT/NN were/VBD related/VBN to/TO fibrosis/NN or/CC to/TO histological/JJ activity/NN index/NN ./.
P10081908A03
MATERIALS/NNS AND/CC METHODS/NNS :/: Overexpression/NN of/IN MMP-1/NN ,/, MMP-2/NN and/CC MMP-9/NN was/VBD analyzed/VBN immunohistochemically/RB in/IN 60/CD patients/NNS with/IN transitional/JJ cell/NN carcinomas/NNS of/IN the/DT urothelium/NN (/( 41/CD were/VBD pTa/NN or/CC pis/NN ,/, 19/CD were/VBD pT1-4/NN )/) ,/, and/CC compared/VBD them/PRP with/IN type/NN IV/CD collagen/NN expression/NN in/IN tumor/NN BM/NN ./.
P10086886A02
The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO determine/VB the/DT effects/NNS of/IN siderophores/NNS ,/, which/WDT are/VBP iron-chelating/JJ molecules/NNS produced/VBN by/IN a/DT variety/NN of/IN microorganisms/NNS ,/, on/IN the/DT activity/NN of/IN MMP-2/NN ./.
P10090151A04
Via/IN Northern/NN and/CC in/FW situ/FW hybridization/NN ,/, we/PRP have/VBP analyzed/VBN the/DT spatio-temporal/JJ expression/NN patterns/NNS of/IN members/NNS of/IN the/DT MMP/NN family/NN (/( stromelysin-3/NN ,/, gelatinases/NNS A/NN and/CC B/NN )/) ,/, as/RB well/RB as/IN their/PRP$ inhibitors/NNS TIMP-1/NN ,/, -2/CD and/CC -3/CD in/IN late/JJ murine/JJ placenta/NN (/( days/NNS 10.5/CD to/TO 18.5/CD of/IN gestation/NN )/) ./.
P10090824A12
RESULTS/NNS ./.
P10098765A07
Immunohistochemical/JJ study/NN showed/VBD strong/JJ TIMP-1/NN staining/NN in/IN the/DT stroma/NN cells/NNS of/IN advanced/JJ stages/NNS of/IN carcinomas/NNS ./.
P10190278A05
This/PRP includes/VBZ activation/NN ,/, assembly/NN at/IN the/DT cell/NN surfaces/NNS as/IN TIMP-2/NN complexes/NNS and/CC subsequent/JJ inactivation/NN by/IN proteolysis/NN or/CC TIMP/NN inhibition/NN ./.
P10203333A02
We/PRP report/VBP the/DT presence/NN of/IN MMP-2/NN ,/, but/CC no/DT MMP-9/NN ,/, and/CC of/IN all/PDT the/DT four/CD known/JJ TIMPs/NNS in/IN neuroepithelial/JJ stem/NN cells/NNS isolated/VBN from/IN the/DT human/NN CNS/NN ./.
P10206300A04
Gelatinase-B/NN transcript/NN and/CC activity/NN levels/NNS were/VBD also/RB higher/JJR than/IN in/IN normal/JJ brain/NN and/CC more/RB strongly/RB correlated/VBN with/IN tumour/NN grade/NN ./.
P10206578A06
RESULTS/NNS :/: Levels/NNS of/IN urokinase/NN and/CC MMPs/NNS (/( MMP-2/NN and/CC MMP-9/NN )/) in/IN retinas/NNS were/VBD significantly/RB increased/VBN in/IN animals/NNS with/IN induced/JJ retinal/JJ neovascularization/NN ./.
P10211985A04
MMP/NN enzyme/NN activity/NN was/VBD determined/VBN by/IN gelatin/NN zymography/NN ./.
P10212153A09
The/DT deposited/JJ basement/NN membrane-type/NN of/IN matrix/NN reproducibly/RB suppressed/VBD HDMEC/NN proliferation/NN and/CC increased/VBD HDMEC/NN adhesion/NN to/TO the/DT substratum/NN ./.
P10215319A04
High/JJ levels/NNS of/IN MMP-2/NN seemed/VBD to/TO result/VB from/IN increased/JJ expression/NN by/IN the/DT cystic/JJ kidneys/NNS predominantly/RB in/IN the/DT second/JJ and/CC third/JJ postnatal/JJ weeks/NNS (/( a/DT time/NN when/WRB the/DT kidneys/NNS are/VBP undergoing/VBG rapid/JJ cystic/JJ enlargement/NN )/) ./.
P10216103A06
Also/RB ,/, immunoassay/NN of/IN plasma/NN cell/NN extracts/NNS showed/VBD significantly/RB higher/JJR (/( P/NN <./SYM 01/CD )/) levels/NNS of/IN the/DT angiogenic/JJ basic/JJ fibroblast/NN growth/NN factor/NN (/( FGF/NN )/) -2/CD in/IN the/DT active/JJ MM/NN patients/NNS than/IN in/IN nonactive/JJ MM/NN and/CC MGUS/NN patients/NNS (/( 153/CD +/-/SYM 59/CD ,/, 23/CD +/-/SYM 17/CD ,/, and/CC 31/CD +/-/SYM 18/CD pg/NN FGF-2/NN //SYM 100/CD micrograms/NNS of/IN protein/NN ,/, respectively/RB )/) ./.
P10220591A05
The/DT degradation/NN of/IN proteoglycan/NN was/VBD inhibited/VBN by/IN and/CC MMP/NN inhibitor/NN ,/, indicating/VBG that/IN MMPs/NNS are/VBP involved/VBN in/IN the/DT degradation/NN of/IN proteoglycans/NNS induced/VBN by/IN high/JJ frequency/NN CTF/NN ./.
P10221718A07
There/EX was/VBD no/DT correlation/NN between/IN the/DT number/NN of/IN MMP-9/NN positive/JJ cells/NNS and/CC the/DT number/NN of/IN bleeding/JJ days/NNS reported/VBN ./.
P10222217A04
The/DT animals/NNS in/IN the/DT second/JJ group/NN (/( no/DT injection/NN group/NN )/) were/VBD not/RB injected/VBN after/IN ACLT/NN ./.
P10223763A05
Regarding/VBG the/DT expression/NN pattern/NN of/IN m-RNA/NN of/IN matrix/NN metalloproteinase-2/NN and/CC tissue/NN inhibitor/NN of/IN metalloproteinase-2/NN in/IN normal/JJ colon/NN tissue/NN ,/, Group/NN B/NN included/VBD 24/CD cases/NNS with/IN matrix/NN metalloproteinase-2/NN negative/JJ ,/, and/CC tissue/NN inhibitor/NN of/IN metalloproteinase-2/NN positive/JJ (/( 24/CD //SYM 46/CD ;/: 52.2/CD percent/NN )/) ./.
P10224058A11
The/DT activated/JJ MMP-9/NN enhances/VBZ the/DT invasive/JJ phenotype/NN of/IN the/DT cultured/JJ cells/NNS as/IN their/PRP$ ability/NN to/TO both/CC degrade/VBP extracellular/JJ matrix/NN and/CC transverse/JJ basement/NN membrane/NN is/VBZ significantly/RB increased/VBN following/VBG zymogen/NN activation/NN ./.
P10226073A03
In/IN this/DT study/NN we/PRP examined/VBD the/DT effects/NNS of/IN FGF-1/NN and/CC FGF-1/NN plus/CC heparin/NN on/IN type/NN I/CD collagen/NN ,/, collagen-binding/JJ stress/NN protein/NN HSP47/NN ,/, interstitial/JJ collagenase/NN (/( matrix/NN metalloproteinase/NN [/( MMP/NN ]/) -1/CD )/) ,/, gelatinase/NN A/NN ,/, and/CC tissue/NN inhibitor/NN of/IN metalloproteinase/NN (/( TIMP/NN )/) -1/CD and/CC TIMP-2/NN expression/NN by/IN normal/JJ human/NN lung/NN fibroblasts/NNS ./.
P10232461A02
The/DT activity/NN of/IN MMPs/NNS is/VBZ regulated/VBN by/IN members/NNS of/IN the/DT TIMP/NN (/( tissue/NN inhibitors/NNS of/IN metalloproteinase/NN )/) family/NN ./.
P10235563A11
Type/NN VII/CD collagen/NN localized/VBD in/IN basal/JJ epithelial/JJ cells/NNS only/RB in/IN this/DT sample/NN ./.
P10319612A01
We/PRP have/VBP evaluated/VBN the/DT correlation/NN between/IN disc/NN herniation/NN or/CC degeneration/NN and/CC the/DT levels/NNS of/IN matrix/NN metalloproteinase-3/NN (/( MMP-3/NN )/) or/CC tissue/NN inhibitor/NN of/IN metalloproteinases-1/NN (/( TIMP-1/NN )/) ./.
P10321809A02
We/PRP postulated/VBD that/IN the/DT repression/NN by/IN synthetic/JJ progestins/NNS of/IN MMP/NN production/NN from/IN HESCs/NNS may/MD not/RB be/VBP fully/RB maintained/VBN in/IN the/DT long/JJ term/NN ,/, and/CC that/IN this/PRP may/MD account/VBP for/IN the/DT disturbed/JJ uterine/JJ bleeding/JJ patterns/NNS in/IN women/NNS using/VBG long-acting/JJ progestins/NNS ./.
P10323763A07
In/IN the/DT coculture/NN experiments/NNS ,/, the/DT presence/NN of/IN coronary/JJ media/NN retarded/VBD adventitial/JJ cell/NN outgrowth/NN ,/, whereas/IN medial/JJ damage/NN abrogated/VBD these/DT effects/NNS ,/, allowing/VBG for/IN fibroblast/NN migration/NN (/( P/NN </SYM 0.001/CD )/) ./.
P10330038A06
The/DT collagen/NN percentage/NN in/IN deposited/JJ ECM/NN was/VBD increased/VBN from/IN 5.8/CD +/-/SYM 0.3/CD (/( control/NN )/) to/TO 9.0/CD +/-/SYM 0.5/CD and/CC 8.8/CD +/-/SYM 0.5/CD %/SYM by/IN TGF-beta1/NN and/CC TGF-beta3/NN ,/, respectively/RB ./.
P10330301A09
These/DT results/NNS demonstrate/VBP that/IN MMPs/NNS and/CC TIMPs/NNS are/VBP upregulated/VBN in/IN MS/NN and/CC may/MD contribute/VBP to/TO the/DT pathogenesis/NN of/IN the/DT disease/NN ./.
P10333542A12
Another/DT function/NN of/IN MT-MMP/NN is/VBZ to/TO degrade/VB collagen/NN types/NNS I/CD and/CC III/CD ./.
P10334190A07
By/IN double/JJ immunostaining/NN ,/, MMP-9/NN protein/NN expression/NN was/VBD noted/VBN to/TO localize/VB within/IN areas/NNS of/IN limited/JJ type/NN IV/CD collagen/NN staining/NN ./.
P10340932A02
As/IN a/DT prerequisite/NN to/TO understanding/NN which/DT specific/JJ MMPs/NNS might/MD be/VBP involved/VBN in/IN the/DT injury/NN and/CC how/WRB they/PRP might/MD function/VBP ,/, it/PRP was/VBD necessary/JJ to/TO know/VB the/DT spectrum/NN of/IN enzymes/NNS present/JJ ./.
P10343138A05
Electron-microscopic/JJ immunohistochemistry/NN of/IN parietal/JJ cells/NNS showed/VBD immunolabeling/NN of/IN MMP-2/NN and/CC TIMP-2/NN in/IN the/DT cisternae/NN of/IN the/DT rough/JJ endoplasmic/JJ reticulum/NN ,/, and/CC that/PRP of/IN MMP-1/NN and/CC MMP-9/NN in/IN tubular/JJ structures/NNS in/IN their/PRP$ cytoplasm/NN ./.
P10353410A07
However/WRB ,/, renal/JJ MMP/NN expression/NN appeared/VBD to/TO be/VB age/NN dependent/JJ ;/: the/DT highest/JJS average/JJ amounts/NNS of/IN urine/NN MMP-2/NN were/VBD detected/VBN during/IN adolescence/NN ,/, while/IN the/DT converse/NN was/VBD true/JJ of/IN urine/NN MMP-9/NN ./.
P10357558A01
Metastatic/JJ disease/NN is/VBZ responsible/JJ for/IN the/DT majority/NN of/IN cancer-related/JJ deaths/NNS ,/, either/CC directly/RB due/JJ to/TO tumor/NN involvement/NN of/IN critical/JJ organs/NNS or/CC indirectly/RB due/JJ to/TO complications/NNS of/IN therapy/NN to/TO control/VB tumor/NN growth/NN and/CC spread/NN ./.
P10357558A16
Therapies/NNS designed/VBN to/TO interfere/VB with/IN specific/JJ MMP/NN actions/NNS may/MD be/VBP useful/JJ in/IN the/DT control/NN of/IN metastatic/JJ disease/NN ./.
P10359049A06
In/IN animals/NNS fed/VBN 0.4/CD %/SYM OPB-3206/NN ,/, the/DT activity/NN of/IN proMMP-9/NN was/VBD increased/VBN ,/, but/CC that/PRP for/IN MMP-9/NN had/VBD become/VBN undetectable/JJ ./.
P10359808A08
Gelatinase/NN B-deficient/JJ mice/NNS failed/VBN to/TO show/VB IL-10/NN production/NN at/IN the/DT site/NN of/IN CHS/NN ,/, an/DT essential/JJ feature/NN of/IN resolution/NN in/IN control/NN mice/NNS ./.
P10365570A05
In/IN JRA/NN ,/, MMP-3/NN levels/NNS of/IN patients/NNS with/IN arthritis/NN were/VBD statistically/RB higher/JJR than/IN those/PRP of/IN patients/NNS without/IN arthritis/NN (/( P/NN </SYM 0.05/CD )/) and/CC MMP-3/NN levels/NNS were/VBD correlated/VBN with/IN C-reactive/JJ protein/NN (/( rs/NN =/SYM 0.465/CD ,/, P/NN </SYM 0.05/CD )/) ,/, while/IN TIMP-1/NN did/VBD not/RB (/( rs/NN =/SYM 0.340/CD )/) ./.
P10366192A09
In/IN plasma/NN ,/, only/RB MMP-9/NN increased/VBD transiently/RB at/IN 2/CD hours/NNS of/IN MCAO/NN ./.
P10366463A15
CONCLUSIONS/NNS :/: Both/CC MMP-2/NN and/CC TIMP-2/NN have/VBP a/DT key/JJ role/NN in/IN extracellular/JJ matrix/NN invasion/NN in/IN cervical/JJ carcinoma/NN ,/, largely/RB through/IN their/PRP$ elaboration/NN by/IN tumor/NN cells/NNS ./.
P10377026A01
Progesterone/NN appears/VBZ essential/JJ for/IN ovulation/NN and/CC luteinization/NN of/IN the/DT primate/NN follicle/NN ,/, but/CC specific/JJ gene/NN targets/NNS of/IN progesterone/NN action/NN remain/VBP elusive/JJ ./.
P10377072A11
Thus/RB ,/, activation/NN of/IN SMCs/NNS and/CC Mphi/NN by/IN proinflammatory/JJ molecules/NNS may/MD influence/VBP extracellular/JJ matrix/NN remodeling/NN in/IN atherosclerosis/NN by/IN regulating/NN MT1-MMP/NN expression/NN ./.
P10377085A05
The/DT adenoviral/JJ vector/NN was/VBD delivered/VBN to/TO the/DT injured/JJ rat/NN carotid/JJ artery/NN ,/, and/CC 4/CD days/NNS later/RB ,/, immunoreactive/JJ protein/NN was/VBD identified/VBN and/CC migration/NN of/IN SMCs/NNS reduced/VBD by/IN 60/CD %/SYM (/( 5.2/CD +/-/SYM 0./CD 5/CD versus/CC 12.8/CD +/-/SYM 1.5/CD cells/NNS per/IN section/NN ,/, P/NN </SYM 0.05/CD ,/, n=5/NN )/) ./.
P10385653A02
These/DT enzymes/NNS are/VBP important/JJ mediators/NNS of/IN cold/NN preservation/NN injury/NN ./.
P10389763A01
Hepatocyte/NN growth/NN factor/NN //SYM scatter/NN factor/NN (/( HGF/NN //SYM SF/NN )/) contributes/VBZ to/TO the/DT malignant/JJ progression/NN of/IN human/NN gliomas/NNS ./.
P10390144A01
Bone/NN metastases/NNS are/VBP a/DT common/JJ complication/NN in/IN prostate/NN and/CC breast/NN cancer/NN patients/NNS ./.
P10390419A02
The/DT accumulation/NN in/IN the/DT submucosa/NN of/IN fibrous/JJ proteins/NNS that/WDT are/VBP substrates/NNS of/IN matrix/NN metalloproteinases/NNS (/( MMP/NN )/) ,/, and/CC the/DT demonstration/NN of/IN increased/JJ levels/NNS of/IN MMP-9/NN in/IN bronchoalveolar/JJ lavage/NN fluid/NN ,/, prompted/VBD us/PRP to/TO determine/VB whether/IN there/EX was/VBD an/DT imbalance/NN between/IN MMPs/NNS and/CC tissue/NN inhibitors/NNS of/IN metalloproteinase/NN (/( TIMP/NN )/) in/IN such/DT patients/NNS ./.
P10397688A09
Casein/NN zymography/NN and/CC in/FW situ/FW zymography/NN demonstrated/VBD that/IN increased/JJ caseinolytic/JJ activity/NN was/VBD confined/VBN to/TO the/DT pericellular/JJ zones/NNS of/IN macrophages/NNS within/IN the/DT lipid/NN core/NN ,/, again/RB consistent/JJ with/IN its/PRP$ restriction/NN by/IN TIMPs/NNS ./.
P10402070A01
OBJECTIVES/NNS :/: To/TO compare/VB plasma/NN levels/NNS of/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) -3/CD ,/, MMP-9/NN and/CC tissue/NN inhibitor/NN of/IN metalloproteinases-1/NN (/( TIMP-1/NN )/) between/IN patients/NNS with/IN knee/NN osteoarthritis/NN and/CC normal/JJ subjects/NNS ,/, to/TO investigate/VB whether/IN the/DT degree/NN of/IN knee/NN joint/NN involvement/NN is/VBZ related/VBN to/TO those/DT measurements/NNS ,/, and/CC to/TO compare/VB patients/NNS with/IN and/CC without/IN generalized/JJ osteoarthritis/NN ./.
P10402168A06
Angiogenesis/NN in/IN the/DT metastatic/JJ group/NN was/VBD higher/JJR than/IN that/PRP of/IN the/DT localized/JJ one/PRP (/( p/NN </SYM 0.05/CD )/) ./.
P10403463A06
ICC/NN results/NNS indicated/VBD that/IN 5/CD of/IN the/DT 20/CD tumors/NNS coincidentally/RB produced/VBD all/DT three/CD MMPs/NNS ./.
P10405207A04
In/IN this/DT study/NN ,/, it/PRP is/VBZ hypothesized/VBN that/IN thrombin/NN may/MD alter/VBP the/DT production/NN and/CC the/DT degradation/NN of/IN type/NN IV/CD collagen/NN ,/, which/WDT is/VBZ an/DT important/JJ component/NN of/IN ECM/NN in/IN the/DT glomeruli/NNS ./.
P10408538A08
RESULTS/NNS :/: The/DT production/NN of/IN MMP-2/NN and/CC MMP-9/NN is/VBZ increased/VBN in/IN nerve/NN tissue/NN in/IN CIDP/NN and/CC NSVN/NN compared/VBN with/IN NIN/NN ./.
P10409657A07
Production/NN of/IN TIMP-2/NN was/VBD about/RB 10-fold/NN higher/JJR in/IN low/JJ invasive/JJ cells/NNS as/IN compared/VBN with/IN high/JJ invasive/JJ melanoma/NN cells/NNS and/CC was/VBD further/RB increased/VBD in/IN the/DT low/JJ invasive/JJ cells/NNS upon/IN contact/NN to/TO collagen/NN ./.
P10411111A05
Gelatin/NN zymography/NN showed/VBD that/IN both/DT tumor/NN cell/NN lines/NNS did/VBD not/RB secrete/VBP MMP-9/NN by/IN themselves/PRP but/CC the/DT host/NN cells/NNS surrounding/VBG the/DT tumor/NN cells/NNS secrete/VBP MMP-9/NN in/FW vivo/FW ./.
P10415717A14
Batimastat/NN and/CC marimastat/NN appear/VBP not/RB to/TO interfere/VB with/IN normal/JJ wound/NN healing/NN ,/, but/CC only/RB in/IN sutured/JJ surgical/JJ wounds/NNS ,/, a/DT situation/NN in/IN which/WDT MMP/NN expression/NN has/VBZ practically/RB no/DT role/NN ./.
P10421601A05
CPB+LPS/NN caused/VBD severe/JJ lung/NN injury/NN ,/, as/IN demonstrated/VBN by/IN a/DT significant/JJ fall/NN in/IN PaO/NN (/( 2/CD )/) and/CC an/DT increase/NN in/IN intrapulmonary/JJ shunt/NN compared/VBN with/IN all/DT groups/NNS (/( P/NN </SYM 0.05/CD )/) ./.
P10426384A06
The/DT addition/NN of/IN recombinant/JJ IGF-1/NN to/TO nondiabetic/JJ NOD-MC/NN resulted/VBD in/IN a/DT decrease/NN in/IN MMP-2/NN and/CC TIMP/NN activity/NN ./.
P10430840A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP implicated/VBN in/IN the/DT pathogenesis/NN of/IN various/JJ inflammatory/JJ diseases/NNS of/IN the/DT central/JJ nervous/JJ system/NN ./.
P10433942A02
Because/IN the/DT excess/JJ matrix/NN deposition/NN is/VBZ potentially/RB reversible/JJ ,/, a/DT labile/JJ imbalance/NN between/IN fibrogenesis/NN and/CC fibrolysis/NN may/MD be/VBP suspected/VBN ./.
P10434927A04
Both/CC zymography/NN and/CC ELISA/NN showed/VBD that/IN MMP-2/NN and/CC MMP-9/NN were/VBD the/DT major/JJ metalloproteinases/NNS found/VBN in/IN the/DT flushings/NNS and/CC only/RB low/JJ concentrations/NNS of/IN MMP-3/NN were/VBD found/VBN ./.
P10438572A11
Immunostaining/NN of/IN keratinocytes/NNS advancing/VBG into/IN the/DT wound/NN revealed/VBD that/IN MMP-2/NN was/VBD localized/VBN in/IN extracellular/JJ matrix/NN contactlike/JJ structures/NNS against/IN the/DT endogenously/RB produced/JJ laminin-5-rich/JJ matrix/NN ./.
P10443293A08
Caseinolytic/JJ bands/NNS observed/VBN were/VBD confirmed/VBN by/IN Western/NN blot/NN analysis/NN to/TO be/VB due/JJ to/TO stromelysin/NN activity/NN ,/, whereas/IN matrilysin/NN was/VBD not/RB detected/VBN by/IN casein/NN zymography/NN ./.
P10444506A03
Accordingly/RB ,/, isolated/JJ Ca/NN (/( 2+/CD )/) -tolerant/JJ LV/NN porcine/JJ myocytes/NNS (/( 10/CD (/( 5/CD )/) cells/NNS //SYM ml/NN )/) in/IN which/WDT selective/JJ disaggregation/NN and/CC resuspension/NN was/VBD performed/VBN (/( 13/CD independent/JJ experiments/NNS )/) were/VBD plated/VBN on/IN basement/NN membrane/NN substrates/NNS including/VBG Matrigel/NN ,/, collagen/NN IV/CD ,/, laminin/NN ,/, and/CC fibronectin/NN as/RB well/RB as/IN poly-L-lysine/NN ./.
P10452757A07
Biopsy/NN specimens/NNS were/VBD examined/VBN for/IN extent/NN of/IN collagen/NN type/NN III/CD in/IN the/DT subepithelial/JJ basement/NN membrane/NN by/IN means/NNS of/IN immunohistochemistry/NN ,/, and/CC expression/NN of/IN both/CC epithelial/JJ and/CC submucosal/JJ MMP-9/NN and/CC TIMP-1/NN was/VBD quantitated/VBN ./.
P10455065A02
The/DT matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) play/VBP a/DT significant/JJ role/NN in/IN extracellular/JJ remodeling/NN ,/, and/CC recent/JJ studies/NNS have/VBP demonstrated/VBN increased/JJ MMP/NN expression/NN and/CC activity/NN with/IN CHF/NN ./.
P10459021A06
As/IN a/DT consequence/NN of/IN reduced/JJ IGFBP-3/NN proteolysis/NN and/CC elevated/JJ IGFBP-3/NN protein/NN levels/NNS ,/, dissociable/JJ IGF-II/NN levels/NNS were/VBD significantly/RB lower/JJR in/IN TIMP-1-overexpressing/JJ animals/NNS ./.
P10465309A06
Most/PRP of/IN the/DT MMPs/NNS and/CC TIMPs/NNS were/VBD expressed/VBN at/IN a/DT constitutive/JJ level/NN throughout/IN the/DT periovulatory/JJ period/NN ./.
P10472357A01
BACKGROUND/NN :/: Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP a/DT family/NN of/IN zinc-dependent/JJ metalloendopeptidases/NNS which/WDT participate/VBP in/IN the/DT degradation/NN of/IN collagen/NN and/CC other/JJ extracellular/JJ matrix/NN macromolecules/NNS ./.
P10474026A08
There/EX was/VBD a/DT correlation/NN between/IN TIMP-2/NN immunoreactivity/NN and/CC disease/NN stage/NN (/( 42/CD %/SYM stage/NN I/CD versus/CC 88/CD %/SYM stages/NNS II/CD ,/, III/CD ,/, and/CC IV/CD )/) (/( p/NN =/SYM 0.0024/CD )/) ./.
P10474160A14
Finally/RB ,/, retinoids/NNS ,/, known/VBN for/IN their/PRP$ dramatic/JJ effects/NNS on/IN the/DT pattern/NN of/IN regenerating/JJ limbs/NNS ,/, can/MD cause/VBP a/DT down/JJ regulation/NN of/IN Mmp-9/NN expression/NN ./.
P10479141A03
The/DT M./NN avium-induced/JJ HIV-1/NN replication/NN was/VBD not/RB associated/VBN with/IN cell/NN activation/NN or/CC differential/JJ cytokine/NN production/NN or/CC utilization/NN ./.
P10485622A05
TIMP-1/NN and/CC TIMP-2/NN expressions/NNS were/VBD localized/VBN overwhelmingly/RB to/TO pericancer/NN stromal/JJ cells/NNS ,/, while/IN malignant/JJ and/CC normal/JJ mucosal/JJ cells/NNS were/VBD weak/JJ or/CC negative/JJ ./.
P10487706A04
Exposure/NN of/IN these/DT cells/NNS ,/, for/IN 1/CD h/NN ,/, to/TO the/DT active/JJ phorbol/NN ester/NN ,/, phorbol/NN 12-myristate/NN 13-acetate/NN (/( TPA/NN ,/, 100/CD nmol/NN //SYM L/NN )/) ,/, acting/VBG via/IN protein/NN kinase/NN C/NN (/( PKC/NN )/) ,/, elicited/VBD an/DT increase/NN in/IN MMP-1/NN mRNA/NN ,/, with/IN a/DT peak/JJ stimulation/NN after/IN a/DT 3-/CD to/TO 4-h/NN culture/NN period/NN ./.
P10493528A10
The/DT clone/NN with/IN the/DT lowest/JJS reduction/NN in/IN S100A4/NN did/VBD not/RB demonstrate/VBP different/JJ motility/NN compared/VBN with/IN control/NN cells/NNS ,/, whereas/IN transfectants/NNS with/IN only/RB 5/CD %/SYM S100A4/NN mRNA/NN showed/VBD a/DT 50/CD %/SYM reduction/NN in/IN motility/NN ./.
P10497310A08
These/DT results/NNS indicate/VBP that/IN tryptase/NN does/VBZ not/RB increase/VBP MMP/NN expression/NN in/IN normal/JJ dermal/JJ fibroblasts/NNS ./.
P10498646A12
Similar/JJ results/NNS were/VBD obtained/VBN using/VBG membrane/NN fractions/NNS from/IN cells/NNS previously/RB cultured/VBN on/IN collagen/NN or/CC plastic/NN ./.
P10502722A09
In/FW situ/FW hybridization/NN showed/VBD carcinoma/NN cells/NNS selectively/RB expressing/VBG MMP-7/NN mRNA/NN ./.
P10508223A02
Using/VBG primary/JJ cultures/NNS of/IN human/NN myometrial/JJ smooth/JJ muscle/NN cells/NNS we/PRP found/VBD that/IN these/DT cells/NNS express/VBP MMP-1/NN ,/, MMP-3/NN ,/, TIMP-1/NN and/CC TIMP-2/NN mRNA/NN and/CC protein/NN ,/, with/IN significantly/RB higher/JJR values/NNS of/IN TIMP/NN than/IN MMP/NN ./.
P10508819A03
Rats/NNS were/VBD instilled/VBN with/IN 50/CD mg/NN of/IN silica/NN and/CC sacrificed/VBN after/IN 15/CD and/CC 60/CD d/NN ./.
P10508828A05
Ethanol/NN ingestion/NN increased/VBD (/( p/NN </SYM 0.05/CD )/) MMP-9/NN and/CC MMP-2/NN activity/NN ,/, as/IN determined/VBN by/IN zymography/NN ,/, in/IN the/DT lung/NN tissue/NN and/CC lavage/NN fluid/NN compared/VBN with/IN control-fed/JJ rats/NNS ,/, and/CC increased/VBD (/( p/NN </SYM 0.05/CD )/) levels/NNS of/IN the/DT 7S/NN fragment/NN of/IN type/NN IV/CD collagen/NN in/IN the/DT lung/NN lavage/NN fluid/NN ./.
P10513800A02
METHODS/NNS :/: Blood/NN was/VBD obtained/VBN from/IN 20/CD RA/NN patients/NNS before/IN they/PRP arose/VBD from/IN a/DT night/NN 's/POS sleep/NN ,/, and/CC again/RB 1/CD and/CC 4/CD hours/NNS after/IN they/PRP had/VBD begun/VBN to/TO perform/VB moderate/JJ physical/JJ activity/NN ./.
P10516419A01
Matrix/NN metalloproteinases/NNS appear/VBP to/TO play/VB a/DT role/NN in/IN cell/NN migration/NN and/CC tissue/NN remodeling/NN and/CC are/VBP postulated/VBN to/TO be/VB important/JJ in/IN the/DT development/NN of/IN embryos/NNS ./.
P10526099A03
Gelatinase/NN A/NN (/( MMP-2/NN )/) and/CC gelatinase/NN B/NN (/( MMP-9/NN )/) are/VBP able/JJ to/TO digest/VB the/DT endothelial/JJ basal/JJ lamina/NN ,/, which/WDT plays/VBZ a/DT major/JJ role/NN in/IN maintaining/NN BBB/NN impermeability/NN ./.
P10529239A07
Reduced/JJ chains/NNS from/IN MMP-3/NN ,/, MMP-7/NN ,/, and/CC MT1-MMP/NN digests/NNS of/IN Fg/NN and/CC XL-Fb/NN were/VBD subjected/VBN to/TO direct/JJ sequence/NN analyses/NNS and/CC D/NN //SYM D-dimer/NN alpha-chain/NN showed/VBD cleavage/NN at/IN both/CC alpha/NN Asp/NN 97-Phe/NN 98/CD and/CC alpha/NN Asn/NN 102-Asn/NN 103/CD ./.
P10535713A07
Zymography/NN and/CC Western/NN blot/NN showed/VBD significant/JJ expression/NN of/IN MMP-2/NN in/IN Calu-3/NN cells/NNS ./.
P10545018A04
The/DT Immnunoblot/NN findings/NNS revealed/VBD the/DT major/JJ gelatinolytic/JJ activities/NNS to/TO be/VB due/JJ to/TO matrix/NN metalloproteinase/NN (/( MMP/NN )/) -2/CD and/CC -9/CD ./.
P10548534A12
Cultures/NNS of/IN late-stage/NN OA/NN human/NN articular/JJ cartilage/NN samples/NNS indicated/VBD that/IN aggrecanase/NN activity/NN was/VBD upregulated/VBN in/IN the/DT absence/NN of/IN catabolic/JJ stimulation/NN when/WRB compared/VBN with/IN normal/JJ porcine/JJ or/CC bovine/JJ cartilage/NN ./.
P10550743A09
The/DT transcription/NN inhibitor/NN actinomycin/NN D/NN ,/, the/DT nuclear/JJ factor/NN kappaB/NN (/( NFkappaB/NN )/) inhibitor/NN N-CBZ-Leu-Leu-Leu-AL/NN ,/, the/DT protein/NN synthesis/NN inhibitor/NN cycloheximide/NN ,/, and/CC the/DT protein/NN kinase/NN C/NN inhibitor/NN H7/NN significantly/RB decreased/VBD MMP-9/NN activity/NN in/IN TNF-alpha-treated/JJ cells/NNS ./.
P10551322A01
Membrane/NN type/NN 1/CD matrix/NN metalloproteinase/NN (/( MT1-MMP/NN )/) with/IN a/DT transmembrane/JJ domain/NN is/VBZ a/DT new/JJ member/NN of/IN the/DT MMP/NN gene/NN family/NN and/CC is/VBZ expressed/VBN on/IN the/DT cell/NN surfaces/NNS of/IN many/DT carcinoma/NN cells/NNS to/TO activate/VB the/DT zymogen/NN of/IN MMP-2/NN (/( gelatinase/NN A/NN )/) ./.
P10555745A08
None/CD of/IN the/DT melanoma/NN cell/NN lines/NNS expressed/VBD MMP-9/NN ./.
P10561218A14
Increased/JJ tumoral/JJ expression/NN of/IN MMP-3/NN ,/, -11/CD ,/, and/CC -14/CD were/VBD independent/JJ negative/JJ prognostic/JJ factors/NNS for/IN survival/NN ./.
P10567441A07
Our/PRP$ results/NNS show/VBP that/IN EMMPRIN/NN is/VBZ an/DT important/JJ factor/NN in/IN tumor/NN progression/NN by/IN causing/NN tumor-associated/JJ stromal/JJ cells/NNS to/TO increase/VB their/PRP$ MMP-2/NN production/NN ,/, thus/RB facilitating/VBG tumor/NN invasion/NN and/CC neoangiogenesis/NN ./.
P10579795A01
BACKGROUND/NN :/: The/DT family/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) has/VBZ been/VBN shown/VBN to/TO be/VB involved/VBN in/IN proteolytic/JJ degradation/NN of/IN the/DT extracellular/JJ matrix/NN ,/, which/WDT is/VBZ an/DT essential/JJ step/NN in/IN tumor/NN invasion/NN and/CC metastasis/NN ./.
P10587545A04
RESULTS/NNS :/: GLS/NN demonstrated/VBD a/DT self-induction/NN of/IN mRNA/NN in/IN cultured/JJ RA/NN FLSs/NNS ./.
P10590246A08
These/DT data/NNS are/VBP compatible/JJ with/IN a/DT role/NN of/IN TIMP-1/NN in/IN the/DT impairment/NN of/IN SMC/NN migration/NN and/CC neointima/NN formation/NN after/IN vascular/JJ injury/NN ,/, as/IN a/DT result/NN of/IN inhibition/NN of/IN MMP/NN activity/NN ./.
P10598711A01
OBJECTIVE/NN :/: To/TO determine/VB the/DT expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMP/NN )/) -1/CD ,/, -2/CD ,/, and/CC -3/CD and/CC the/DT tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMP/NN )/) -1/CD ,/, -2/CD ,/, and/CC -3/CD in/IN 12/CD tissue/NN samples/NNS from/IN normal/JJ pituitary/NN glands/NNS and/CC in/IN 28/CD human/NN pituitary/NN tumors/NNS ranging/VBG from/IN Grade/NN 0/CD to/TO Grade/NN IV/CD ,/, and/CC to/TO establish/VB a/DT correlation/NN between/IN the/DT level/NN of/IN expression/NN of/IN MMPs/NNS and/CC TIMPs/NNS and/CC the/DT tumor/NN grade/NN ./.
P10600941A05
Northern/NN blot/NN analyses/NNS revealed/VBD a/DT single/JJ approximately/RB 4.5-kb/NN mRNA/NN transcript/NN of/IN MT-1-MMP/NN ,/, and/CC its/PRP$ expression/NN was/VBD developmentally/RB regulated/VBN ./.
P10601286A04
Evidence/NN of/IN relatively/RB slow/JJ motion/NN indicative/JJ of/IN exchange/NN between/IN two/CD or/CC more/DT local/JJ conformations/NNS on/IN a/DT microsecond/NN to/TO millisecond/NN time/NN scale/NN was/VBD also/RB found/VBN in/IN the/DT free/JJ protein/NN ,/, including/VBG two/CD other/JJ regions/NNS of/IN the/DT MMP/NN binding/JJ site/NN (/( the/DT CD/NN and/CC EF/NN loops/NNS )/) ./.
P10611071A02
Expression/NN and/CC activation/NN mechanisms/NNS for/IN proMMP-2/NN differ/VBP from/IN other/JJ MMPs/NNS ;/: in/IN many/DT cells/NNS proMMP-2/NN is/VBZ specifically/RB activated/VBN by/IN membrane-type/NN (/( MT/NN )/) -MMPs/NNS ./.
P10616801A07
In/IN contrast/NN ./.
P10617637A10
On/IN the/DT other/JJ hand/NN ,/, the/DT inhibition/NN was/VBD not/RB seen/VBN after/IN the/DT addition/NN of/IN the/DT cyclic/JJ AMP-dependent/JJ kinase/NN inhibitor/NN ,/, H-8/NN ./.
P10620188A12
CONCLUSION/NN :/: We/PRP conclude/VBP that/IN NO/NN modulates/VBZ cytokine-mediated/JJ expression/NN of/IN MMP-9/NN and/CC TIMP-1/NN in/IN rat/NN MCs/NNS in/IN culture/NN ./.
P10620388A08
Galardin/NN significantly/RB reduced/VBD the/DT amounts/NNS of/IN collagen/NN degraded/VBN by/IN P./NN aeruginosa/NN culture/NN broth/NN ,/, whether/IN keratocytes/NNS were/VBD present/JJ or/CC absent/JJ in/IN the/DT gel/NN ./.
P10621835A07
METHODS/NNS :/: The/DT synthesis/NN of/IN proteinases/NNS and/CC their/PRP$ inhibitors/NNS was/VBD compared/VBN in/IN paired/JJ tumour/NN and/CC normal/JJ tissue/NN samples/NNS from/IN patients/NNS with/IN colorectal/JJ cancer/NN (/( n/NN =/SYM 24/CD )/) ./.
P10623524A05
The/DT MMP-dependent/JJ conformational/JJ changes/NNS in/IN the/DT ridge/NN include/VBP a/DT dramatic/JJ bending/NN of/IN AB/NN loop/NN residues/NNS Glu28/NN through/IN Leu34/NN ,/, moderate/JJ hinge/NN bending/NN of/IN the/DT CD-loop/NN about/IN residues/NNS Ala65/NN and/CC Cys70/NN ,/, and/CC modest/JJ bending/NN of/IN the/DT Cys1/NN through/IN Pro6/NN segment/NN ./.
P10623708A08
BAY/NN 12-9566/CD was/VBD well/RB tolerated/VBN on/IN all/DT dose/NN schedules/NNS ,/, and/CC there/EX was/VBD no/DT consistent/JJ dose-limiting/JJ toxicity/NN that/WDT precluded/VBD treatment/NN in/IN the/DT range/NN of/IN dose/NN schedules/NNS evaluated/VBN ./.
P10625713A01
BACKGROUND/NN AND/CC PURPOSE/NN :/: Acute/JJ disruption/NN of/IN atherosclerotic/JJ plaques/NNS precedes/VBZ the/DT onset/NN of/IN clinical/JJ syndromes/NNS ,/, and/CC studies/NNS have/VBP implicated/VBN a/DT role/NN for/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) in/IN this/DT process/NN ./.
P10628798A02
Altered/JJ expression/NN of/IN matrix/NN degrading/JJ enzymes/NNS may/MD indicate/VBP an/DT increased/JJ potential/NN for/IN invasive/JJ growth/NN ./.
P10633007A01
Tissue/NN injury/NN and/CC pelvic/JJ inflammation/NN often/RB results/VBZ in/IN peritoneal/JJ scar/NN tissue/NN formation/NN ./.
P10634397A07
These/DT results/NNS define/VBP a/DT new/JJ additional/JJ mechanism/NN for/IN the/DT control/NN of/IN pituitary/NN hormone/NN secretion/NN and/CC indicate/VBP new/JJ potential/JJ therapeutic/JJ targets/NNS for/IN pituitary/NN adenomas/NNS ./.
P10638966A05
Zymogram/NN analysis/NN revealed/VBD that/IN the/DT effects/NNS of/IN the/DT growth/NN factors/NNS depended/VBD upon/IN the/DT cell/NN lines/NNS used/VBN in/IN the/DT study/NN ./.
P10642509A03
Both/CC fMT1-MMP/NN and/CC sMT1-MMP/NN expressed/VBN in/IN the/DT expression/NN system/NN were/VBD found/VBN not/RB to/TO contain/VB the/DT pro-domain/NN and/CC were/VBD able/JJ to/TO activate/VB the/DT TIMP-2-free/JJ pro-MMP-2/NN ./.
P10642956A14
Active/JJ ,/, TIMP/NN free/JJ MMP2/NN levels/NNS were/VBD increased/VBN during/IN PROM/NN (/( mean/NN 233/CD pg/NN //SYM ml/NN )/) compared/VBN to/TO those/PRP at/IN term/NN (/( mean/NN 132/CD pg/NN //SYM ml/NN ;/: p/NN </SYM 0.05/CD )/) or/CC PTL/NN (/( mean/NN 132/CD pg/NN //SYM ml/NN ;/: p/NN </SYM 0.05/CD )/) ./.
P10645258A07
MMP-2/NN reached/VBD a/DT peak/NN on/IN day/NN 3/CD ,/, whereas/IN the/DT highest/JJS expression/NN of/IN MMP-7/NN occurred/VBD on/IN day/NN 7/CD ./.
P10650781A05
RESULTS/NNS :/: MMP-1/NN ,/, MMP-2/NN ,/, and/CC TIMP-2/NN were/VBD detected/VBN by/IN immunohistochemistry/NN in/IN 74/CD %/SYM (/( 113/CD //SYM 154/CD )/) ,/, 32/CD %/SYM (/( 49/CD //SYM 154/CD )/) ,/, and/CC 80/CD %/SYM (/( 107/CD //SYM 154/CD )/) of/IN the/DT tumor/NN samples/NNS ,/, respectively/RB ./.
P10657374A02
METHODS/NNS :/: Quantitative/JJ reverse/JJ transcription-PCR/NN //SYM ELISA/NN assays/NNS were/VBD performed/VBN for/IN MMP/NN and/CC TIMP/NN RNA/NN ,/, and/CC corresponding/JJ circulating/JJ protein/NN concentrations/NNS were/VBD studied/VBN by/IN ELISA/NN in/IN 20/CD healthy/JJ controls/NNS ,/, 40/CD patients/NNS with/IN CAH/NN ,/, and/CC 20/CD patients/NNS with/IN hepatitis/NN C-induced/JJ cirrhosis/NN (/( Ci/NN )/) ./.
P10664012A06
Since/IN MMP-1/NN and/CC -2/CD are/VBP considered/VBN to/TO be/VB major/JJ enzymes/NNS involved/VBN in/IN the/DT degradation/NN of/IN matrix/NN components/NNS ,/, the/DT accumulation/NN of/IN elastotic/JJ materials/NNS in/IN actinic/JJ elastosis/NN may/MD be/VBP related/VBN to/TO the/DT degradation/NN process/NN ./.
P10664501A02
Doxycycline/NN (/( Dox/NN )/) has/VBZ direct/JJ MMP-inhibiting/JJ properties/NNS in/FW vitro/FW ,/, and/CC it/PRP effectively/RB suppresses/VBZ the/DT development/NN of/IN elastase-induced/JJ AAAs/NNS in/IN rodents/NNS ./.
P10670469A02
METHODS/NNS :/: Expression/NN of/IN transcripts/NNS and/CC proteins/NNS of/IN MMPs/NNS ,/, TIMPs/NNS ,/, and/CC urokinase/NN plasminogen/NN activator/NN (/( uPA/NN )/) by/IN cultured/JJ normal/JJ human/NN conjunctival/JJ and/CC conjunctivochalasis/NN fibroblasts/NNS was/VBD determined/VBN by/IN Northern/NN hybridization/NN ,/, enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/) ,/, and/CC Western/NN blot/NN analysis/NN ,/, respectively/RB ./.
P10675223A08
The/DT data/NNS show/VBP that/IN (/( 1/CD )/) MMP-9/NN activity/NN is/VBZ present/JJ in/IN the/DT CSF/NN of/IN patients/NNS with/IN neuroborreliosis/NN ,/, (/( 2/CD )/) macrophages/NNS stimulated/VBN with/IN B/NN burgdorferi/NN are/VBP a/DT possible/JJ source/NN of/IN MMP-9/NN increase/NN ,/, and/CC (/( 3/CD )/) activation/NN of/IN NF-kappaB/NN may/MD play/VBP a/DT part/NN in/IN the/DT upregulation/NN of/IN MMP-9/NN by/IN B/NN burgdorferi/NN ./.
P10679106A02
Animal/NN models/NNS have/VBP shown/VBN that/IN lipoxin/NN A4/NN (/( LXA4/NN )/) down-regulates/VBZ inflammation/NN in/FW vivo/FW ./.
P10682680A12
In/IN previous/JJ studies/NNS we/PRP have/VBP shown/VBN that/IN exposure/NN of/IN normal/JJ skin/NN to/TO epidermal/JJ growth/NN factor/NN in/IN organ/NN culture/NN induces/VBZ MMP/NN up-regulation/NN and/CC activation/NN ./.
P10689021A12
Western/NN blot/NN analysis/NN showed/VBD the/DT presence/NN of/IN MMP-7/NN and/CC MMP-9/NN in/IN menstrual/JJ serum/NN ./.
P10697171A07
Two/CD animals/NNS at/IN a/DT time/NN were/VBD reanesthetized/VBN ,/, and/CC all/DT eight/CD wounds/NNS on/IN each/DT animal/NN were/VBD excised/VBN at/IN 12/CD and/CC 24/CD hours/NNS and/CC at/IN 2/CD ,/, 3/CD ,/, 5/CD ,/, 7/CD ,/, 10/CD ,/, and/CC 14/CD days/NNS after/IN injury/NN ./.
P10706098A10
MT6-MMP/NN was/VBD also/RB detected/VBN at/IN high/JJ levels/NNS in/IN SW480/NN colon/NN carcinoma/NN cells/NNS as/RB well/RB as/IN in/IN some/DT anaplastic/JJ astrocytomas/NNS and/CC glioblastomas/NNS ,/, but/CC not/RB in/IN normal/JJ colon/NN or/CC brain/NN or/CC in/IN meningiomas/NNS ./.
P10706134A09
In/IN parallel/NN with/IN MMP-9/NN up-regulation/NN ,/, all/DT EGF-like/JJ ligands/NNS increased/VBD tumor/NN cell/NN invasion/NN through/IN Matrigel/NN in/IN in/FW vitro/FW Transwell/NN assays/NNS ./.
P10709099A05
TIMP-2/NN values/NNS could/MD not/RB be/VBP measured/VBN ./.
P10712992A01
BACKGROUND/NN :/: A/DT central/JJ feature/NN in/IN the/DT pathogenesis/NN of/IN COPD/NN is/VBZ the/DT inflammation/NN coexisting/VBG with/IN an/DT abnormal/JJ protease/NN //SYM antiprotease/NN balance/NN ./.
P10716770A02
Ten/CD SCI/NN subjects/NNS participated/VBN in/IN an/DT 18-month/NN program/NN of/IN functional/JJ electrical/JJ stimulation/NN (/( FES/NN )/) of/IN their/PRP$ leg/NN muscles/NNS ./.
P10719361A06
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP believed/VBN to/TO be/VB the/DT main/JJ mediators/NNS of/IN ECM/NN degradation/NN ./.
P10726683A08
The/DT ratio/NN of/IN MMP-2/NN //SYM TIMP-2/NN mRNAs/NNS was/VBD significantly/RB higher/JJR in/IN the/DT advanced/JJ stages/NNS versus/CC early/JJ stages/NNS (/( mean/NN +/-/SYM SD/NN =/SYM 1.66/CD +/-/SYM 0.65/CD and/CC 1.11/CD +/-/SYM 0.34/CD ,/, respectively/RB ;/: P/NN =/SYM .02/CD )/) and/CC in/IN patients/NNS who/WP died/VBD of/IN progressive/JJ disease/NN versus/CC alive/JJ patients/NNS (/( mean/NN =/SYM 2.13/CD +/-/SYM 0.78/CD and/CC 1.21/CD +/-/SYM 0.36/CD ,/, respectively/RB ;/: P/NN =/SYM .0006/CD )/) ./.
P10727268A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP implicated/VBN in/IN the/DT degradation/NN of/IN extracellular/JJ matrix/NN ;/: they/PRP play/VBP important/JJ roles/NNS in/IN the/DT invasion/NN of/IN the/DT trophoblast/NN cell/NN into/IN the/DT maternal/JJ endometrium/NN during/IN placentation/NN ./.
P10727268A16
The/DT same/JJ cytotrophoblast/NN cells/NNS that/WDT produced/VBD MMPs/NNS could/MD also/RB secrete/VBP various/JJ substrates/NNS for/IN these/DT enzymes/NNS ./.
P10728589A03
MT1-MMP/NN expression/NN is/VBZ accompanied/VBN by/IN the/DT functional/JJ activation/NN of/IN integrin/NN alphaVbeta3/NN ,/, thereby/RB increasing/VBG vitronectin-mediated/JJ adhesion/NN and/CC migration/NN of/IN MCF7/NN cells/NNS transfected/VBN with/IN MT1-MMP/NN and/CC integrin/NN alphaVbeta3/NN ./.
P10731089A06
MMP/NN and/CC TIMP/NN messages/NNS were/VBD detected/VBN using/VBG RT-PCR/NN with/IN specific/JJ primers/NNS to/TO MMPs/NNS 2/CD ,/, 3/CD ,/, 7/CD ,/, 9/CD and/CC 13/CD and/CC TIMPs/NNS 1/CD and/CC 2/CD ./.
P10731924A08
Immunoreactivity/NN for/IN COX-2/NN was/VBD predominantly/RB noted/VBN in/IN macrophages/NNS and/CC smooth/JJ muscle/NN cells/NNS (/( SMCs/NNS )/) of/IN the/DT intima/NN including/VBG atherosclerotic/JJ plaque/NN itself/PRP and/CC the/DT medial/JJ layer/NN of/IN the/DT plaque/NN base/NN ,/, as/RB well/RB as/IN in/IN SMCs/NNS and/CC endothelial/JJ lining/NN of/IN the/DT vasa/NN vasorum/NN in/IN the/DT adventitia/NN ./.
P10736239A05
We/PRP observed/VBD a/DT high/JJ degree/NN of/IN coexpression/NN of/IN MT2-MMP/NN ,/, MT1-MMP/NN and/CC MMP-2/NN mRNAs/NNS in/IN single/JJ extravillous/JJ cytotrophoblasts/NNS that/WDT had/VBD invaded/VBD the/DT endometrium/NN and/CC tubal/JJ wall/NN ./.
P10737720A02
We/PRP determined/VBD the/DT production/NN of/IN active/JJ MMP-2/NN in/IN five/CD glial/JJ (/( U138MG/NN ,/, U373MG/NN ,/, A172/NN ,/, C6/NN ,/, GOS-3/NN )/) ,/, two/CD neuronal/JJ (/( SK-N-SH/NN ,/, SK-N-MC/NN )/) ,/, and/CC two/CD pluripotent/JJ cell/NN lines/NNS with/IN facultative/JJ neuronal/JJ and/CC glial/JJ differentiation/NN (/( P19/NN and/CC NT2/NN )/) by/IN gelatin/NN zymography/NN ./.
P10745174A01
In/IN order/NN to/TO evaluate/VB the/DT significance/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) in/IN predicting/NN the/DT metastatic/JJ potential/NN of/IN oral/JJ squamous/JJ cell/NN carcinomas/NNS (/( SCCs/NNS )/) ,/, we/PRP compared/VBD MMP-2/NN and/CC -9/CD expression/NN in/IN 19/CD metastasizing/JJ oral/JJ SCCs/NNS with/IN that/PRP in/IN 25/CD non-metastasizing/JJ cases/NNS by/IN immunohistochemistry/NN and/CC gelatin/NN zymography/NN ./.
P10747288A06
The/DT p53/NN level/NN was/VBD measured/VBN by/IN western/NN blot/NN analysis/NN ./.
P10760816A04
The/DT ability/NN of/IN cells/NNS to/TO invade/VB through/IN Matrigel/NN was/VBD found/VBN to/TO be/VB higher/JJR in/IN the/DT EGFR/NN overexpressing/JJ cell/NN lines/NNS (/( p/NN </SYM 0./CD 0001/CD )/) ./.
P10764764A08
The/DT NF-Y/NN and/CC the/DT Sp1/NN binding/JJ site/NN are/VBP both/PRP involved/VBN in/IN cAMP-dependent/JJ up-regulation/NN of/IN TIMP-2/NN ./.
P10765925A14
By/IN this/DT mechanism/NN ,/, CaPPS/NN may/MD be/VBP able/JJ to/TO modulate/VB joint/NN tissue/NN destruction/NN in/IN rheumatoid/JJ arthritis/NN ./.
P10766841A07
Consistently/RB ,/, TIMP-2/NN enhanced/VBD the/DT activation/NN of/IN pro-MMP-2/NN by/IN MT1-MMP/NN ./.
P10772252A08
The/DT addition/NN of/IN cytokines/NNS to/TO stimulate/VB bone/NN resorption/NN resulted/VBD in/IN pronounced/JJ TRAP/NN activity/NN along/IN bone/NN surfaces/NNS ,/, indicating/VBG active/JJ resorption/NN ./.
P10773235A12
MMP-8/NN and/CC MMP-14/NN protein/NN levels/NNS increased/VBD later/RB during/IN heart/NN failure/NN progression/NN ./.
P10775672A06
Immunohistochemical/JJ techniques/NNS were/VBD used/VBN to/TO show/VB the/DT pattern/NN and/CC distribution/NN of/IN MMPs/NNS and/CC TIMP/NN proteins/NNS in/IN the/DT muscle/NN ./.
P10780671A08
This/DT effect/NN was/VBD observed/VBN also/RB under/IN conditions/NNS of/IN angiogenic/JJ stimulation/NN by/IN basic/JJ fibroblast/NN growth/NN factor/NN ./.
P10792961A13
Increased/JJ expression/NN of/IN TIMP-1/NN was/VBD noted/VBN in/IN vein/NN grafts/NNS from/IN both/CC the/DT treated/JJ and/CC the/DT control/NN groups/NNS ,/, 7/CD and/CC 28/CD days/NNS following/VBG graft/NN placement/NN ./.
P10793352A09
TIMP-1/NN was/VBD expressed/VBN in/IN all/DT specimens/NNS ./.
P10793622A08
Apoptosis/NN was/VBD identified/VBN by/IN morphological/JJ criteria/NNS and/CC also/RB by/IN TdT-mediated/JJ dUTP/NN nick/NN end/NN labelling/NN ./.
P10807502A05
Prostaglandin/NN E2/NN (/( PGE2/NN )/) was/VBD measured/VBN by/IN an/DT enzyme/NN immunoassay/NN ./.
P10808169A12
It/PRP was/VBD suggested/VBN that/IN overproduction/NN of/IN MMP-9/NN and/CC TIMP-1/NN after/IN asthma/NN exacerbation/NN might/MD contribute/VBP significantly/RB to/TO airway/NN tissue/NN remodeling/NN and/CC that/IN TIMP-1/NN production/NN in/IN acute/JJ asthma/NN might/MD not/RB be/VBP suppressed/VBN by/IN glucocorticosteroid/NN ./.
P10820340A06
Localization/NN of/IN gelatinase/NN activity/NN was/VBD also/RB confirmed/VBN in/IN carcinoma/NN cells/NNS by/IN in/FW situ/FW zymography/NN ./.
P10831344A09
CONCLUSION/NN :/: Using/VBG an/DT in/FW situ/FW hybridization/NN technique/NN ,/, we/PRP disclosed/VBD a/DT direct/JJ correlation/NN between/IN the/DT presence/NN of/IN mRNA/NN and/CC protein/NN expression/NN for/IN both/CC MMP-9/NN and/CC TIMP-1/NN ./.
P10834863A07
MMP-7/NN and/CC MMP-13/NN were/VBD detectable/JJ in/IN more/RB than/IN 45/CD %/SYM of/IN RA/NN SFs/NNS and/CC in/IN less/RB than/IN 20/CD %/SYM of/IN OA/NN SFs/NNS ,/, respectively/RB ./.
P10845554A01
Sixty/CD human/NN brain/NN tumors/NNS ,/, classified/VBN according/VBG to/TO the/DT New/JJ World/NN Health/NN Organization/NN (/( WHO/WP )/) classification/NN including/VBG ,/, grade/NN I/CD schwannomas/NNS ,/, meningiomas/NNS and/CC pilocytic/JJ astrocytomas/NNS ,/, grade/NN II/CD astrocytomas/NNS ,/, grade/NN III/CD anaplastic/JJ astrocytomas/NNS ,/, grade/NN IV/CD glioblastomas/NNS ,/, grade/NN III/CD anaplastic/JJ oligodendrogliomas/NNS and/CC grade/NN IV/CD glioblastomas/NNS and/CC lung/NN and/CC melanoma/NN metastases/NNS were/VBD analyzed/VBN for/IN the/DT expression/NN of/IN three/CD matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, two/CD tissue/NN inhibitors/NNS of/IN MMPs/NNS (/( TIMPs/NNS )/) and/CC for/IN MMP/NN activity/NN ./.
P10845563A03
In/IN this/DT paper/NN we/PRP examined/VBD the/DT effects/NNS of/IN ligands/NNS with/IN different/JJ c-erbB/NN receptor/NN specificities/NNS in/IN terms/NNS of/IN their/PRP$ stimulation/NN of/IN HNSCC/NN proliferation/NN ,/, expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC invasion/NN ./.
P10845589A05
Cultured/JJ epithelial/JJ cells/NNS and/CC their/PRP$ supernatants/NNS were/VBD also/RB treated/VBN with/IN doxycycline/NN before/IN MMP-3/NN was/VBD added/VBN ./.
P10856282A11
We/PRP hypothesize/VBP a/DT potential/JJ role/NN for/IN 8-iso-PGF/NN (/( 2alpha/NN )/) in/IN the/DT reduced/JJ trophoblast/NN invasion/NN in/IN preeclampsia/NN ./.
P10859268A01
Satisfactory/JJ development/NN of/IN bovine/JJ follicles/NNS in/FW vitro/FW remains/VBZ elusive/JJ ./.
P10861227A03
Increased/JJ secretion/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) correlates/VBZ with/IN transformation/NN of/IN colon/NN epithelial/JJ cells/NNS ./.
P10861447A02
Binding/NN of/IN MMP-2/NN to/TO integrin/NN alpha/NN (/( v/CD )/) beta/NN (/( 3/CD )/) has/VBZ been/VBN implicated/VBN in/IN presenting/NN activated/JJ MMP-2/NN on/IN the/DT cell/NN surface/NN of/IN invasive/JJ cells/NNS ,/, but/CC interactions/NNS with/IN the/DT MT1-MMP-TIMP-2/NN system/NN have/VBP not/RB been/VBN considered/VBN ./.
P10861469A06
Transcripts/NNS of/IN membrane-type/NN matrix/NN metalloproteinase-1/NN (/( MT1-MMP/NN )/) ,/, which/WDT is/VBZ thought/VBN to/TO be/VB present/JJ on/IN the/DT cell/NN surface/NN and/CC to/TO work/VB as/IN a/DT candidate/NN activator/NN of/IN MMP-2/NN ,/, were/VBD detected/VBN in/IN both/DT cancer/NN cell/NN lines/NNS ./.
P10873619A02
The/DT degradation/NN of/IN the/DT extracellular/JJ matrix/NN (/( ECM/NN )/) by/IN specialized/JJ matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) is/VBZ another/DT major/JJ step/NN in/IN tumor/NN invasion/NN and/CC metastasis/NN ./.
P10878545A06
Cell/NN surface/NN expression/NN level/NN of/IN MT1-MMP/NN ,/, as/IN determined/VBN by/IN flow/NN cytometry/NN ,/, was/VBD similar/JJ on/IN all/DT cell/NN lines/NNS ./.
P10882449A02
We/PRP measured/VBD the/DT levels/NNS of/IN MMPs/NNS ,/, specific/JJ tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) ,/, and/CC interleukin-6/NN (/( IL-6/NN )/) in/IN synovial/JJ fluid/NN from/IN the/DT knees/NNS of/IN 36/CD patients/NNS with/IN cartilage/NN lesions/NNS subdivided/VBN according/VBG to/TO severity/NN based/VBN on/IN arthroscopic/JJ findings/NNS ./.
P10885745A11
These/DT data/NNS suggest/VBP a/DT mechanism/NN by/IN which/WDT Pax-6/NN may/MD direct/VBP gelB/NN expression/NN in/IN an/DT eye-specific/JJ manner/NN ./.
P10889296A15
K1/NN and/CC K6/NN were/VBD negative/JJ for/IN Neurokinin/NN 1/CD receptor/NN (/( NK1-R/NN )/) but/CC positive/JJ for/IN Calcitonin/NN gene/NN related/JJ peptide/NN receptor/NN type/NN 1/CD (/( CGRP-1R/NN )/) and/CC Calcitonin/NN gene/NN related/JJ peptide/NN receptor/NN component/NN protein/NN (/( CGRP-RCP/NN )/) ./.
P10890358A01
The/DT human/NN retrovirus/NN HTLV-I/NN is/VBZ responsible/JJ for/IN the/DT chronic/JJ progressive/JJ myelopathy/NN ,/, TSP/NN //SYM HAM/NN ,/, characterized/VBN by/IN the/DT presence/NN of/IN infiltrated/JJ T/NN lymphocytes/NNS ,/, cytokines/NNS ,/, and/CC matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) within/IN spinal/JJ cord/NN lesions/NNS ./.
P10896779A05
Since/IN MMP/NN expression/NN is/VBZ thus/RB necessary/JJ for/IN myoblast/NN migration/NN ,/, we/PRP have/VBP undertaken/VBN the/DT identification/NN and/CC characterization/NN of/IN the/DT MMPs/NNS expressed/VBN by/IN the/DT C/NN (/( 2/CD )/) C/NN (/( 12/CD )/) cell/NN line/NN ./.
P10910039A03
We/PRP have/VBP called/VBN this/DT type/NN of/IN movement/NN "/`` cohort/NN migration/NN "/'' and/CC developed/VBN a/DT two-dimensional/JJ in/FW vitro/FW cohort/NN migration/NN model/NN ,/, in/IN which/WDT human/NN rectal/JJ well-differentiated/JJ adenocarcinoma/NN cells/NNS (/( L-10/NN )/) migrate/VBP from/IN piled-up/JJ cell/NN islands/NNS as/IN coherent/JJ sheets/NNS of/IN cells/NNS when/WRB stimulated/VBN with/IN hepatocyte/NN growth/NN factor/NN //SYM scatter/NN factor/NN ./.
P10913401A03
CSF/NN levels/NNS of/IN MMP-9/NN were/VBD higher/JJR (/( P/NN </SYM .05/CD )/) in/IN 5/CD patients/NNS who/WP developed/VBD hearing/JJ impairment/NN or/CC secondary/JJ epilepsy/NN than/IN in/IN those/PRP who/WP recovered/VBD without/IN neurological/JJ deficits/NNS ./.
P10919715A09
Expression/NN of/IN MMP-1/NN ,/, 2/CD ,/, 3/CD ,/, 10/CD ,/, 14/CD and/CC 17/CD showed/VBD no/DT correlation/NN to/TO capacity/NN to/TO infiltrate/VB ./.
P10922168A02
All/DT patients/NNS were/VBD fully/RB investigated/VBN ,/, by/IN visual/JJ analogue/NN pain/NN scores/NNS ,/, plain/JJ radiographs/NNS and/CC double-contrast/NN arthrotomograms/NNS ./.
P10930399A09
These/DT results/NNS support/VBP the/DT hypothesis/NN of/IN an/DT impaired/JJ thrombolytic/JJ potential/NN of/IN MMP-degraded/JJ Factor/NN XII/CD in/FW vivo/FW ./.
P10935492A08
Stable/JJ expression/NN of/IN this/DT construct/NN in/IN ER/NN negative/JJ squamous/JJ cell/NN carcinoma/NN (/( SCC/NN )/) lines/NNS produced/VBD an/DT estradiol/NN dependent/JJ decrease/NN in/IN the/DT number/NN of/IN cells/NNS that/WDT migrated/VBD through/IN a/DT reconstituted/JJ basement/NN membrane/NN ./.
P10937947A11
To/TO estimate/VB a/DT putative/JJ role/NN of/IN these/DT gelatinases/NNS ,/, several/JJ sarcomeric/JJ contractile/JJ proteins/NNS were/VBD digested/VBN in/FW vitro/FW by/IN purified/JJ active/JJ MMP-9/NN ./.
P10937974A09
A/DT number/NN of/IN bioactive/JJ peptides/NNS and/CC cytokines/NNS influence/VBP MMP/NN and/CC TIMP/NN expression/NN and/CC activity/NN ./.
P10946762A10
This/PRP could/MD be/VBP blocked/VBN using/VBG a/DT human/NN recombinant/JJ anti-SF/NN antibody/NN ./.
P10952170A10
These/DT data/NNS are/VBP consistent/JJ with/IN the/DT concept/NN that/IN regulation/NN of/IN matrix/NN turnover/NN via/IN MMP-9/NN may/MD be/VBP involved/VBN in/IN the/DT events/NNS leading/VBG to/TO myotube/NN formation/NN ,/, including/VBG migration/NN ./.
P10958381A04
In/IN the/DT present/JJ study/NN ,/, we/PRP investigated/VBD the/DT effect/NN of/IN heparin/NN and/CC related/JJ glycosaminoglycans/NNS on/IN PDGF-induced/JJ lung/NN fibroblast/NN proliferation/NN and/CC chemotactic/JJ response/NN in/FW vitro/FW ./.
P10960024A10
RESULTS/NNS :/: Tiludronate/NN significantly/RB inhibited/VBN both/CC MMP-1/NN and/CC MMP-3/NN activity/NN in/IN a/DT concentration-dependent/JJ manner/NN ./.
P10969041A06
Efficacy/NN of/IN hTIMP-1/NN gene/NN transfer/NN was/VBD assessed/VBN both/CC by/IN ELISA/NN on/IN bronchoalveolar/JJ lavages/NNS and/CC by/IN hTIMP-1/NN immunofluorescence/NN on/IN lung/NN sections/NNS ./.
P10969817A14
This/DT work/NN highlights/VBZ the/DT role/NN played/VBN by/IN COX/NN in/IN disturbing/NN the/DT balance/NN between/IN MMPs/NNS and/CC TIMPs/NNS in/IN prostate/NN cancer/NN cells/NNS ,/, and/CC it/PRP points/VBZ to/TO the/DT potential/JJ use/NN of/IN COX/NN inibitors/NNS ,/, especially/RB COX-2/NN selective/JJ inhibitors/NNS ,/, in/IN the/DT prevention/NN and/CC therapy/NN of/IN prostate/NN cancer/NN invasion/NN ./.
P10971173A08
Gene/NN expression/NN was/VBD determined/VBN by/IN band/NN densitometry/NN ./.
P10980128A13
Thus/RB ,/, the/DT present/JJ studies/NNS indicate/VBP that/IN MMPs/NNS and/CC TN-C/NN play/VBP a/DT role/NN in/IN elastin-oriented/JJ calcification/NN ./.
P10984375A04
OBJECTIVE/NN :/: To/TO study/VB the/DT effects/NNS of/IN PAR-2-mediated/JJ airway/NN epithelial/JJ cell/NN activation/NN on/IN the/DT production/NN of/IN MMP-9/NN ./.
P10985432A10
These/DT results/NNS provide/VBP support/NN for/IN the/DT idea/NN that/IN temporospatially/RB controlled/JJ interactions/NNS between/IN MMPs/NNS and/CC their/PRP$ substrates/NNS may/MD be/VBP pivotal/JJ in/IN modulating/NN events/NNS in/IN palatal/JJ morphogenesis/NN ./.
P10995877A08
With/IN respect/NN to/TO clinical/JJ stage/NN ,/, the/DT triple/JJ diffuse/JJ positive/JJ rate/NN in/IN advanced-stage/NN (/( stage/NN II/CD //SYM III/CD //SYM IV/CD )/) carcinomas/NNS was/VBD significantly/RB higher/JJR than/IN that/PRP in/IN early-stage/NN (/( stage/NN I/CD )/) carcinomas/NNS ./.
P10997695A07
In/IN contrast/NN transforming/JJ growth/NN factor/NN (/( TGF/NN )/) -beta/NN can/MD decrease/VBP MMP/NN expression/NN ./.
P11005153A08
Salivary/JJ MMP/NN levels/NNS and/CC activities/NNS in/IN type/NN 2/CD diabetic/JJ patients/NNS were/VBD in/IN general/NN similar/JJ to/TO those/PRP in/IN the/DT control/NN group/NN ./.
P11007798A01
The/DT tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) are/VBP a/DT family/NN of/IN four/CD secreted/JJ inhibitors/NNS of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ./.
P11007969A06
Increased/JJ plasma/NN membrane/NN and/CC secreted/JJ MMP/NN activities/NNS were/VBD found/VBN in/IN primary/JJ WR/NN astrocytes/NNS ./.
P11010969A02
Biochemical/JJ and/CC immunological/JJ characterization/NN of/IN the/DT purified/JJ enzyme/NN demonstrated/VBD that/IN it/PRP is/VBZ distinct/JJ from/IN the/DT chicken/NN 72-kDa/NN gelatinase/NN A/NN (/( MMP-2/NN )/) ./.
P11020282A06
Some/DT N-hydroxysulfonamides/NNS also/RB showed/VBD inhibitory/JJ properties/NNS (/( in/IN the/DT micromolar/JJ range/NN )/) against/IN MMP-1/NN ,/, MMP-2/NN ,/, MMP-8/NN ,/, MMP-9/NN ,/, and/CC ChC/NN ./.
P11025397A03
The/DT present/JJ study/NN investigates/VBZ the/DT effects/NNS of/IN the/DT synthetic/JJ MMP/NN inhibitor/NN batimastat/NN (/( BB94/NN )/) on/IN vascular/JJ SMCs/NNS ./.
P11027004A09
MMP-9/NN was/VBD not/RB detectable/JJ in/IN the/DT media/NN of/IN corticosteroid-treated/JJ explant/NN organ/NN cultures/NNS ./.
P11027427A06
HGF/NN //SYM SF/NN stimulated/VBD the/DT expression/NN of/IN MMP-1/NN ,/, 9/CD and/CC MT1-MMP/NN and/CC had/VBD a/DT slight/JJ effect/NN on/IN expression/NN of/IN the/DT MMP/NN inhibitor/NN TIMP-1/NN but/CC not/RB TIMP-2/NN ./.
P11033124A03
At/IN 0/CD ,/, 6/CD ,/, 24/CD ,/, 48/CD ,/, and/CC 72/CD hours/NNS after/IN wounding/NN ,/, mRNA/NN expression/NN of/IN 72/CD kDa/NN type/NN gelatinase/NN (/( MMP-2/NN )/) ,/, 92/CD kDa/NN type/NN gelatinase/NN (/( MMP-9/NN )/) ,/, and/CC tissue/NN inhibitor/NN of/IN matrix/NN metalloproteinases-1/NN (/( TIMP-1/NN )/) were/VBD analyzed/VBN by/IN reverse/JJ transcription/NN polymerase/NN chain/NN reaction/NN in/IN those/DT corneas/NNS ./.
P11038285A12
The/DT sensitivity/NN of/IN this/DT ELISA-like/JJ assay/NN is/VBZ comparable/JJ to/TO that/PRP of/IN gelatin/NN zymography/NN ,/, a/DT method/NN widely/RB used/VBN to/TO detect/VB gelatinases/NNS ./.
P11040401A04
Palatal/JJ shelves/NNS were/VBD harvested/VBN at/IN embryonic/JJ days/NNS (/( E/NN )/) 15/CD ,/, 16/CD and/CC 17/CD as/RB well/RB as/IN post-partum/NN ./.
P11042184A07
TIMP-2/NN induces/VBZ a/DT decrease/NN in/IN phosphorylation/NN of/IN EGFR/NN and/CC a/DT concomitant/JJ reduction/NN in/IN Grb-2/NN association/NN ./.
P11044166A02
MMP-2/NN is/VBZ a/DT major/JJ protease/NN in/IN the/DT wall/NN of/IN small/JJ aneurysms/NNS and/CC is/VBZ produced/VBN at/IN increased/JJ levels/NNS by/IN smooth/JJ muscle/NN cells/NNS derived/VBN from/IN AAAs/NNS compared/VBN with/IN normal/JJ controls/NNS ./.
P11044366A01
Elevated/JJ expression/NN of/IN type/NN IV/CD collagenases/NNS (/( MMP-2/NN and/CC MMP-9/NN )/) has/VBZ been/VBN strongly/RB correlated/VBN with/IN tumour/NN progression/NN and/CC metastasis/NN in/IN various/JJ tumours/NNS ./.
P11044467A08
Secretion/NN of/IN the/DT tissue/NN inhibitor/NN of/IN MMPs-9/NN (/( TIMP-1/NN )/) was/VBD not/RB significantly/RB different/JJ between/IN untreated/JJ (/( 3.07/CD +/-/SYM 0.266/CD microg/NN //SYM ml/NN //SYM 24/CD h/NN )/) and/CC FBS-treated/JJ (/( 3./CD 85/CD +/-/SYM 0.24/CD microg/NN //SYM ml/NN //SYM 24/CD h/NN )/) cultures/NNS during/IN the/DT first/JJ 4/CD days/NNS in/IN culture/NN ./.
P11048298A06
Both/PRP are/VBP characterized/VBN with/IN the/DT accumulation/NN of/IN active/JJ inflammatory/JJ cells/NNS ,/, matrix/NN remodeling/NN and/CC epithelial/JJ changes/NNS ./.
P11053050A01
Mammalian/JJ kidney/NN development/NN is/VBZ initiated/VBN by/IN the/DT mutual/JJ interaction/NN between/IN embryonic/JJ metanephric/JJ mesenchyme/NN (/( MM/NN )/) and/CC the/DT ureteric/JJ bud/NN (/( UB/NN )/) ,/, leading/VBG to/TO tightly/RB controlled/JJ UB/NN branching/JJ morphogenesis/NN ./.
P11058543A04
We/PRP demonstrated/VBD villous/JJ trophoblast/NN expression/NN of/IN both/CC MMP-2/NN and/CC MMP-9/NN by/IN in/FW situ/FW immunohistochemistry/NN and/CC by/IN Western/NN blot/NN analysis/NN and/CC zymography/NN of/IN lysates/NNS and/CC culture/NN supernatants/NNS of/IN highly/RB purified/JJ villous/JJ CTs/NNS ./.
P11058950A01
OBJECTIVE/NN :/: To/TO study/VB the/DT effect/NN of/IN hypoxia/NN on/IN the/DT expression/NN and/CC activity/NN of/IN matrix/NN metalloproteinase-2/NN (/( MMP-2/NN )/) in/IN the/DT hepatic/JJ stellate/JJ cell/NN (/( HSC/NN )/) ./.
P11062605A12
Of/IN the/DT 21/CD non-RA/NN patients/NNS ,/, seven/CD had/VBD a/DT spondylarthropathy/NN and/CC 14/CD had/VBD undifferentiated/JJ arthritis/NN ./.
P11062605A28
Although/IN serum/NN MMP-2/NN levels/NNS were/VBD not/RB of/IN prognostic/JJ value/NN ,/, high/JJ synovial/JJ tissue/NN levels/NNS of/IN MMP-2/NN activity/NN were/VBD significantly/RB correlated/VBN with/IN the/DT presence/NN of/IN early/JJ erosions/NNS ./.
P11062755A01
Structural/JJ changes/NNS in/IN the/DT extracellular/JJ matrix/NN (/( ECM/NN )/) are/VBP necessary/JJ for/IN cell/NN migration/NN during/IN tissue/NN remodeling/NN and/CC local/JJ neoplastic/JJ cell/NN invasion/NN ./.
P11069839A08
The/DT characteristic/JJ contributions/NNS of/IN matrix-degrading/JJ proteins/NNS may/MD relate/VBP to/TO the/DT distinct/JJ prognostic/JJ features/NNS of/IN these/DT diseases/NNS ./.
P11075535A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP important/JJ enzymes/NNS found/VBN in/IN connective/JJ tissues/NNS and/CC thought/VBN to/TO be/VB involved/VBN in/IN cartilage/NN degradation/NN ./.
P11085528A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP overexpressed/VBN in/IN a/DT variety/NN of/IN tumor/NN tissues/NNS and/CC cell/NN lines/NNS ,/, and/CC their/PRP$ expression/NN is/VBZ highly/RB correlated/VBN to/TO tumor/NN invasion/NN and/CC metastasis/NN ./.
P11092396A02
We/PRP investigated/VBD if/IN these/DT changes/NNS might/MD be/VBP mediated/VBN by/IN remodeling/NN of/IN ECM/NN ,/, and/CC we/PRP focused/VBD our/PRP$ study/NN on/IN the/DT neutral/JJ metalloproteinases/NNS (/( MMPs/NNS )/) ,/, known/JJ agents/NNS of/IN matrix/NN remodeling/NN ,/, and/CC on/IN their/PRP$ tissue/NN inhibitors/NNS (/( TIMPs/NNS )/) ./.
P11095607A02
The/DT purpose/NN of/IN this/DT study/NN was/VBD to/TO determine/VB the/DT expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN MMPs/NNS (/( TIMPs/NNS )/) at/IN the/DT advancing/JJ pterygium/NN edge/NN ./.
P11095911A02
In/IN the/DT present/JJ study/NN ,/, we/PRP therefore/RB investigated/VBD a/DT possible/JJ role/NN of/IN matrix/NN metalloproteinases/NNS in/IN cataract/NN and/CC posterior/JJ capsule/NN opacification/NN ./.
P11097207A13
Alternatively/RB collagenase-1/NN production/NN by/IN mast/JJ cells/NNS may/MD play/VBP a/DT critical/JJ role/NN in/IN cell/NN invasion/NN and/CC migration/NN into/IN sites/NNS of/IN inflammation/NN ./.
P11101274A01
Rats/NNS were/VBD studied/VBN to/TO determine/VB if/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN MMPs/NNS (/( TIMPs/NNS )/) were/VBD detectable/JJ in/IN developing/JJ embryonic/JJ and/CC uterine/JJ tissues/NNS during/IN the/DT implantation/NN period/NN ;/: that/PRP is/VBZ ,/, Days/NNS 6-8/CD of/IN pregnancy/NN ./.
P11104745A10
CONCLUSIONS/NNS :/: MMP-9/NN induction/NN is/VBZ associated/VBN with/IN the/DT formation/NN of/IN intimal/JJ hyperplasia/NN and/CC does/VBZ not/RB require/VBP frank/JJ mechanical/JJ injury/NN ./.
P11106565A09
Proteolysis/NN was/VBD localized/VBN to/TO infiltrating/JJ leukocytes/NNS in/IN diseased/JJ severe/JJ combined/JJ immunodeficient/JJ mice/NNS ./.
P11112863A08
Importantly/RB ,/, although/IN less/RB frequently/RB detectable/JJ than/IN pro-MMP-9/NN ,/, pro-/JJ MMP-2/NN (/( 72/CD kD/NN )/) was/VBD found/VBN more/RB frequently/RB in/IN asthmatics/NNS (/( 50/CD %/SYM )/) than/IN in/IN control/NN subjects/NNS (/( 5/CD %/SYM )/) (/( p/NN </SYM 0./CD 005/CD )/) ./.
P11115151A01
Wound/NN healing/NN is/VBZ a/DT complex/JJ process/NN involving/VBG the/DT interactions/NNS of/IN many/DT different/JJ cell/NN types/NNS ,/, matrix/NN components/NNS and/CC biological/JJ factors/NNS ,/, including/VBG proteinases/NNS and/CC cytokines/NNS ./.
P11115618A03
In/IN this/DT study/NN ,/, we/PRP examined/VBD the/DT expression/NN of/IN MMP/NN and/CC TIMP/NN in/IN rabbit/NN aortic/JJ neointima/NN at/IN a/DT relatively/RB late/JJ stage/NN of/IN lesion/NN development/NN ,/, between/IN 4/CD and/CC 12/CD weeks/NNS after/IN initial/JJ de-endothelialization/NN ./.
P11116076A01
Tears/NNS in/IN the/DT internal/JJ elastic/JJ lamina/NN (/( IEL/NN )/) can/MD be/VBP observed/VBN after/IN chronic/JJ increases/NNS in/IN arterial/JJ blood/NN flow/NN ,/, suggesting/VBG a/DT potential/JJ role/NN for/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) in/IN flow-induced/JJ vascular/JJ remodeling/NN ./.
P11117243A02
We/PRP determined/VBD whether/IN these/DT cells/NNS were/VBD able/JJ to/TO synthesize/VB the/DT matrix/NN degrading/JJ enzymes/NNS ,/, matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, likely/RB to/TO be/VB responsible/JJ for/IN the/DT breakdown/NN of/IN this/DT membrane/NN ,/, and/CC whether/IN this/DT secretion/NN could/MD be/VBP modulated/VBN by/IN cytokines/NNS involved/VBN in/IN the/DT inflammatory/JJ response/NN ./.
P11120556A08
MMP-9/NN mRNA/NN expression/NN was/VBD low/JJ in/IN untreated/JJ eyes/NNS and/CC did/VBD not/RB increase/VBP following/VBG laser/NN treatment/NN ./.
P11120638A03
The/DT aim/NN of/IN this/DT study/NN was/VBD to/TO examine/VB the/DT relationship/NN among/IN shear/NN force/NN ,/, metalloproteinase/NN activity/NN ,/, and/CC intimal/JJ thickening/NN in/IN human/NN saphenous/JJ vein/NN segments/NNS maintained/VBN in/IN organ/NN culture/NN ./.
P11121376A02
We/PRP tested/VBD the/DT hypothesis/NN that/IN oxidative/JJ stress/NN can/MD regulate/VBP extracellular/JJ matrix/NN in/IN cardiac/JJ fibroblasts/NNS ./.
P11129784A04
Reverse/JJ transcription/NN polymerase/NN chain/NN reaction/NN showed/VBD increased/JJ transcription/NN of/IN MMP-9/NN ./.
P11145040A14
Most/RBS important/JJ ,/, increased/JJ MMP/NN activity/NN stemmed/VBD from/IN exocrine/JJ epithelial/JJ cells/NNS and/CC was/VBD not/RB due/JJ to/TO infiltrating/JJ lymphocytes/NNS ./.
P11145811A10
For/IN all/PRP of/IN the/DT enzymes/NNS ,/, there/EX was/VBD most/DT staining/NN in/IN the/DT herniation/NN specimens/NNS and/CC least/PRP in/IN the/DT autopsy/NN samples/NNS ./.
P11146452A11
We/PRP conclude/VBP that/IN ,/, in/IN this/DT model/NN ,/, genetic/JJ increase/NN of/IN TIMP-2/NN inhibits/VBZ tumor/NN growth/NN ,/, apparently/RB by/IN affecting/NN the/DT recruitment/NN and/CC organization/NN of/IN host/NN endothelial/JJ cells/NNS by/IN the/DT transformed/JJ cells/NNS ./.
P11146729A09
CLINICAL/JJ RELEVANCE/NN :/: Overexpression/NN of/IN MMP-1/NN and/CC MMP-3/NN ,/, a/DT phenotype/NN previously/RB linked/VBN with/IN UV/NN exposure/NN in/IN dermal/JJ fibroblasts/NNS to/TO explain/VB the/DT pathologic/JJ finding/NN of/IN elastotic/JJ degeneration/NN ,/, suggests/VBZ that/IN pterygium/NN head/NN fibroblasts/NNS might/MD be/VBP intrinsically/RB altered/VBN by/IN UV/NN ,/, which/WDT might/MD be/VBP responsible/JJ for/IN corneal/JJ invasion/NN ./.
P11148597A07
Diabetic/JJ rats/NNS were/VBD induced/VBN by/IN streptozotocin/NN injection/NN ./.
P11157561A01
The/DT family/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) comprises/VBZ endopeptidases/NNS that/WDT are/VBP capable/JJ of/IN degrading/NN all/DT extracellular/JJ matrix/NN components/NNS ./.
P11167375A02
The/DT present/JJ study/NN was/VBD conducted/VBN to/TO investigate/VB whether/IN the/DT elevated/JJ amounts/NNS of/IN MMP-9/NN and/CC TIMP-1/NN found/VBN in/IN such/DT patients/NNS '/POS airways/NNS may/MD be/VBP linked/VBN to/TO an/DT enhanced/JJ secretion/NN by/IN granulocytes/NNS ./.
P11168235A11
Furthermore/RB ,/, peri-implantitis/NN and/CC periodontitis/NN were/VBD shown/VBN to/TO be/VB similar/JJ inflammatory/JJ lesions/NNS in/IN respect/NN to/TO MMP-1/NN and/CC -8/CD and/CC collagenase/NN activities/NNS ,/, even/RB though/IN the/DT TIMP-1/NN //SYM MMP-1/NN +/SYM MMP-8/NN ratio/NN was/VBD significantly/RB lower/JJR in/IN peri-implantitis/NN than/IN in/IN periodontitis/NN ./.
P11169735A02
Myocardial/JJ tumors/NNS are/VBP rarely/RB malignant/JJ ./.
P11169735A17
The/DT reduced/JJ levels/NNS of/IN TIMP-4/NN elicit/VBP cellular/JJ transformation/NN and/CC may/MD lead/VBP to/TO adverse/JJ extracellular/JJ matrix/NN degradation/NN (/( remodeling/NN )/) ,/, cardiac/JJ hypertrophy/NN and/CC failure/NN ./.
P11171688A04
Collagenase/NN activity/NN was/VBD determined/VBN with/IN the/DT diffuse/JJ fibril/NN assay/NN using/VBG 3H/NN acetylated/JJ collagen/NN ./.
P11172685A07
Using/VBG an/DT in/FW vitro/FW spectrophotometric/JJ technique/NN ,/, the/DT Zn/NN (/( ++/SYM )/) reactivity/NN of/IN several/JJ CMTs/NNS was/VBD assessed/VBN and/CC found/VBN to/TO be/VB positively/RB related/VBN to/TO the/DT potency/NN of/IN these/DT compounds/NNS as/IN MMP/NN inhibitors/NNS ./.
P11172697A06
Biomolecular/JJ structures/NNS used/VBN in/IN the/DT design/NN of/IN MMP/NN inhibitors/NNS are/VBP thoroughly/RB covered/VBN ./.
P11172829A05
INTERVENTION/NN (/( S/NNS )/) :/: Prospective/JJ record/NN of/IN bleeding/JJ patterns/NNS and/CC endometrial/JJ biopsy/NN ./.
P11174024A10
We/PRP concluded/VBD that/IN increased/JJ MMP-9/NN and/CC TIMP-1/NN levels/NNS might/MD be/VBP associated/VBN with/IN peritoneal/JJ ECM/NN remodeling/NN during/IN peritonitis/NN ./.
P11178975A08
Interestingly/RB ,/, the/DT TIMP-4/NN protein/NN was/VBD detected/VBN by/IN immunohistochemical/JJ staining/NN in/IN infiltrating/JJ breast/NN carcinoma/NN cells/NNS in/IN tumor/NN tissues/NNS ./.
P11179039A03
Three/CD days/NNS post-MI/NN ,/, rats/NNS were/VBD randomized/VBN to/TO treatment/NN with/IN the/DT ET/NN (/( A/NN )/) -selective/JJ receptor/NN antagonist/NN sitaxsentan/NN (/( n/NN =/SYM 12/CD )/) or/CC a/DT control/NN group/NN (/( n/NN =/SYM 12/CD )/) ./.
P11181900A04
Cells/NNS were/VBD treated/VBN for/IN 24/CD h/NN with/IN lacidipine/NN and/CC the/DT conditioned/JJ media/NNS were/VBD analyzed/VBN ./.
P11182067A05
However/WRB ,/, there/EX is/VBZ little/JJ data/NN available/JJ on/IN MMPs/NNS or/CC their/PRP$ tissue/NN inhibitors/NNS (/( TIMPs/NNS )/) in/IN NSCLC/NN ./.
P11192834A08
The/DT enzyme/NN inhibitors/NNS ,/, TIMP-1/NN and/CC TIMP-2/NN ,/, were/VBD quantified/VBN by/IN dot/NN blot/NN immunoassay/NN ./.
P11196190A04
Therefore/RB ,/, we/PRP have/VBP examined/VBN the/DT role/NN of/IN MMPs/NNS during/IN TCIPA/NN and/CC its/PRP$ regulation/NN by/IN nitric/JJ oxide/NN (/( NO/NN )/) in/FW vitro/FW ./.
P11201850A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP proteolytic/JJ enzymes/NNS that/WDT degrade/VBP components/NNS of/IN the/DT extracellular/JJ matrix/NN (/( ECM/NN )/) and/CC basement/NN membrane/NN ./.
P11203734A03
METHODS/NNS :/: The/DT various/JJ types/NNS of/IN MMPs/NNS and/CC TIMPs/NNS were/VBD detected/VBN by/IN Western/NN blotting/NN with/IN monoclonal/JJ antibodies/NNS and/CC gelatin/NN zymography/NN ./.
P11204422A05
1Alpha/NN ,/, 25/CD (/( OH/NN )/) 2D3/NN increased/VBD steady-state/NN messenger/NN RNA/NN (/( mRNA/NN )/) and/CC protein/NN levels/NNS of/IN MMP-13/NN ./.
P11205871A06
The/DT present/JJ experiments/NNS were/VBD performed/VBN to/TO define/VB the/DT time-course/NN ,/, isozyme/NN subtypes/NNS ,/, and/CC cellular/JJ source/NN of/IN increased/JJ MMP/NN expression/NN that/WDT occurs/VBZ following/JJ MI/NN in/IN an/DT experimental/JJ rabbit/NN model/NN ./.
P11212844A10
It/PRP is/VBZ clear/JJ that/IN the/DT activation/NN of/IN MMPs/NNS and/CC their/PRP$ inhibitors/NNS occurs/VBZ in/IN a/DT very/RB well/RB orchestrated/JJ manner/NN ./.
P11213361A02
This/DT study/NN was/VBD performed/VBN to/TO examine/VB whether/IN NO/NN modulates/VBZ the/DT production/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ,/, which/WDT degrade/VBP all/DT components/NNS of/IN extracellular/JJ matrix/NN (/( ECM/NN )/) ,/, in/IN rheumatoid/JJ synovial/JJ cells/NNS ./.
P11216574A15
CONCLUSIONS/NNS :/: Our/PRP$ results/NNS suggest/VBP that/IN high/JJ thrombin/NN levels/NNS suppress/VBP MMP-2/NN activity/NN through/IN decreased/JJ MMP-2/NN and/CC increased/JJ TIMP-1/NN synthesis/NN ./.
P11222449A02
Devic/NN 's/POS neuromyelitis/NN optica/NN (/( DNO/NN )/) is/VBZ a/DT demyelinating/JJ syndrome/NN that/WDT involves/VBZ the/DT optic/JJ nerve/NN and/CC cervical/JJ cord/NN but/CC differs/VBZ pathologically/RB from/IN multiple/JJ sclerosis/NN ./.
P11222998A04
Spontaneously/RB hypertensive/JJ rats/NNS (/( SHR/NN )/) had/VBD a/DT 90/CD min/NN middle/JJ cerebral/JJ artery/NN occlusion/NN (/( MCAO/NN )/) followed/VBD by/IN reperfusion/NN for/IN times/NNS from/IN 3/CD h/NN to/TO 21/CD days/NNS ./.
P11235952A06
In/IN addition/NN ,/, the/DT expression/NN levels/NNS and/CC proMMP-2/NN activation/NN ratio/NN were/VBD remarkably/RB higher/JJR in/IN glioblastomas/NNS associated/VBN with/IN cerebrospinal/JJ fluid/NN (/( CSF/NN )/) dissemination/NN than/IN in/IN those/PRP not/RB associated/VBN with/IN CSF/NN dissemination/NN ./.
P11235993A04
MMP-3/NN ,/, and/CC MMP-13/NN in/IN highly/RB invasive/JJ MDA-MB-231/NN cells/NNS ,/, but/CC not/RB in/IN slightly/RB invasive/JJ cell/NN lines/NNS ./.
P11235994A02
The/DT levels/NNS of/IN MMP-1/NN ,/, 2/CD ,/, 3/CD ,/, 8/CD ,/, 9/CD ,/, 13/CD and/CC TIMP-1/NN were/VBD significantly/RB higher/JJR in/IN the/DT carcinoma/NN samples/NNS than/IN in/IN the/DT control/NN ./.
P11240131A03
In/IN the/DT presence/NN of/IN the/DT calcium/NN ionophore/NN ,/, ionomycin/NN ,/, proteolytic/JJ processing/NN of/IN MT1/NN MMP/NN was/VBD restricted/VBN and/CC collagenolysis/NN did/VBD not/RB occur/VBP indicating/VBG that/IN the/DT 63/CD kDa/NN form/NN of/IN the/DT enzyme/NN is/VBZ not/RB a/DT functional/JJ collagenase/NN ./.
P11240267A01
Stasis/NN dermatitis/NN is/VBZ a/DT common/JJ disorder/NN ,/, which/WDT is/VBZ a/DT consequence/NN of/IN impaired/JJ venous/JJ drainage/NN of/IN the/DT legs/NNS ./.
P11241738A03
In/IN normal/JJ and/CC glaucomatous/JJ ONH/NN ,/, we/PRP detected/VBD MMP/NN and/CC TIMP/NN expression/NN by/IN immunohistochemistry/NN ./.
P11242804A01
BACKGROUND/NN :/: Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) have/VBP been/VBN implicated/VBN in/IN the/DT remodelling/NN of/IN extracellular/JJ matrix/NN (/( ECM/NN )/) ,/, including/VBG basement/NN membrane/NN ./.
P11248661A01
In/IN an/DT effort/NN to/TO elucidate/VB the/DT role/NN of/IN mechanical/JJ stimuli/NNS in/IN rheumatoid/JJ arthritis/NN ,/, we/PRP determined/VBD mRNA/NN levels/NNS of/IN matrix/NN metalloproteinase/NN (/( MMP/NN )/) -1/CD ,/, MMP-3/NN ,/, MMP-13/NN ,/, tissue/NN inhibitor/NN of/IN metalloproteinase/NN (/( TIMP/NN )/) -1/CD and/CC TIMP-2/NN ,/, and/CC three/CD transcription/NN factors/NNS (/( c-fos/NN ,/, ets-1/NN ,/, and/CC ets-2/NN )/) under/IN two/CD mechanical/JJ shearing/JJ conditions/NNS as/RB well/RB as/IN simulated/JJ unloading/NN ./.
P11263773A10
Confirmation/NN that/IN chondrocytes/NNS can/MD produce/VBP these/DT 6/CD MMPs/NNS was/VBD obtained/VBN from/IN HAC/NN cultures/NNS treated/VBN with/IN either/CC IL-1beta/NN ,/, TNFalpha/NN ,/, or/CC PMA/NN ;/: conditioned/JJ medium/NN from/IN activated/JJ HAC/NN contained/VBD all/PDT the/DT MMPs/NNS demonstrated/VBN by/IN immunohistochemistry/NN ./.
P11266461A10
We/PRP conclude/VBP that/IN MMPs/NNS ,/, especially/RB Str1/NN ,/, determine/VBP the/DT rate/NN of/IN adipocyte/NN differentiation/NN during/IN involutive/JJ mammary/JJ gland/NN remodeling/NN ./.
P11274235A05
Matrix/NN metalloproteinase-9/NN (/( MMP-9/NN )/) activity/NN fell/VBP in/IN all/DT UUO/NN groups/NNS but/CC remained/VBD significantly/RB higher/JJR in/IN the/DT timp-1/NN group/NN compared/VBN with/IN the/DT Timp-1/NN group/NN ./.
P11279294A01
Polycystic/JJ ovarian/JJ syndrome/NN (/( PCOS/NN )/) involves/VBZ follicular/JJ atresia/NN ,/, formation/NN of/IN multiple/JJ ovarian/JJ cysts/NNS and/CC is/VBZ frequently/RB associated/VBN with/IN a/DT higher/JJR abortion/NN rate/NN ./.
P11281552A05
Non-parametric/JJ correlation/NN analysis/NN and/CC receiver/NN operating/JJ characteristics/NNS curves/NNS show/VBP that/IN MMP-2/NN ,/, MMP-7/NN ,/, and/CC TIMP-1/NN provide/VBP the/DT best/JJS discrimination/NN between/IN cirrhosis/NN and/CC pre-cirrhotic/JJ stages/NNS ./.
P11286132A09
Thus/RB ,/, it/PRP seems/VBZ that/IN the/DT stromelysins/NNS are/VBP involved/VBN in/IN the/DT generalized/JJ growth/NN and/CC expansion/NN of/IN the/DT neoplastic/JJ cell/NN mass/NN ,/, while/IN MMP-2/NN is/VBZ involved/VBN in/IN the/DT neoangiogenic/JJ and/CC focal/JJ clonal/JJ selection/NN and/CC expansion/NN phenomena/NNS associated/VBN with/IN in/FW situ/FW tumor/NN progression/NN ,/, invasion/NN of/IN the/DT microvasculature/NN ,/, and/CC metastasis/NN ./.
P11286133A03
Expression/NN of/IN MMP-2/NN ,/, -3/CD ,/, -9/CD ,/, -10/CD ,/, and/CC -13/CD was/VBD investigated/VBN in/IN human/NN pancreatic/JJ adenocarcinomas/NNS employing/VBG an/DT indirect/JJ alkaline/JJ phosphatase/NN conjugated/JJ immunocytochemical/JJ technique/NN ./.
P11289097A07
Analysis/NN of/IN TIMP-4/NN expression/NN in/IN human/NN mammary/JJ specimens/NNS indicates/VBZ that/IN TIMP-4/NN protein/NN is/VBZ increased/VBN in/IN mammary/JJ carcinoma/NN cells/NNS compared/VBN with/IN normal/JJ mammary/JJ epithelial/JJ cells/NNS ./.
P11296850A04
MMP-9/NN expression/NN was/VBD analyzed/VBN by/IN Western/NN blotting/JJ analysis/NN of/IN microdissected/JJ regions/NNS of/IN muscle/NN and/CC immunolabeling/NN of/IN muscle/NN sections/NNS ./.
P11306379A07
Levels/NNS of/IN MMP-2/NN and/CC MMP-9/NN correlated/VBD with/IN each/DT other/PRP and/CC with/IN tumor/NN stage/NN and/CC grade/NN ./.
P11306704A07
A/DT dose/NN range/NN of/IN 2.5/CD to/TO 10/CD ng/NN //SYM ml/NN of/IN TWHF/NN was/VBD effectively/RB inhibitory/JJ for/IN IL-1/NN ./.
P11308257A12
Even/RB after/IN 6/CD days/NNS ,/, however/WRB ,/, there/EX was/VBD only/RB a/DT low/JJ level/NN of/IN gelatin-hydrolytic/JJ activity/NN and/CC no/DT measurable/JJ collagen-hydrolytic/JJ activity/NN ./.
P11310848A02
Although/IN the/DT effects/NNS of/IN individual/JJ cytokines/NNS on/IN monocyte/NN MMP/NN expression/NN have/VBP been/VBN studied/VBN extensively/RB ,/, few/JJ studies/NNS have/VBP examined/VBN the/DT influence/NN of/IN combinations/NNS of/IN cytokines/NNS ,/, which/WDT are/VBP likely/RB present/JJ at/IN inflammatory/JJ sites/NNS ./.
P11315101A06
Inostamycin/NN partially/RB blocked/VBD both/CC EGF-/NN and/CC phorbol/NN 12-myristate/NN 13-acetate-stimulated/JJ pro-MMP-9/NN production/NN ./.
P11319136A04
We/PRP examined/VBD the/DT functional/JJ roles/NNS of/IN MMP-9/NN and/CC TIMP-3/NN during/IN in/FW vitro/FW ECM/NN degradation/NN by/IN mouse/NN embryos/NNS ./.
P11325829A07
In/IN concanavalin/NN A-stimulated/JJ homozygous/JJ Timp2/NN -/-/SYM fibroblasts/NNS or/CC unstimulated/JJ MT1-MMP-transfected/JJ Timp2/NN -/-/SYM cells/NNS ,/, which/WDT can/MD not/RB activate/VBP progelatinase/NN A/NN ,/, activation/NN was/VBD restored/VBN by/IN the/DT addition/NN of/IN 0.3-5/CD nM/NN TIMP-2/NN but/CC not/RB by/IN TIMP-4/NN ,/, unequivocally/RB showing/VBG the/DT TIMP-2/NN dependency/NN of/IN MT1-MMP-induced/JJ activation/NN of/IN gelatinase/NN A/NN and/CC the/DT fact/NN that/IN TIMP-4/NN can/MD not/RB support/VBP activation/NN ./.
P11326313A01
Tumor/NN cell/NN invasion/NN and/CC metastasis/NN require/VBP precise/JJ coordination/NN of/IN adherence/NN to/TO extracellular/JJ matrix/NN (/( ECM/NN )/) and/CC controlled/JJ degradation/NN of/IN its/PRP$ components/NNS ./.
P11328721A09
After/IN 11/CD days/NNS of/IN MD/NN ,/, alpha1/NN (/( I/CD )/) collagen/NN mRNA/NN levels/NNS were/VBD 34/CD %/SYM lower/JJR ,/, and/CC MMP-2/NN mRNA/NN levels/NNS were/VBD 66/CD %/SYM higher/JJR in/IN the/DT deprived/JJ eyes/NNS than/IN in/IN the/DT control/NN eyes/NNS ./.
P11339506A08
Further/JJ pharmacokinetic/JJ analysis/NN revealed/VBD IC50/NN values/NNS of/IN 26/CD microM/NN and/CC 16/CD microM/NN for/IN the/DT inhibition/NN of/IN collagenase/NN activity/NN and/CC mRNA/NN expression/NN ,/, respectively/RB ./.
P11343173A07
Only/RB in/IN the/DT case/NN of/IN MT-MMP-1/NN was/VBD the/DT difference/NN between/IN AAA/NN and/CC AOD/NN not/RB statistically/RB significant/JJ ./.
P11346467A08
MMP/NN inhibitor/NN BE16627B/NN (/( 66.6/CD mg/NN //SYM kg/NN i.v./NN ,/, given/VBN 2/CD times/NNS )/) or/CC SI-27/NN (/( 10/CD mg/NN //SYM kg/NN i.p./NN ,/, given/VBN 2/CD times/NNS )/) significantly/RB suppressed/VBD the/DT ONOO/NN (/( -/SYM )/) -induced/JJ EPR/NN effect/NN in/IN S-180/NN tumors/NNS and/CC in/IN normal/JJ skin/NN ./.
P11346728A12
The/DT elevated/JJ levels/NNS of/IN MMP-2/NN ,/, MMP-9/NN ,/, and/CC MMP-8/NN in/IN the/DT SF/NN of/IN patients/NNS with/IN mild/JJ TMJ-ID/NN eventually/RB reflect/VBP the/DT active/JJ phase/NN of/IN TMJ/NN destruction/NN ./.
P11350830A04
Expression/NN of/IN the/DT genes/NNS for/IN TIMP-2/NN ,/, TIMP-3/NN ,/, and/CC interstitial/JJ collagenase/NN (/( matrix/NN metalloproteinase-13/NN )/) was/VBD unaltered/VBN in/IN the/DT injured/JJ lung/NN ./.
P11355979A07
We/PRP conclude/VBP that/IN 5-FU/NN may/MD reduce/VBP adhesions/NNS by/IN limiting/NN the/DT migratory/JJ capacity/NN of/IN synovial/JJ fibroblasts/NNS (/( extrinsic/JJ healing/NN )/) ./.
P11356303A04
Ischemia/NN was/VBD induced/VBN by/IN intraluminal/JJ middle/JJ cerebral/JJ artery/NN occlusion/NN (/( MCAO/NN )/) in/IN mice/NNS under/IN halothane/NN anesthesia/NN ./.
P11368514A07
However/WRB ,/, MMP-2/NN is/VBZ stabilized/VBN from/IN autolysis/NN in/IN the/DT presence/NN of/IN type/NN I/CD collagen/NN ,/, but/CC not/RB by/IN elastin/NN ,/, fibrinogen/NN ,/, or/CC laminin/NN ./.
P11373158A09
No/DT differences/NNS in/IN MMP-2/NN and/CC MMP-9/NN distribution/NN could/MD be/VBP observed/VBN between/IN cows/NNS with/IN proper/JJ release/NN of/IN fetal/JJ membranes/NNS and/CC cows/NNS with/IN retained/JJ fetal/JJ membranes/NNS ./.
P11381054A09
Stretching/NN stationary/JJ organ/NN cultures/NNS or/CC stretching/NN TM/NN cells/NNS grown/VBN on/IN membranes/NNS resulted/VBD in/IN similar/JJ increases/NNS in/IN gelatinase/NN A/NN without/IN changes/NNS in/IN gelatinase/NN B/NN or/CC stromelysin/NN levels/NNS ./.
P11382769A09
Direct/JJ interaction/NN of/IN claudin-1/NN with/IN MT1-MMP/NN and/CC MMP-2/NN was/VBD demonstrated/VBN by/IN immunoprecipitation/NN analysis/NN ./.
P11382924A06
Known/JJ regulators/NNS of/IN MEC/NN growth/NN and/CC differentiation/NN were/VBD evaluated/VBN for/IN their/PRP$ ability/NN to/TO modulate/VB gelatinase/NN activity/NN in/IN primary/JJ culture/NN ./.
P11395366A03
In/IN this/DT report/NN we/PRP have/VBP demonstrated/VBN a/DT role/NN for/IN EMMPRIN/NN in/IN cancer/NN progression/NN ./.
P11398836A05
While/IN the/DT WHO/WP grade/NN I/CD and/CC II/CD tumors/NNS had/VBD MT1/NN //SYM MT3/NN ratios/NNS below/IN 1/CD ,/, the/DT malignant/JJ (/( grade/NN III/CD and/CC IV/CD )/) tumors/NNS had/VBD ratios/NNS above/IN 1/CD ./.
P11400152A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC their/PRP$ tissue/NN inhibitors/NNS (/( TIMPs/NNS )/) play/VBP an/DT important/JJ role/NN in/IN several/JJ diseases/NNS ./.
P11401321A02
The/DT regulation/NN of/IN MMP-2/NN activation/NN and/CC subsequent/JJ targets/NNS is/VBZ vital/JJ to/TO understanding/NN the/DT metastatic/JJ process/NN ./.
P11401328A05
Additionally/RB ,/, this/DT study/NN demonstrated/VBD a/DT correlation/NN between/IN the/DT expression/NN of/IN MMP-3/NN (/( stromelysin-1/NN )/) and/CC the/DT level/NN of/IN ras/NN expressed/VBN in/IN cells/NNS and/CC with/IN the/DT cells/NNS '/POS ability/NN to/TO form/VB tumors/NNS and/CC with/IN malignant/JJ potential/NN ./.
P11401482A05
Treatment/NN of/IN A10/NN SMC/NN conditioned/JJ media/NN with/IN a/DT neutralising/JJ anti-TIMP-2/NN antibody/NN prevented/VBD the/DT suppression/NN of/IN HUVEC/NN pro-MMP-2/NN activation/NN ./.
P11404174A09
We/PRP evaluated/VBD lung/NN injury/NN histologically/RB ./.
P11404367A03
Gelatinase/NN B/NN activity/NN is/VBZ under/IN strict/JJ control/NN at/IN various/JJ levels/NNS :/: transcription/NN of/IN the/DT gene/NN by/IN cytokines/NNS and/CC cellular/JJ interactions/NNS ;/: activation/NN of/IN the/DT pro-enzyme/NN by/IN a/DT cascade/NN of/IN enzymes/NNS comprising/VBG serine/NN proteases/NNS and/CC other/JJ MMPs/NNS ;/: and/CC regulation/NN by/IN specific/JJ tissue/NN inhibitors/NNS of/IN MMPs/NNS (/( TIMPs/NNS )/) or/CC by/IN unspecific/JJ inhibitors/NNS ,/, such/JJ as/IN alpha2-macroglobulin/NN ./.
P11407790A13
The/DT localization/NN of/IN matrix/NN metalloproteinase-9/NN to/TO damaged/JJ cartilage/NN matrix/NN suggested/VBD matrix/NN proteolysis/NN ,/, which/WDT was/VBD confirmed/VBN with/IN DIPEN341/NN localization/NN ./.
P11412041A01
The/DT relative/JJ expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN MMPs/NNS (/( TIMPs/NNS )/) is/VBZ an/DT important/JJ determinant/NN in/IN trophoblast/NN invasion/NN of/IN the/DT uterus/NN and/CC tumor/NN invasion/NN and/CC metastasis/NN ./.
P11420220A04
The/DT results/NNS showed/VBD that/IN MMP-2/NN and/CC -9/CD were/VBD expressed/VBN earlier/JJR than/IN MMP-14/NN and/CC TIMPs/NNS in/IN the/DT pregnant/JJ endometrium/NN ./.
P11420245A08
The/DT expression/NN of/IN MMP-14/NN was/VBD regulated/VBN in/IN a/DT manner/NN similar/JJ to/TO that/PRP of/IN MMP-2/NN ./.
P11420306A06
Electron/NN paramagnetic/JJ resonance/NN studies/NNS indicate/VBP that/IN BAECs/NNS chronically/RB grown/VBN in/IN high/JJ glucose/NN conditions/NNS produce/VBP 70/CD %/SYM more/DT ROS/NN than/IN do/VBP control/NN cells/NNS ./.
P11421072A10
The/DT large/JJ donor/NN variability/NN for/IN MMP-1/NN in/IN all/PDT the/DT studies/NNS demonstrates/VBZ that/IN it/PRP is/VBZ important/JJ to/TO analyze/VB gene/NN expression/NN individually/RB ./.
P11425778A08
MMP9/NN expression/NN was/VBD rapidly/RB induced/VBN after/IN injury/NN ,/, whereas/IN the/DT increase/NN in/IN MMP2/NN expression/NN was/VBD delayed/VBN ./.
P11426939A06
This/DT gene/NN induction/NN pattern/NN corresponded/VBD to/TO the/DT differential/JJ activation/NN of/IN the/DT transcription/NN factor/NN nuclear/JJ factor/NN kappaB/NN (/( NF-kappaB/NN )/) regulating/VBG MMP-9/NN ,/, but/CC not/RB signal/NN transducer/NN and/CC activator/NN of/IN transcription/NN 3/CD (/( STAT3/NN )/) ,/, which/WDT is/VBZ involved/VBN in/IN TIMP-1/NN gene/NN regulation/NN ./.
P11448065A05
Cytochalasin-D/NN in/IN the/DT presence/NN of/IN PMA/NN suppressed/VBD MMP-9/NN expression/NN and/CC capillary/NN formation/NN ,/, but/CC colchicine-B/NN had/VBD no/PDT such/DT effect/NN ./.
P11448356A04
DESIGN/NN :/: This/DT study/NN included/VBD 54/CD consecutive/JJ patients/NNS with/IN primary/JJ HNSCC/NN ,/, 27/CD of/IN which/WDT showed/VBD lymph/NN node/NN metastasis/NN ./.
P11454044A10
MMP-1/NN expression/NN in/IN the/DT mucosa/NN may/MD be/VBP related/VBN to/TO the/DT initial/JJ step/NN of/IN ulceration/NN in/IN UC/NN ./.
P11457749A15
These/DT data/NNS support/VBP both/CC the/DT systemic/JJ nature/NN of/IN aneurysmal/JJ disease/NN and/CC a/DT primary/JJ role/NN of/IN MMP-2/NN in/IN aneurysm/NN formation/NN ./.
P11466032A10
The/DT MMP-9/NN //SYM total/JJ protein/NN ratios/NNS in/IN pleural/JJ fluid/NN were/VBD higher/JJR in/IN TB/NN compared/VBN to/TO CHF/NN (/( 0.4492/CD +/-/SYM 0.1633/CD vs/CC 0.0364/CD +/-/SYM 0.0145/CD ,/, P/NN </SYM 0.005/CD )/) but/CC the/DT TIMP-1/NN ratios/NNS were/VBD lower/JJR (/( 139.0/CD +/-/SYM 28.7/CD vs/CC 517.8/CD +/-/SYM 183.7/CD ,/, P/NN </SYM 0.0005/CD )/) ./.
P11467772A08
Interestingly/RB ,/, only/RB the/DT K562/NN cells/NNS expressed/VBD matrilysin/NN suggesting/VBG a/DT potential/JJ role/NN for/IN matrilysin/NN in/IN leukaemia/NN cell/NN invasion/NN ./.
P11467888A07
RESULTS/NNS :/: IL-1/NN increased/VBD the/DT expression/NN and/CC activity/NN of/IN MMPs/NNS ./.
P11477554A08
Expression/NN of/IN pro-MMP-9/NN protein/NN and/CC mRNA/NN was/VBD also/RB induced/VBN in/IN metastatic/JJ PC-3/NN cells/NNS grown/VBN in/IN human/NN fetal/JJ bone/NN implants/NNS in/IN SCID/NN mice/NNS ./.
P11480246A06
RESULTS/NNS :/: Basal/JJ production/NN of/IN MMPs/NNS was/VBD significantly/RB greater/JJR in/IN fibroblasts/NNS grown/VBN in/IN 3D/NN gels/NNS than/IN in/IN cells/NNS grown/VBN as/IN monolayers/NNS ./.
P11486102A04
Therefore/RB ,/, we/PRP sought/VBD to/TO determine/VB the/DT temporal/JJ profile/NN of/IN MMP/NN expression/NN in/IN patients/NNS with/IN acute/JJ ischemic/JJ stroke/NN and/CC to/TO investigate/VB its/PRP$ relationship/NN to/TO stroke/NN severity/NN ,/, location/NN of/IN arterial/JJ occlusion/NN ,/, and/CC total/JJ infarct/NN volume/NN ./.
P11500442A02
To/TO investigate/VB the/DT role/NN of/IN MMPs/NNS in/IN immunity/NN to/TO mycobacterial/JJ infections/NNS ,/, we/PRP incubated/VBD murine/JJ peritoneal/JJ macrophages/NNS with/IN viable/JJ Mycobacterium/NN bovis/NN BCG/NN or/CC Mycobacterium/NN tuberculosis/NN H37Rv/NN and/CC assayed/VBD MMP/NN activity/NN in/IN the/DT supernatants/NNS by/IN zymography/NN ./.
P11507673A10
In/IN conclusion/NN ,/, progesterone/NN increases/VBZ MT1-MMP/NN protein/NN and/CC mRNA/NN levels/NNS in/IN MG-63/NN cells/NNS ,/, but/CC has/VBZ no/DT effects/NNS on/IN proMMP-2/NN activation/NN ,/, which/WDT is/VBZ partly/RB attributable/JJ to/TO the/DT undetectable/JJ levels/NNS of/IN tissue/NN inhibitor/NN of/IN metalloproteinase-2/NN (/( TIMP-2/NN )/) ./.
P11508425A10
Zymography/NN demonstrated/VBD enzyme/NN activity/NN in/IN all/DT synovium/NN samples/NNS from/IN all/DT 9/CD patients/NNS assessed/VBN ./.
P11509885A03
RESULTS/NNS :/: After/IN 6/CD months/NNS of/IN IFN-alpha/NN treatment/NN ,/, the/DT histological/JJ status/NN of/IN liver/NN fibrosis/NN showed/VBD improvement/NN in/IN 9/CD patients/NNS (/( IF/NN group/NN )/) and/CC no/DT change/NN or/CC a/DT worsening/NN in/IN 18/CD patients/NNS (/( NIF/NN group/NN )/) ./.
P11511522A01
Membrane-type/NN matrix/NN metalloproteinases-1/NN and/CC -3/CD (/( MT1-/NN and/CC MT3-MMPs/NNS )/) are/VBP expressed/VBN by/IN activated/JJ smooth/JJ muscle/NN cells/NNS (/( SMCs/NNS )/) both/CC in/FW vitro/FW and/CC in/FW vivo/FW (/( 19/CD )/) ./.
P11514263A11
Myocardial/JJ interstitial/JJ MMP/NN fluorogenic/JJ activity/NN became/VBD detectable/JJ within/IN the/DT ischemic/JJ region/NN as/RB early/RB as/IN 10/CD min/NN after/IN coronary/JJ occlusion/NN and/CC significantly/RB increased/VBD after/IN 1/CD h/NN post-MI/NN ./.
P11514351A08
MMP-9/NN mRNA/NN remained/VBD predominantly/RB in/IN the/DT theca/NN during/IN this/DT period/NN ./.
P11518695A08
The/DT data/NNS indicate/VBP that/IN MMP/NN and/CC TIMP/NN secretion/NN by/IN AGS/NN cells/NNS is/VBZ modulated/VBN by/IN H./NN pylori/NN infection/NN and/CC that/IN host/NN MMP-3/NN and/CC a/DT TIMP-3/NN homolog/NN expressed/VBN by/IN H./NN pylori/NN mediate/VBP at/IN least/JJS part/NN of/IN the/DT host/NN cell/NN response/NN to/TO infection/NN ./.
P11520947A06
Also/RB ,/, a/DT 54-kDa/NN band/NN ,/, likely/RB to/TO be/VB proMMP-1/NN ,/, was/VBD elevated/VBN in/IN a/DT pattern/NN similar/JJ to/TO MMP-2/NN and/CC -9/CD ./.
P11522674A01
Adipocyte/NN hypertrophy/NN and/CC hyperplasia/NN together/RB with/IN angiogenesis/NN contribute/VBP to/TO the/DT growth/NN of/IN the/DT fat/NN mass/NN ./.
P11525779A02
We/PRP have/VBP investigated/VBN effects/NNS of/IN pirfenidone/NN ,/, antifibrotic/JJ agent/NN ,/, and/CC batimastat/NN ,/, inhibitor/NN of/IN MMPs/NNS ,/, on/IN gelatinase/NN activities/NNS ,/, on/IN release/NN of/IN tumor/NN necrosis/NN factor-alpha/NN (/( TNF-alpha/NN )/) and/CC transforming/JJ growth/NN factor-beta/NN (/( TGF-beta/NN )/) ,/, as/RB well/RB as/IN on/IN recruitment/NN of/IN inflammatory/JJ cells/NNS in/IN bronchoalveolar/JJ lavage/NN (/( BAL/NN )/) fluid/NN after/IN aerosol/NN administration/NN of/IN lipopolysaccharide/NN (/( LPS/NN )/) in/IN mice/NNS ./.
P11531282A05
MMP-9/NN immunoreactivity/NN was/VBD detected/VBN by/IN immunohistochemistry/NN and/CC gelatinolytic/JJ activity/NN was/VBD localized/VBN in/IN ovarian/JJ cancer/NN tissue/NN by/IN in/FW situ/FW zymography/NN ./.
P11533337A03
The/DT aims/NNS of/IN our/PRP$ study/NN were/VBD to/TO characterize/VB the/DT presence/NN and/CC molecular/JJ weight/NN forms/NNS of/IN MMP-2/NN ,/, -8/CD ,/, and/CC -9/CD and/CC their/PRP$ specific/JJ inhibitor/NN ,/, tissue/NN inhibitor/NN of/IN metalloproteinases/NNS (/( TIMP/NN )/) -2/CD ,/, in/IN lungs/NNS of/IN preterm/NN infants/NNS during/IN the/DT early/JJ postnatal/JJ period/NN and/CC to/TO determine/VB whether/IN levels/NNS of/IN these/DT MMPs/NNS and/CC TIMP-2/NN in/IN tracheal/JJ aspirate/NN fluid/NN (/( TAF/NN )/) are/VBP associated/VBN with/IN acute/JJ or/CC chronic/JJ lung/NN morbidity/NN of/IN the/DT preterm/NN infant/NN ./.
P11546917A06
CONCLUSIONS/NNS :/: The/DT data/NNS do/VBP not/RB support/VBP the/DT hypothesis/NN that/IN MMP/NN gene/NN variations/NNS influence/VBP the/DT development/NN of/IN intracranial/JJ aneurysms/NNS in/IN the/DT population/NN studied/VBN ./.
P11551917A03
In/IN the/DT present/JJ study/NN ,/, we/PRP examined/VBD the/DT role/NN of/IN Tiam1-Rac/NN signaling/NN in/IN migration/NN and/CC invasion/NN of/IN human/NN renal/JJ cell/NN carcinomas/NNS ./.
P11560951A04
As/RB early/RB as/IN 13/CD months/NNS of/IN age/NN animals/NNS become/VBP moribund/JJ ./.
P11565871A06
Finally/RB ,/, using/VBG semiquantitative/JJ reverse/JJ transcriptase-polymerase/NN chain/NN reaction/NN ,/, the/DT authors/NNS demonstrated/VBD that/IN LY294002/NN decreased/VBD messenger/NN (/( m/NN )/) RNA/NN levels/NNS for/IN both/DT MMPs/NNS ./.
P11577169A05
Seven/CD metalloproteinases/NNS (/( MMP-1/NN ,/, MMP-2/NN ,/, MMP-3/NN ,/, MMP-7/NN ,/, MMP-8/NN ,/, MMP-9/NN ,/, and/CC MMP-13/NN )/) were/VBD tested/VBN against/IN two/CD substrates/NNS :/: gelatin/NN and/CC alpha-casein/NN ./.
P11583842A05
Incorporation/NN of/IN human/NN serum/NN in/IN the/DT assay/NN mixture/NN had/VBD no/DT effect/NN on/IN the/DT degradation/NN of/IN TIMP-1/NN by/IN P./NN gingivalis/NN ,/, whereas/IN a/DT cysteine/NN proteinase/NN inhibitor/NN caused/VBD a/DT complete/JJ inhibition/NN ./.
P11585118A08
Intragroup/NN analysis/NN :/: At/IN week/NN 2/CD following/VBG surgery/NN ,/, when/WRB compared/VBN to/TO baseline/NN all/DT parameters/NNS in/IN each/DT study/NN group/NN ,/, except/IN MMP-1/NN ,/, significantly/RB increased/VBD (/( p/NN </SYM 0.05/CD )/) ./.
P11586466A05
In/IN addition/NN there/EX is/VBZ a/DT marked/JJ increase/NN in/IN expression/NN of/IN TIMP-1/NN leading/VBG to/TO a/DT more/RB global/JJ inhibition/NN of/IN degradation/NN of/IN fibrillar/JJ liver/NN collagens/NNS by/IN interstitial/JJ collagenases/NNS (/( MMP-1/NN //SYM MMP-13/NN )/) ./.
P11589731A09
GM/NN 6001/CD prevented/VBD activation/NN of/IN MMP-2/NN and/CC increased/VBD latent/JJ MMP-9/NN levels/NNS ./.
P11592306A04
TGFbeta1/NN dose-dependently/RB stimulated/VBD the/DT secretion/NN of/IN a/DT 68-kDa/NN gelatinase/NN ,/, which/WDT was/VBD characterized/VBN as/IN an/DT MMP/NN because/IN its/PRP$ activity/NN was/VBD inhibited/VBN by/IN a/DT metalloproteinase/NN inhibitor/NN 1/CD ,/, 10-phenanthroline/NN ,/, and/CC by/IN a/DT synthetic/JJ MMP/NN inhibitor/NN BB3103/NN ./.
P11592410A05
While/IN the/DT pyrimidine-trione/NN template/NN is/VBZ used/VBN as/IN the/DT zinc-chelating/JJ moiety/NN ,/, the/DT substituents/NNS have/VBP been/VBN optimized/VBN to/TO yield/VB inhibitors/NNS comparable/JJ in/IN their/PRP$ inhibition/NN efficiency/NN of/IN matrix/NN metalloproteinases/NNS to/TO hydroxamic/JJ acid/NN derivatives/NNS such/JJ as/IN batimastat/NN ./.
P11592852A06
The/DT second/JJ wave/NN showed/VBD a/DT massive/JJ increase/NN in/IN MMP-2/NN protein/NN expression/NN and/CC activation/NN by/IN day/NN 4/CD ,/, which/WDT was/VBD compatible/JJ with/IN abundant/JJ MMP-2/NN in/IN reactive/JJ microglia/NNS //SYM macrophages/NNS ./.
P11594775A12
The/DT results/NNS suggest/VBP that/IN activities/NNS of/IN active/JJ MMP-2/NN and/CC proMMP-9/NN in/IN the/DT bile/NN may/MD be/VBP useful/JJ markers/NNS for/IN predicting/NN liver/NN metastasis/NN in/IN colorectal/JJ cancer/NN ./.
P11595703A01
PURPOSE/NN :/: Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) degrade/VBP components/NNS of/IN the/DT extracellular/JJ matrix/NN and/CC are/VBP implicated/VBN in/IN tissue/NN remodeling/NN and/CC tumor/NN infiltration/NN ./.
P11641250A03
ET-1/NN [/( 1-32/CD ]/) rapidly/RB down-regulated/VBD the/DT expression/NN of/IN L-selectin/NN and/CC up-regulated/VBD expression/NN of/IN CD11b/NN //SYM CD18/NN on/IN the/DT neutrophil/NN surface/NN ,/, with/IN EC50/NN values/NNS of/IN 1-3/CD nM/NN ./.
P11642414A05
In/IN these/DT patients/NNS ,/, the/DT MMP-9/NN concentration/NN was/VBD significantly/RB higher/JJR (/( p/NN </SYM 0.05/CD )/) during/IN the/DT attack/NN than/IN during/IN the/DT remission/NN ./.
P11665967A10
In/IN RA/NN patients/NNS ,/, serum/NN levels/NNS of/IN CRP/NN correlated/VBN with/IN MMP-3/NN and/CC TIMP-1/NN levels/NNS ,/, but/CC not/RB with/IN MMP-1/NN levels/NNS ./.
P11676550A07
Lung/NN permeability/NN was/VBD assayed/VBN by/IN Evans/NN blue/JJ dye/NN extravasation/NN ./.
P11678909A07
MT1-MMP/NN protein/NN expression/NN on/IN synovial/JJ cells/NNS was/VBD examined/VBN by/IN anti-MT1-MMP/NN immunoblot/NN ./.
P11680936A06
The/DT imbalance/NN of/IN MMP-9/NN dominance/NN in/IN tumor/NN cells/NNS was/VBD implicated/VBN in/IN liver/NN metastasis/NN ./.
P11687525A05
Trabecular/JJ protein/NN kinase/NN C/NN (/( PKC/NN )/) isoforms/NNS were/VBD identified/VBN and/CC localized/VBN by/IN using/NN Western/NN immunoblots/NNS and/CC confocal/JJ immunohistochemistry/NN ./.
P11692106A03
One/CD reason/NN for/IN this/PRP might/MD be/VBP differing/JJ expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) or/CC their/PRP$ inhibitors/NNS (/( TIMPs/NNS )/) ./.
P11699482A09
The/DT active/JJ form/NN of/IN MMP-9/NN and/CC the/DT amount/NN of/IN TIMP-1/NN were/VBD positively/RB correlated/VBN with/IN the/DT number/NN of/IN CD22+/NN ,/, CD68+/NN ,/, and/CC TIA-1+/NN cells/NNS ./.
P11700497A13
MMP-9/NN was/VBD not/RB detected/VBN by/IN IHC/NN ./.
P11704473A06
In/IN all/DT LTx/NN patients/NNS ,/, MMP-9/NN and/CC the/DT MMP-9/NN :/: TIMP-1/NN ratio/NN were/VBD negatively/RB correlated/VBN with/IN forced/JJ expiratory/JJ volume/NN in/IN 1/CD second/NN values/NNS (/( rho/NN =/SYM -0.47/CD ,/, p/NN =/SYM 0.01/CD ,/, and/CC rho/NN =/SYM -0.53/CD ,/, p/NN =/SYM 0.003/CD ,/, respectively/RB )/) ./.
P11705862A04
RESULTS/NNS :/: MMP-1/NN was/VBD detected/VBN in/IN urine/NN samples/NNS from/IN 21/CD of/IN 131/CD (/( 16/CD %/SYM )/) patients/NNS with/IN bladder/NN cancer/NN but/CC was/VBD undetectable/JJ in/IN samples/NNS from/IN all/DT other/JJ groups/NNS (/( P/NN </SYM 0.0001/CD )/) ./.
P11709491A09
Inhibition/NN of/IN MMP/NN activity/NN was/VBD shown/VBN to/TO significantly/RB decrease/VB liver/NN injury/NN in/IN ischemic/JJ //SYM reperfused/JJ liver/NN tissue/NN as/IN assessed/VBN by/IN histological/JJ studies/NNS and/CC serum/NN hepatic/JJ enzyme/NN levels/NNS ./.
P11709701A06
The/DT ability/NN of/IN MMAC/NN //SYM PTEN/NN to/TO induce/VB anoikis/NN in/IN U251/NN cells/NNS was/VBD accompanied/VBN by/IN a/DT significant/JJ inhibition/NN of/IN in/FW vitro/FW invasion/NN (/( 70/CD %/SYM )/) ./.
P11710594A09
RESULTS/NNS :/: The/DT coprecipitation/NN of/IN MMP-2/NN with/IN alphavbeta3/NN by/IN anti-alphav/NN antibody/NN is/VBZ a/DT strong/JJ indication/NN that/IN SiHa/NN cell/NN surface/NN alphavbeta3/NN integrin/NN is/VBZ a/DT receptor/NN for/IN MMP-2/NN ./.
P11713105A08
Retinoic/JJ acid/NN attenuated/VBD the/DT induction/NN and/CC activation/NN of/IN MMP-1/NN and/CC MMP-3/NN ./.
P11716072A09
These/DT data/NNS underline/VBP the/DT importance/NN of/IN functional/JJ interaction/NN of/IN MMPs/NNS with/IN accessory/NN proteins/NNS such/JJ as/IN integrins/NNS during/IN invasion/NN ,/, and/CC the/DT need/NN for/IN further/RB studies/NNS to/TO elucidate/VB the/DT molecular/JJ underpinnings/NNS of/IN this/DT process/NN ./.
P11716080A14
In/IN addition/NN agents/NNS that/WDT target/VBP protein/NN synthesis/NN or/CC the/DT protein/NN kinase/NN C/NN pathway/NN in/IN human/NN pulp/NN cells/NNS inhibit/VBP MMP-2/NN production/NN ,/, and/CC such/DT inhibition/NN may/MD contribute/VBP to/TO the/DT pathogenesis/NN of/IN pulpal/JJ inflammation/NN ./.
P11716537A08
Synthetic/JJ MMP/NN inhibitors/NNS CGS27023A/NN and/CC MMP/NN inhibitor/NN I/CD ,/, which/WDT inhibit/VBP MMPs/NNS 1/CD ,/, 2/CD ,/, 3/CD ,/, and/CC 9/CD ,/, markedly/RB augmented/VBD deposition/NN of/IN laminin/NN 5/CD and/CC type/NN IV/CD and/CC VII/CD collagens/NNS at/IN the/DT dermal-epidermal/JJ junction/NN ,/, resulting/VBG in/IN formation/NN of/IN continuous/JJ epidermal/JJ BM/NN ./.
P11716687A11
With/IN these/DT attributes/NNS ,/, 111In-DTPA-N-TIMP-2/NN is/VBZ a/DT suitable/JJ radiopharmaceutical/NN for/IN in/FW vivo/FW biological/JJ and/CC clinical/JJ investigation/NN of/IN the/DT potential/JJ benefits/NNS of/IN imaging/NN MMP/NN expression/NN ./.
P11720009A02
Stroke/NN is/VBZ associated/VBN with/IN changes/NNS in/IN immune/JJ responses/NNS within/IN the/DT central/JJ nervous/JJ system/NN as/RB well/RB as/IN systemically/RB ./.
P11721189A04
The/DT expression/NN of/IN MMP-2/NN ,/, MMP-9/NN ,/, TIMP-1/NN and/CC TIMP-2/NN was/VBD examined/VBN by/IN immunohistochemistry/NN and/CC RT-PCR/NN ./.
P11726397A10
Our/PRP$ results/NNS suggest/VBP that/IN MMPs/NNS play/VBP an/DT important/JJ role/NN in/IN the/DT development/NN of/IN VILI/NN in/IN rat/NN lungs/NNS and/CC that/IN the/DT MMP-inhibitor/NN Prinomastat/NN is/VBZ effective/JJ in/IN attenuating/NN this/DT type/NN of/IN lung/NN injury/NN ./.
P11726737A12
This/PRP may/MD indicate/VBP that/IN decreased/JJ collagen/NN turnover/NN by/IN fibroblasts/NNS contributes/VBZ to/TO fibrosis/NN in/IN BPD/NN development/NN ./.
P11728453A10
Moreover/RB ,/, a/DT non-selective/JJ COX/NN inhibitor/NN indomethacin/NN also/RB suppressed/VBD the/DT expression/NN of/IN MMP-2/NN ./.
P11729853A14
In/FW vitro/FW stimulation/NN of/IN the/DT cell/NN lines/NNS with/IN the/DT PMA/NN increased/VBD MMP/NN production/NN ,/, particularly/RB of/IN active/JJ MMP-2/NN and/CC latent/JJ MMP-9/NN ,/, resulting/VBG in/IN a/DT profile/NN of/IN MMP/NN production/NN similar/JJ to/TO that/PRP seen/VBN in/FW vivo/FW ./.
P11736941A07
Hence/RB ,/, we/PRP concluded/VBD that/IN (/( i/CD )/) MMPs/NNS //SYM TIMPs/NNS are/VBP secreted/VBN by/IN normal/JJ human/NN bone/NN marrow/NN haematopoietic/JJ and/CC stromal/JJ cells/NNS and/CC may/MD play/VBP an/DT important/JJ role/NN in/IN intercellular/JJ cross-talk/NN in/IN haematopoiesis/NN ;/: and/CC (/( ii/CD )/) only/RB latent/JJ forms/NNS of/IN MMPs/NNS are/VBP present/JJ under/IN LTMC/NN conditions/NNS ,/, indicating/VBG that/IN the/DT specific/JJ media/NN used/VBN for/IN weekly/RB re-feeding/NN of/IN LTMC/NN can/MD block/VBP activation/NN of/IN MMP-2/NN and/CC MMP-9/NN ,/, maintaining/VBG the/DT integrity/NN of/IN the/DT stromal/JJ layer/NN and/CC supporting/VBG haematopoiesis/NN in/FW vitro/FW ./.
P11744025A01
OBJECTIVES/NNS :/: Peroxynitrite/NN (/( ONOO/NN (/( -/SYM )/) )/) mediates/VBZ in/IN part/NN both/CC ischemia-reperfusion/NN and/CC pro-inflammatory/JJ cytokine-induced/JJ injury/NN to/TO the/DT heart/NN ./.
P11745204A06
In/IN contrast/NN ,/, patients/NNS with/IN rectal/JJ carcinoma/NN (/( n/NN =/SYM 10/CD patients/NNS )/) had/VBD revealed/VBD the/DT same/JJ high/JJ activity/NN of/IN MMP-9/NN in/IN tumor/NN regions/NNS and/CC corresponding/JJ healthy/JJ tissue/NN ./.
P11751597A14
This/DT study/NN highlights/VBZ the/DT complex/JJ nature/NN of/IN MMP/NN //SYM TIMP/NN regulation/NN during/IN reproductive/JJ tissue/NN growth/NN and/CC suggests/VBZ that/IN TIMP-1/NN and/CC TIMP-2/NN may/MD be/VBP involved/VBN in/IN other/JJ aspects/NNS of/IN the/DT growth/NN process/NN ./.
P11756180A02
TIMP-1/NN is/VBZ active/JJ primarily/RB in/IN B/NN cells/NNS and/CC B-cell/NN lymphomas/NNS ,/, whereas/IN TIMP-2/NN expression/NN is/VBZ restricted/VBN to/TO T/NN cells/NNS ./.
P11757034A05
Different/JJ expressions/NNS were/VBD also/RB observed/VBN between/IN the/DT cells/NNS deriving/VBG from/IN the/DT primary/JJ cell/NN cultures/NNS ,/, the/DT benign/JJ cell/NN line/NN BPH-1/NN ,/, and/CC the/DT malignant/JJ cell/NN lines/NNS LNCaP/NN ,/, D-145/NN ,/, and/CC PC-3/NN ./.
P11757634A06
MMP-2/NN and/CC -9/CD activities/NNS were/VBD elevated/VBN under/IN prolonged/JJ hyperoxic/JJ exposure/NN ./.
P11773040A02
It/PRP has/VBZ been/VBN shown/VBN that/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP elevated/VBN in/IN the/DT retina/NN during/IN the/DT neovascularization/NN process/NN ./.
P11773040A17
Increased/JJ production/NN of/IN MMPs/NNS by/IN RMVECs/NNS does/VBZ not/RB occur/VBP directly/RB in/IN response/NN to/TO a/DT hypoxic/JJ stimulus/NN ./.
P11773164A11
COL-3-related/JJ grade/NN 3/CD or/CC 4/CD adverse/JJ events/NNS were/VBD reported/VBN by/IN six/CD patients/NNS and/CC included/VBD photosensitivity/NN ,/, rash/NN ,/, and/CC headache/NN ./.
P11773278A13
MMP/NN inhibition/NN reduced/VBD proliferating/JJ tumor/NN cells/NNS from/IN 20.8/CD %/SYM (/( 95/CD %/SYM CI/NN =/SYM 19.9/CD %/SYM to/TO 21.7/CD %/SYM )/) to/TO 7.4/CD %/SYM (/( 95/CD %/SYM CI/NN =/SYM 5.2/CD %/SYM to/TO 9.6/CD %/SYM )/) (/( P/NN =.006/CD )/) ,/, without/IN affecting/NN angiogenesis/NN or/CC apoptosis/NN ./.
P11775947A03
The/DT mRNA/NN expression/NN of/IN MMP-9/NN ,/, MMP-2/NN ,/, TIMP-1/NN ,/, TIMP-2/NN genes/NNS were/VBD determined/VBN by/IN RT-PCR/NN ./.
P11776634A07
When/WRB SKOV3/NN cells/NNS were/VBD treated/VBN with/IN 10/CD micrograms/NNS //SYM ml/NN fibronectin/NN for/IN 1/CD hr/NN ,/, the/DT cellular/JJ MMP-2/NN mRNA/NN dramatically/RB increased/VBD ./.
P11781293A05
Congruence/NN of/IN PMN/NN and/CC MMP/NN expression/NN in/IN lung/NN tissue/NN was/VBD evaluated/VBN by/IN neutrophil/NN depletion/NN and/CC fluorescent/JJ immunohistochemistry/NN (/( IHC/NN )/) ./.
P11790786A02
Small/JJ molecular/JJ weight/NN synthetic/JJ inhibitors/NNS for/IN these/DT enzymes/NNS are/VBP highly/RB sought/VBN for/IN potential/JJ use/NN as/IN anti-metastatic/JJ agents/NNS ./.
P11792884A12
The/DT analysis/NN of/IN the/DT serum/NN concentrations/NNS of/IN TIMP-1/NN and/CC TIMP-2/NN showed/VBD that/IN their/PRP$ levels/NNS were/VBD also/RB elevated/VBN in/IN RA/NN patients/NNS compared/VBN with/IN OA/NN patients/NNS (/( P/NN </SYM 0.001/CD and/CC P/NN </SYM 0.01/CD respectively/RB )/) ./.
P11795995A05
RESULTS/NNS :/: Collagenase/NN and/CC gelatinase/NN activity/NN significantly/RB increased/VBD in/IN the/DT knee/NN cartilage/NN of/IN rats/NNS injected/VBN with/IN iodoacetate/NN with/IN peak/JJ activity/NN by/IN day/NN 7/CD ./.
P11796838A01
Tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) are/VBP endogenous/JJ regulators/NNS of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ./.
P11815431A10
Stromelysin-1/NN (/( MMP-3/NN )/) and/CC TIMP-3/NN were/VBD ,/, however/WRB ,/, over/RB expressed/VBN in/IN the/DT AAA/NN samples/NNS and/CC may/MD be/VBP involved/VBN aneurysm/NN pathogenesis/NN ./.
P11827795A03
The/DT SFD/NN mutations/NNS characterized/VBN result/VBP in/IN introduction/NN of/IN an/DT unpaired/JJ cysteine/NN residue/NN in/IN the/DT C-terminal/JJ domain/NN of/IN TIMP-3/NN ./.
P11839588A03
We/PRP found/VBD that/IN cultured/JJ human/NN umbilical/JJ vein/NN endothelial/JJ cells/NNS shed/VBP vesicles/NNS (/( 300/CD to/TO 600/CD nm/NN )/) originating/VBG from/IN localized/JJ areas/NNS of/IN the/DT cell/NN plasma/NN membrane/NN ,/, as/IN revealed/VBN by/IN ultrastructural/JJ analysis/NN ./.
P11841363A01
BACKGROUND/NN :/: Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN MMPs/NNS (/( TIMPs/NNS )/) have/VBP important/JJ functions/NNS during/IN skin/NN development/NN ,/, repair/NN and/CC maintenance/NN ./.
P11849655A08
The/DT immunohistochemical/JJ expression/NN of/IN these/DT MMPs/NNS and/CC TIMPs/NNS were/VBD examined/VBN in/IN treated/JJ aortic/JJ sections/NNS with/IN lesions/NNS and/CC control/NN aortic/JJ sections/NNS without/IN lesions/NNS ./.
P11852234A04
Collagen/NN denaturation/NN was/VBD determined/VBN by/IN alpha-chymotrypsin/NN digestion/NN ./.
P11854068A10
In/IN addition/NN ,/, arecoline/NN was/VBD found/VBN to/TO inhibit/VB MMP-2/NN secretion/NN and/CC production/NN at/IN the/DT concentration/NN level/NN of/IN 40/CD microg/NN //SYM ml/NN ./.
P11872217A04
PATIENT/NN (/( S/NNS )/) :/: Five/CD samples/NNS of/IN hydrosalpinx/NN fluid/NN were/VBD obtained/VBN at/IN the/DT time/NN of/IN ovocyte/NN retrieval/NN ./.
P11872911A09
At/IN 12/CD hours/NNS ,/, tPA-treated/JJ rats/NNS showed/VBD significantly/RB higher/JJR levels/NNS of/IN pro-MMP-9/NN and/CC cleaved/JJ MMP-9/NN than/IN untreated/JJ controls/NNS ./.
P11876751A06
The/DT levels/NNS of/IN serum/NN TIMP-1/NN were/VBD significantly/RB reduced/VBN in/IN AD/NN patients/NNS following/VBG conventional/JJ treatments/NNS ./.
P11878827A02
The/DT mechanisms/NNS underlying/VBG drusen/NN formation/NN are/VBP not/RB well/RB characterized/VBN ./.
P11882331A13
MMP-2/NN levels/NNS in/IN the/DT coronary/JJ sinus/NN blood/NN were/VBD significantly/RB higher/JJR in/IN patients/NNS with/IN late/JJ restenosis/NN than/IN in/IN those/PRP without/IN restenosis/NN ./.
P11884904A08
RESULTS/NNS :/: In/IN the/DT anulus/NN fibrosus/NN chondroitinase/NN ABC/NN and/CC interleukin-1/NN synergistically/RB increased/VBD the/DT collagenase/NN activity/NN ,/, which/WDT was/VBD at/IN a/DT significantly/RB higher/JJR level/NN than/IN the/DT increment/NN solely/RB due/JJ to/TO interleukin-1/NN ./.
P11889208A03
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) are/VBP the/DT main/JJ mediators/NNS of/IN ECM/NN degradation/NN ./.
P11911253A14
This/DT analysis/NN confirms/VBZ previous/JJ results/NNS obtained/VBN in/IN a/DT keratinocyte/NN tumor/NN cell/NN model/NN and/CC provides/VBZ evidence/NN for/IN a/DT more/RB general/JJ biological/JJ association/NN between/IN MMP-expression/NN and/CC tumor/NN cell/NN growth/NN ./.
P11912288A03
Levels/NNS of/IN pro-MMP-9/NN in/IN choriocarcinoma/NN and/CC those/PRP of/IN TIMP-1/NN in/IN both/CC hydatidiform/NN mole/NN and/CC choriocarcinoma/NN were/VBD also/RB increased/VBN ./.
P11918086A10
The/DT results/NNS suggest/VBP that/IN stress-activated/JJ protein/NN kinases/NNS like/IN p38MAPK/NN are/VBP involved/VBN in/IN regulation/NN of/IN expression/NN of/IN MMP-2/NN as/RB well/RB as/IN in/FW vitro/FW invasion/NN of/IN malignant/JJ melanoma/NN cells/NNS ./.
P11920503A04
Twenty-nine/CD endometrial/JJ carcinoma/NN biopsies/NNS were/VBD investigated/VBN immunohistochemically/RB to/TO determine/VB the/DT tissue/NN localization/NN of/IN MMP-2/NN (/( gelatinase/NN A/NN )/) ,/, MMP-9/NN (/( gelatinase/NN B/NN )/) ,/, MT1-MMP/NN ,/, and/CC TIMPs/NNS 1-3/CD ./.
P11920505A02
Because/IN of/IN their/PRP$ ability/NN to/TO degrade/VB extracellular/JJ matrix/NN components/NNS (/( EMC/NN )/) ,/, matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) have/VBP been/VBN implicated/VBN in/IN the/DT breakdown/NN of/IN basement/NN membranes/NNS and/CC underlying/JJ stroma/NN ,/, thereby/RB facilitating/VBG tumor/NN growth/NN and/CC invasion/NN ./.
P11925127A07
The/DT invasion/NN of/IN cervical/JJ carcinoma/NN cells/NNS was/VBD suppressed/VBN by/IN MMI-166/NN ./.
P11935159A14
CONCLUSIONS/NNS //SYM INTERPRETATION/NN :/: These/DT results/NNS indicate/VBP that/IN the/DT impairment/NN of/IN matrix/NN degradation/NN contributes/VBZ to/TO matrix/NN accumulation/NN in/IN diabetic/JJ nephropathy/NN and/CC that/IN the/DT beneficial/JJ effects/NNS of/IN ACE/NN inhibition/NN could/MD in/IN part/NN be/VBP mediated/VBN by/IN modulation/NN of/IN changes/NNS in/IN matrix/NN degradative/JJ pathways/NNS ./.
P11939809A10
CONCLUSION/NN :/: Production/NN ,/, release/NN ,/, and/CC activation/NN of/IN MMP-9/NN in/IN hypertrophic/JJ scars/NNS could/MD be/VBP an/DT effector/NN mechanism/NN responsible/JJ for/IN hypertrophy/NN regression/NN induced/VBN by/IN mechanical/JJ compression/NN ./.
P11940298A09
MMP-9/NN expression/NN did/VBD not/RB correlate/VBP with/IN proteinuria/NN ,/, but/CC negatively/RB correlated/VBN with/IN serum/NN creatinine/NN levels/NNS (/( P/NN </SYM 0.05/CD )/) ./.
P11949943A10
Targeting/NN pregnancy-associated/JJ factors/NNS that/WDT inhibit/VBP endometrial-specific/JJ MMP/NN expression/NN and/CC action/NN may/MD enhance/VBP the/DT effectiveness/NN of/IN progestin-related/JJ treatments/NNS for/IN endometriosis/NN ./.
P11949963A05
Although/IN most/PRP of/IN the/DT menstrual/JJ fluid/NN exits/VBZ the/DT body/NN ,/, reflux/NN of/IN some/DT material/NN occurs/VBZ in/IN most/DT women/NNS ,/, providing/VBG a/DT poorly/RB understood/JJ opportunity/NN for/IN ectopic/JJ endometrial/JJ growth/NN and/CC establishment/NN of/IN the/DT disease/NN endometriosis/NN ./.
P11955860A08
CONCLUSIONS/NNS :/: Both/CC TIMPs/NNS and/CC MMP-2/NN remained/VBD inactive/JJ during/IN hypertrophy/NN ,/, per/FW se/FW ;/: they/PRP were/VBD activated/VBN during/IN the/DT transition/NN to/TO CHF/NN ./.
P11956636A04
Membrane/NN type/NN 1-MMP/NN (/( MT1-MMP/NN )/) was/VBD originally/RB identified/VBN as/IN an/DT activator/NN of/IN MMP-2/NN ./.
P11964371A10
These/DT results/NNS demonstrate/VBP H/NN //SYM R-mediated/JJ modulation/NN of/IN EC/NN MMP-2/NN at/IN both/CC transcriptional/JJ and/CC posttranscriptional/JJ levels/NNS ./.
P11970913A08
Dexamethasone/NN prevented/VBD the/DT increase/NN in/IN MMP-9/NN release/NN ,/, and/CC increased/VBD TIMP-1/NN release/NN ./.
P11970978A11
However/WRB ,/, MMP-9/NN was/VBD only/RB required/VBN for/IN Langerhans/NN cell/NN migration/NN and/CC not/RB maturation/NN ,/, since/IN nonmigrating/JJ Langerhans/NN cells/NNS isolated/VBN from/IN the/DT epidermis/NN matured/VBD normally/RB with/IN regard/NN to/TO morphology/NN ,/, phenotype/NN ,/, and/CC T/NN cell/NN stimulatory/JJ function/NN ./.
P11971672A10
RESULTS/NNS :/: Increasing/JJ concentrations/NNS of/IN L-NMMA/NN produced/VBD a/DT dose-dependent/JJ decrease/NN in/IN NO/NN (/( x/SYM )/) (/( 2214/CD +/-/SYM 405/CD to/TO 347/CD +/-/SYM 37/CD ng/NN //SYM mg/NN ,/, P/NN </SYM 0.001/CD )/) ./.
P11971760A08
Finally/RB ,/, we/PRP showed/VBD that/IN the/DT expression/NN of/IN 1.9/CD kb/NN of/IN human/NN MMP-9/NN gene/NN promoter/NN coupled/VBN with/IN luciferase/NN (/( MMP-9-luc/NN )/) was/VBD increased/VBN 7.65/CD +/-/SYM 1.2-fold/NN by/IN gastrin/NN ,/, via/IN a/DT pathway/NN which/WDT includes/VBZ stimulation/NN of/IN protein/NN kinase/NN C/NN ,/, and/CC activation/NN of/IN Raf/NN and/CC the/DT mitogen-activated/JJ protein/NN (/( MAP/NN )/) kinase/NN pathway/NN ./.
P11984824A03
The/DT 64-kDa/NN MMP-2/NN activity/NN was/VBD the/DT highest/NN on/IN day/NN 2/CD (/( P/NN </SYM 0.01/CD )/) and/CC higher/JJR on/IN day/NN 5/CD and/CC 6/CD (/( P/NN </SYM 0.05/CD )/) ./.
P11984824A15
The/DT results/NNS suggested/VBD that/IN the/DT implanting/JJ rat/NN embryo/NN strongly/RB induced/VBD MMP-2/NN and/CC -9/CD proteins/NNS and/CC gene/NN expression/NN for/IN decidulization/NN and/CC embryo/NN invasion/NN ,/, which/WDT were/VBD strictly/RB controlled/VBN and/CC balanced/VBN by/IN the/DT simultaneous/JJ expression/NN of/IN TIMP-1/NN ,/, -2/CD and/CC -3/CD ./.
P12000730A11
TGF-beta1/NN (/( 10/CD ng/NN //SYM ml/NN )/) down-regulated/VBD MMP-9/NN by/IN 54/CD %/SYM and/CC MMP-3/NN by/IN 34/CD %/SYM whereas/IN TGF-beta/NN 1-neutralizing/JJ antibody/NN increased/VBD MMP-9/NN expression/NN by/IN 39/CD %/SYM ./.
P12005365A05
Under/IN the/DT stimulation/NN of/IN IL-1alpha/NN ,/, heparinoid/NN increased/VBD the/DT production/NN of/IN TIMP-3/NN in/IN a/DT concentration-dependent/JJ manner/NN ,/, but/CC not/RB TIMP-1/NN ,/, TIMP-2/NN ,/, MMP-1/NN or/CC MMP-3/NN ./.
P12009332A03
Synovial/JJ cells/NNS were/VBD cultured/VBN on/IN a/DT collagen-coated/JJ agar/NN block/NN and/CC exposed/VBN to/TO 2/CD %/SYM cyclic/JJ strain/NN at/IN 6/CD rev/NN ./.
P12009387A08
Histology/NN of/IN the/DT plug/NN sites/NNS revealed/VBD good/JJ integration/NN of/IN the/DT collagen/NN plug/NN without/IN complete/JJ restoration/NN of/IN membrane/NN integrity/NN ./.
P12010506A12
There/EX was/VBD no/DT difference/NN in/IN the/DT serum/NN concentration/NN of/IN TIMP-1/NN between/IN patients/NNS and/CC the/DT controls/NNS ./.
P12011369A03
METHODS/NNS :/: Serum/NN samples/NNS were/VBD collected/VBN from/IN 60/CD RA/NN patients/NNS at/IN baseline/NN and/CC after/IN 8/CD or/CC 12/CD weeks/NNS of/IN treatment/NN ./.
P12011989A09
This/PRP was/VBD partly/RB reproduced/VBN by/IN their/PRP$ conditioned/JJ media/NN ./.
P12014920A07
All/DT quantitations/NNS were/VBD normalized/VBN to/TO the/DT 18s/NN rRNA/NN values/NNS (/( endogenous/JJ control/NN )/) and/CC changes/NNS in/IN gene/NN expression/NN were/VBD reported/VBN as/IN fold/NN increase/NN relative/JJ to/TO untreated/JJ controls/NNS ./.
P12021040A07
Expression/NN of/IN MMP-14/NN was/VBD also/RB observed/VBN in/IN the/DT granulosal/JJ layer/NN after/IN the/DT gonadotropin/NN surge/NN ./.
P12027249A01
BACKGROUND/NN :/: Matrix/NN metalloproteinase-1/NN (/( MMP-1/NN )/) is/VBZ a/DT member/NN of/IN a/DT family/NN of/IN enzymes/NNS which/WDT are/VBP capable/JJ of/IN degrading/NN most/DT extracellular/JJ matrix/NN macromolecules/NNS ./.
P12032297A04
The/DT present/JJ crystal/NN structure/NN of/IN the/DT human/NN proMMP-2/NN //SYM TIMP-2/NN complex/NN reveals/VBZ an/DT interaction/NN between/IN the/DT hemopexin/NN domain/NN of/IN proMMP-2/NN and/CC the/DT C-terminal/JJ domain/NN of/IN TIMP-2/NN ,/, leaving/VBG the/DT catalytic/JJ site/NN of/IN MMP-2/NN and/CC the/DT inhibitory/JJ site/NN of/IN TIMP-2/NN distant/JJ and/CC spatially/RB isolated/VBN ./.
P12035934A05
These/DT data/NNS suggest/VBP that/IN thyroid/NN carcinoma/NN or/CC tumor-associated/JJ inflammatory/JJ cells/NNS might/MD secrete/VBP a/DT factor/NN (/( s/NNS )/) which/WDT stimulates/VBZ MMP-1/NN or/CC TIMP-1/NN expression/NN by/IN surrounding/JJ tissues/NNS ./.
P12039803A11
Both/PRP were/VBD stimulated/VBN by/IN FXa/NN and/CC inhibited/VBN by/IN the/DT selective/JJ FXa/NN inhibitor/NN DX-9065a/NN and/CC the/DT MMP/NN inhibitor/NN GM/NN 6001/CD but/CC not/RB by/IN hirudin/NN or/CC aprotinin/NN ./.
P12042738A03
METHODS/NNS :/: Rat/NN aortic/JJ smooth/JJ muscle/NN cells/NNS were/VBD harvested/VBN from/IN Sprague-Dawley/NN rats/NNS ./.
P12044662A09
Ischemic/JJ brain/NN exhibited/VBD high/JJ activity/NN lysis/NN zones/NNS within/IN the/DT infarcted/JJ area/NN (/( detected/VBN by/IN microtubuli/NNS associated/JJ protein-2/NN staining/NN )/) ./.
P12051403A13
CONCLUSION/NN :/: We/PRP confirm/VBP previous/JJ observations/NNS that/IN MMPs/NNS and/CC TIMPs/NNS may/MD play/VBP an/DT important/JJ role/NN in/IN various/JJ rheumatic/JJ diseases/NNS ./.
P12051699A06
Cells/NNS expressing/VBG mutant/JJ PDGF/NN receptors/NNS unable/JJ to/TO associate/VB with/IN Src/NN or/CC PLCgamma/NN ,/, retained/VBD the/DT ability/NN to/TO induce/VB MMP-3/NN expression/NN as/IN a/DT result/NN of/IN PDGF-BB/NN stimulation/NN ./.
P12054499A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) play/VBP an/DT important/JJ role/NN in/IN cancer/NN metastasis/NN ./.
P12058032A07
PMS-induced/JJ pro-MMP-2/NN activation/NN was/VBD regulated/VBN by/IN the/DT receptor/NN tyrosine/NN kinases/NNS ,/, especially/RB the/DT receptors/NNS of/IN platelet-derived/JJ growth/NN factor/NN and/CC vascular/JJ endothelial/JJ growth/NN factor/NN ,/, and/CC downstream/JJ on/IN the/DT phosphatidylinositol/NN 3-kinase/NN //SYM NF-kappa/NN B/NN pathway/NN but/CC not/RB Ras/NN ,/, cAMP-dependent/JJ protein/NN kinase/NN ,/, protein/NN kinase/NN C/NN ,/, and/CC mitogen-activated/JJ protein/NN kinases/NNS ./.
P12060118A10
The/DT AML/NN patients/NNS with/IN lower/JJR MMP-9/NN levels/NNS (/( </SYM or/CC =/SYM 4.4/CD ng/NN //SYM ml/NN )/) tended/VBD to/TO have/VB longer/JJR survival/NN time/NN than/IN those/PRP with/IN higher/JJR levels/NNS (/( >/SYM 12/CD months/NNS vs/CC 4/CD months/NNS ,/, P/NN =/SYM 0.12/CD )/) ./.
P12061424A05
Both/DT enzymes/NNS induced/VBD prominent/JJ tissue/NN alterations/NNS and/CC conspicuous/JJ increments/NNS in/IN interleukin/NN (/( IL/NN )/) -1beta/NN ,/, IL-6/NN and/CC a/DT number/NN of/IN MMPs/NNS ,/, especially/RB gelatinase/NN MMP-9/NN ,/, rapidly/RB after/IN injection/NN ./.
P12063180A04
Results/NNS showed/VBD a/DT roughly/RB constitutive/JJ TIMP-1/NN expression/NN opposed/VBN to/TO an/DT inducible/JJ MMP-9/NN synthesis/NN ./.
P12064464A05
Either/DT type/NN of/IN cell/NN did/VBD not/RB secrete/VBP MMP-9/NN ./.
P12076079A13
No/DT corresponding/JJ increase/NN in/IN TIMP-1/NN and/CC TIMP-2/NN protein/NN activity/NN and/CC protein/NN level/NN was/VBD detected/VBN by/IN reverse/JJ zymography/NN and/CC western/NN blot/NN ./.
P12081746A10
CONCLUSION/NN :/: Failure/NN of/IN extracellular/JJ matrix/NN degradation/NN may/MD be/VBP an/DT important/JJ molecular/JJ mechanism/NN in/IN the/DT pathogenesis/NN of/IN chronic/JJ renal/JJ allograft/NN damage/NN ./.
P12082030A10
Immuno-localization/NN analysis/NN of/IN membrane/NN type-1/NN (/( MT1/NN )/) -MMP/NN indicated/VBD that/IN migration/NN is/VBZ associated/VBN with/IN the/DT redistribution/NN of/IN this/DT protein/NN from/IN the/DT endoplasmic/JJ reticulum/NN to/TO the/DT plasma/NN membrane/NN ./.
P12084592A02
BACKGROUND/NN :/: Nitroglycerin/NN is/VBZ one/CD of/IN the/DT most/RBS frequently/RB used/JJ therapeutic/JJ agents/NNS for/IN the/DT symptomatic/JJ relief/NN of/IN stable/JJ or/CC unstable/JJ coronary/JJ artery/NN disease/NN ;/: however/WRB ,/, its/PRP$ effects/NNS on/IN vascular/JJ biology/NN are/VBP poorly/RB characterized/VBN ./.
P12095558A09
Symptoms/NNS increased/VBD further/RB from/IN 2/CD weeks/NNS to/TO 6/CD weeks/NNS ,/, whereas/IN endoscopic/JJ and/CC cellular/JJ evidence/NN of/IN proctitis/NN did/VBD not/RB ./.
P12097550A04
Infection/NN of/IN immunosuppressed/JJ mice/NNS suggested/VBD that/IN expression/NN of/IN most/DT MMP/NN ,/, TIMP/NN ,/, and/CC chemokine/NN mRNA/NN was/VBD induced/VBN primarily/RB in/IN CNS-resident/NN cells/NNS ./.
P12097800A07
However/WRB ,/, the/DT increased/JJ levels/NNS of/IN MMPs/NNS seem/VBP not/RB to/TO be/VB able/JJ to/TO overcome/VB the/DT overproduction/NN and/CC accumulation/NN of/IN the/DT exfoliative/JJ material/NN ./.
P12099554A02
METHODS/NNS :/: Two-cell/NN mouse/NN embryos/NNS were/VBD cultured/VBN for/IN 96/CD h/NN in/IN the/DT presence/NN or/CC absence/NN of/IN various/JJ concentrations/NNS of/IN TGF-alpha/NN ./.
P12103373A09
Immunostaining/NN for/IN collagen/NN IV/CD and/CC laminin/NN was/VBD used/VBN to/TO study/VB degradation/NN of/IN basal/JJ lamina/NN ./.
P12105240A04
METHODS/NNS :/: We/PRP performed/VBD immunohistochemistry/NN with/IN polyclonal/JJ anti-MMP-2/NN and/CC MMP-9/NN antibodies/NNS ,/, and/CC analysed/VBD gelatin/NN zymograms/NNS of/IN five/CD isolated/JJ glomeruli/NNS from/IN various/JJ types/NNS of/IN human/NN renal/JJ disease/NN ./.
P12109221A03
It/PRP has/VBZ been/VBN shown/VBN that/IN overexpression/NN of/IN TIMPs/NNS in/IN tumors/NNS of/IN various/JJ origins/NNS leads/VBZ to/TO reduced/JJ tumor/NN growth/NN and/CC formation/NN of/IN metastases/NNS ./.
P12111403A04
Basement/NN lamina/NN was/VBD present/VBP only/RB focally/RB ./.
P12113554A07
Minor/JJ gelatinolytic/JJ bands/NNS were/VBD also/RB observed/VBN at/IN 92/CD kDa/NN regions/NNS that/WDT correspond/VBP to/TO MMP-9/NN ./.
P12114911A06
CONCLUSIONS/NNS :/: MMP/NN levels/NNS in/IN the/DT pregnant/JJ and/CC postpartum/NN rat/NN uterus/NN and/CC cervix/NN are/VBP regulated/VBN in/IN part/NN by/IN a/DT PGE/NN (/( 2/CD )/) -cAMP/NN mechanism/NN ./.
P12115185A02
METHODS/NNS :/: The/DT metabolic/JJ profile/NN of/IN human/NN OA/NN cartilage/NN was/VBD determined/VBN at/IN the/DT time/NN of/IN harvest/NN and/CC after/IN 24-hour/NN exposure/NN to/TO n-3/NN PUFAs/NNS or/CC other/JJ classes/NNS of/IN fatty/JJ acids/NNS ,/, followed/VBN by/IN explant/NN culture/NN for/IN 4/CD days/NNS in/IN the/DT presence/NN or/CC absence/NN of/IN interleukin-1/NN (/( IL-1/NN )/) ./.
P12118337A05
ACLA-differentiated/JJ cells/NNS exhibited/VBD an/DT increased/JJ proMMP-9/NN secretion/NN which/WDT has/VBZ been/VBN observed/VBN by/IN gelatin/NN zymography/NN and/CC immunoassay/NN ./.
P12118680A09
The/DT potential/NN for/IN physiologically/RB relevant/JJ regulation/NN of/IN expression/NN of/IN these/DT genes/NNS by/IN PGE2/NN is/VBZ a/DT consideration/NN in/IN the/DT use/NN of/IN drugs/NNS that/WDT inhibit/VBP prostanoid/NN synthesis/NN in/IN the/DT treatment/NN of/IN equine/JJ arthropathies/NNS ./.
P12133319A06
Transcriptional/JJ levels/NNS of/IN MMP-2/NN and/CC TIMP-1/NN mRNA/NN in/IN the/DT lungs/NNS were/VBD assessed/VBN by/IN semiquantitative/JJ reverse/JJ transcription-polymerase/NN chain/NN reaction/NN (/( RT-PCR/NN )/) ./.
P12133379A04
(/( 2/CD )/) The/DT ratio/NN of/IN MMP/NN //SYM TIMP/NN in/IN trabecular/JJ meshwork/NN cells/NNS was/VBD much/RB higher/JJR than/IN that/PRP in/IN ciliary/JJ muscle/NN cells/NNS ./.
P12134900A02
In/IN the/DT present/JJ study/NN ,/, by/IN assessing/NN the/DT effect/NN of/IN a/DT specific/JJ p38/NN mitogen-activated/JJ protein/NN kinase/NN (/( MAPK/NN )/) inhibitor/NN ,/, SB203580/NN ,/, on/IN the/DT secretion/NN of/IN MMPs/NNS and/CC in/FW vitro/FW invasion/NN of/IN various/JJ glioma/NN cells/NNS ,/, the/DT authors/NNS attempt/VBP to/TO define/VB the/DT role/NN of/IN the/DT p38/NN MAPK/NN pathway/NN in/IN the/DT regulation/NN of/IN MMPs/NNS and/CC tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) activated/VBN by/IN phorbol/NN ester/NN (/( phorbol-12-myristate-13-acetate/NN [/( PMA/NN ]/) )/) in/IN the/DT D54/NN human/NN glioblastoma/NN cell/NN line/NN ./.
P12136400A01
AIMS/NNS //SYM HYPOTHESIS/NN :/: The/DT molecular/JJ factors/NNS that/WDT cause/VBP an/DT acute/JJ wound/NN in/IN diabetic/JJ patients/NNS to/TO become/VB chronic/JJ have/VBP not/RB yet/RB been/VBN established/VBN ./.
P12137602A08
RESULTS/NNS :/: The/DT pathological/JJ changes/NNS of/IN bronchi/NNS and/CC lung/NN tissue/NN ,/, the/DT changes/NNS of/IN lung/NN function/NN and/CC blood/NN gas/NN analysis/NN were/VBD similar/JJ to/TO those/PRP of/IN the/DT COPD/NN patients/NNS ./.
P12139676A07
Serum/NN MMP-9/NN activity/NN and/CC TIMP-1/NN level/NN in/IN patients/NNS with/IN SSc/NN were/VBD not/RB correlated/VBN ./.
P12145178A10
Glycation/NN of/IN matrix/NN decreased/VBD TGF-beta/NN mRNA/NN by/IN 38.2/CD %/SYM and/CC total/JJ and/CC active/JJ TGF-beta/NN by/IN 35.5/CD and/CC 21.5/CD %/SYM ,/, respectively/RB ,/, opposite/JJ the/DT effects/NNS of/IN high/JJ glucose/NN concentrations/NNS ./.
P12146533A10
CONCLUSIONS/NNS :/: These/DT data/NNS strongly/RB suggest/VBP that/IN future/JJ clinical/JJ studies/NNS investigating/VBG the/DT role/NN of/IN IL-6/NN in/IN periodontal/JJ disease/NN must/MD also/RB determine/VBP the/DT levels/NNS of/IN sIL-6r/NN within/IN the/DT periodontal/JJ tissues/NNS ./.
P12147532A04
Angiotensin-converting/JJ enzyme/NN activity/NN was/VBD determined/VBN by/IN use/NN of/IN a/DT specific/JJ substrate/NN ./.
P12147614A09
TGF-beta/NN (/( 2/CD )/) also/RB stimulated/VBD MT2-MMP/NN cell/NN surface/NN expression/NN and/CC release/NN of/IN TIMP-1/NN ./.
P12149192A05
The/DT closely/RB related/JJ chemokines/NNS MCP-1/NN ,/, MCP-2/NN ,/, and/CC MCP-4/NN were/VBD not/RB cleaved/VBN by/IN MMP-2/NN or/CC MT1-MMP/NN ,/, but/CC were/VBD cleaved/VBN by/IN MMP-1/NN and/CC MMP-3/NN with/IN varying/JJ efficiency/NN ./.
P12154073A02
Endothelial/JJ tubulogenesis/NN was/VBD also/RB increased/VBN in/IN co-culture/NN with/IN tumour/NN cells/NNS such/JJ as/IN U87/NN glioma/NN cells/NNS ,/, but/CC not/RB with/IN non-tumorigenic/JJ cell/NN types/NNS such/JJ as/IN Madin-Darby/NN canine/JJ kidney/NN (/( MDCK/NN )/) epithelial/JJ cells/NNS ./.
P12160135A12
S-2444/NN ,/, a/DT specific/JJ chromogenic/JJ peptide/NN ,/, was/VBD useful/JJ for/IN quantitative/JJ analysis/NN of/IN the/DT activity/NN of/IN MMP/NN subtypes/NNS in/IN this/DT study/NN ./.
P12162654A01
The/DT extracellular/JJ matrix/NN ,/, composed/VBN mainly/RB of/IN collagen/NN ,/, is/VBZ considered/VBN responsible/JJ for/IN the/DT residual/JJ toughness/NN of/IN meat/NN ./.
P12164864A06
METHODS/NNS :/: Expression/NN of/IN mRNAs/NNS for/IN receptors/NNS of/IN growth/NN factors/NNS (/( bFGF/NN ,/, PDGF/NN ,/, TGF-beta1/NN )/) ,/, the/DT proteinases/NNS and/CC their/PRP$ inhibitors/NNS in/IN differentiated/JJ podocytes/NNS were/VBD shown/VBN by/IN RT-PCR/NN ./.
P12165796A11
This/DT model/NN can/MD be/VBP applied/VBN in/IN detecting/NN patients/NNS with/IN poor/JJ prognosis/NN and/CC patients/NNS who/WP may/MD benefit/VBP from/IN MMPI/NN treatment/NN ./.
P12172142A06
In/IN this/DT study/NN ,/, we/PRP examined/VBD the/DT ontogeny/NN of/IN ten/CD matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC their/PRP$ tissue/NN inhibitors/NNS (/( TIMPs/NNS )/) in/IN nonwounded/JJ fetal/JJ rat/NN skin/NN and/CC fibroblasts/NNS as/IN a/DT function/NN of/IN gestational/JJ age/NN ./.
P12173379A03
RESULTS/NNS :/: We/PRP found/VBD that/IN type/NN IV/CD collagenase/NN activity/NN in/IN pancreatic/JJ and/CC colon/NN carcinomas/NNS with/IN liver/NN metastases/NNS was/VBD significantly/RB higher/JJR than/IN in/IN pancreatic/JJ and/CC colon/NN carcinomas/NNS without/IN liver/NN metastases/NNS ./.
P12174907A04
Squamous/JJ cell/NN carcinomas/NNS of/IN the/DT head/NN and/CC neck/NN (/( SCCHN/NN )/) are/VBP known/VBN to/TO be/VB highly/RB invasive/JJ tumors/NNS with/IN early/JJ locoregional/JJ metastatic/JJ spread/NN ./.
P12184536A04
Specimens/NNS of/IN colon/NN tumors/NNS and/CC of/IN adjacent/JJ normal/JJ mucosa/NN were/VBD obtained/VBN from/IN 22/CD patients/NNS at/IN the/DT time/NN of/IN surgical/JJ resection/NN ./.
P12185105A10
In/IN conclusion/NN ,/, this/PRP is/VBZ the/DT first/JJ report/NN of/IN MMP/NN activity/NN in/IN normal/JJ and/CC abnormal/JJ human/NN sperm/NN samples/NNS and/CC of/IN TIMP/NN presence/NN in/IN sperm/NN samples/NNS ./.
P12193736A04
To/TO clarify/VB these/DT roles/NNS ,/, we/PRP investigated/VBD the/DT development/NN of/IN Ab-induced/JJ arthritis/NN ,/, one/CD of/IN the/DT murine/JJ models/NNS of/IN rheumatoid/JJ arthritis/NN ,/, in/IN MMP-2/NN or/CC MMP-9/NN knockout/NN (/( KO/NN )/) mice/NNS ./.
P12194986A11
In/IN functional/JJ studies/NNS ,/, increasing/NN calcium/NN enhanced/VBD MMP-dependent/JJ cellular/JJ migration/NN on/IN laminin-5-rich/JJ matrix/NN using/VBG an/DT in/FW vitro/FW colony/NN dispersion/NN assay/NN ./.
P12198653A05
The/DT goal/NN of/IN this/DT work/NN was/VBD to/TO determine/VB whether/IN apoptosis/NN induction/NN in/IN human/NN hepatic/JJ myofibroblasts/NNS modulates/VBZ the/DT gene/NN expression/NN of/IN MMP-2/NN and/or/CC its/PRP$ activation/NN by/IN MT1-MMP/NN ./.
P12200138A01
Release/NN and/CC activation/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) significantly/RB contribute/VBP to/TO myocardial/JJ stunning/JJ injury/NN immediately/RB after/IN ischemia/NN and/CC reperfusion/NN ,/, however/WRB ,/, their/PRP$ role/NN in/IN preconditioning/NN remains/VBZ unknown/VBN ./.
P12200461A09
MMP-2/NN protein/NN was/VBD prominent/JJ in/IN late/JJ ,/, but/CC not/RB early/JJ CL/NN microvasculature/NN ./.
P12202125A11
However/WRB ,/, failure/NN to/TO detect/VB protein/NN expression/NN for/IN MMPs/NNS 2/CD ,/, 7/CD ,/, 9/CD ,/, 13/CD and/CC TIMPs/NNS 1/CD and/CC 2/CD in/IN murine/JJ chondrocytes/NNS by/IN immunohistochemistry/NN indicates/VBZ that/IN the/DT changes/NNS in/IN mRNA/NN levels/NNS in/IN STR/NN //SYM ort/NN mice/NNS must/MD be/VBP interpreted/VBN with/IN caution/NN ./.
P12209100A08
However/WRB ,/, with/IN the/DT exception/NN of/IN one/CD individual/NN for/IN whom/WP active/JJ MMP-9/NN was/VBD not/RB detected/VBN ,/, tear/NN fluid/NN from/IN all/DT patients/NNS with/IN VKC/NN contained/VBD both/CC proforms/NNS and/CC active/JJ forms/NNS of/IN MMP-2/NN and/CC MMP-9/NN ./.
P12210832A02
It/PRP has/VBZ been/VBN previously/RB demonstrated/VBN that/IN increased/JJ expression/NN of/IN TGFbeta/NN has/VBZ consequences/NNS for/IN the/DT levels/NNS of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC their/PRP$ specific/JJ inhibitors/NNS (/( tissue/NN inhibitors/NNS of/IN MMPs/NNS ,/, or/CC TIMPs/NNS )/) ./.
P12231217A11
The/DT disproportional/JJ increase/NN in/IN MT1-MMP/NN and/CC TIMP-2/NN might/MD contribute/VBP to/TO MMP-2/NN activation/NN ./.
P12235077A06
Gene/NN array/NN analysis/NN and/CC in/FW situ/FW hybridisation/NN were/VBD performed/VBN to/TO investigate/VB changes/NNS in/IN MMP/NN gene/NN expression/NN ./.
P12237340A08
This/DT effect/NN of/IN NO/NN may/MD be/VBP important/JJ in/IN the/DT context/NN of/IN pathophysiological/JJ conditions/NNS such/JJ as/IN inflammation/NN or/CC atherogenesis/NN [/( corrected/VBN ]/) ./.
P12237942A07
Taken/VBN together/RB ,/, our/PRP$ results/NNS suggest/VBP that/IN MMP-2/NN and/CC TIMP-3/NN may/MD have/VBP functional/JJ roles/NNS in/IN rat/NN luteal/JJ formation/NN ,/, while/IN TIMP-2/NN may/MD be/VBP implicated/VBN in/IN both/CC formation/NN and/CC regression/NN of/IN the/DT pregnant/JJ CL/NN ./.
P12269680A10
TIMP-2/NN levels/NNS were/VBD lower/JJR in/IN serum/NN of/IN subjects/NNS with/IN moderate/JJ //SYM extensive/JJ adhesions/NNS compared/VBN with/IN subjects/NNS without/IN adhesions/NNS ./.
P12297832A05
We/PRP also/RB examined/VBD the/DT effect/NN of/IN TIMP-1/NN on/IN HSC/NN apoptosis/NN ./.
P12323181A02
MATERIAL/NN AND/CC METHODS/NNS :/: in/IN a/DT series/NN of/IN 40/CD patients/NNS with/IN AAA/NN >/SYM or/CC =5cm/NN in/IN maximal/JJ cross-sectional/JJ diameter/NN ,/, C./NN pneumoniae-DNA/NN was/VBD identified/VBN in/IN the/DT aneurysm/NN wall/NN by/IN nested/JJ PCR/NN in/IN 14/CD (/( 35/CD %/SYM )/) patients/NNS ./.
P12351448A01
Pathological/JJ remodeling/NN characterized/VBN by/IN extracellular/JJ matrix/NN (/( ECM/NN )/) deposition/NN contributes/VBZ to/TO the/DT diabetic/JJ vascular/JJ complications/NNS ./.
P12354802A05
METHODS/NNS :/: Immunohistochemistry/NN for/IN MMP-13/NN was/VBD performed/VBN on/IN formalin/NN fixed/JJ ,/, paraffin/NN wax/NN embedded/JJ sections/NNS of/IN a/DT large/JJ series/NN of/IN colorectal/JJ cancers/NNS (/( n/NN =/SYM 249/CD )/) ,/, all/PRP of/IN which/WDT had/VBD uniform/JJ clinical/JJ and/CC pathological/JJ information/NN available/JJ ./.
P12359766A06
These/DT data/NNS demonstrate/VBP a/DT link/NN between/IN increased/JJ specificity/NN of/IN MMPIs/NNS and/CC enhanced/JJ anticancer/NN activity/NN ./.
P12361907A05
On/IN the/DT protein/NN level/NN ,/, expression/NN of/IN MMP-9/NN was/VBD significantly/RB higher/JJR and/CC TIMP-1/NN expression/NN was/VBD significantly/RB lower/JJR ,/, MMP-2/NN was/VBD unchanged/VBN and/CC the/DT ratios/NNS of/IN MMP-2/NN and/CC MMP-9/NN to/TO TIMP-1/NN were/VBD increased/VBN in/IN tumor/NN tissue/NN ./.
P12370004A06
The/DT interaction/NN of/IN MMPs/NNS with/IN chemical/JJ mediators/NNS and/CC inflammatory/JJ cytokines/NNS has/VBZ also/RB been/VBN reported/VBN in/IN some/DT recent/JJ studies/NNS ./.
P12374789A03
Myoglobin/NN was/VBD used/VBN as/IN a/DT novel/JJ recombinant/JJ fusion/NN protein/NN partner/NN because/IN spectroscopic/JJ measurement/NN of/IN the/DT heme/NN Soret/NN absorbance/NN at/IN 408/CD nm/NN readily/RB enabled/VBD calculation/NN of/IN the/DT molar/JJ equivalent/NN of/IN the/DT red-colored/JJ recombinant/JJ protein/NN ,/, even/RB in/IN complex/JJ protein/NN mixtures/NNS ./.
P12379519A02
OBJECTIVE/NN :/: To/TO examine/VB the/DT in/FW vitro/FW invasiveness/NN of/IN synoviocytes/NNS obtained/VBN from/IN inflamed/JJ joints/NNS of/IN patients/NNS with/IN arthritis/NN in/IN relation/NN to/TO the/DT expression/NN of/IN MMP/NN 1-14/CD ,/, 17/CD ,/, 19/CD ,/, cathepsin-K/NN ,/, the/DT tissue/NN inhibitors/NNS of/IN matrix/NN metalloproteinases/NNS TIMP-1/NN and/CC TIMP-2/NN by/IN FLS/NN ./.
P12381651A05
Increased/JJ MMP-2/NN was/VBD only/RB found/VBN in/IN IDCM/NN (/( 3.68/CD (/( 0.41/CD )/) ng/NN //SYM ml/NN )/) ./.
P12384502A06
In/IN a/DT zymography/NN assay/NN ,/, MMP-9-PEX/NN was/VBD able/JJ to/TO inhibit/VB MMP-9/NN activity/NN ./.
P12384564A04
In/IN the/DT lung/NN metastasis/NN model/NN ,/, tumor/NN cells/NNS (/( PC14/NN ,/, PC14PE6/NN ,/, H226/NN ,/, A549/NN )/) inoculated/VBN i.v./NN into/IN nude/JJ or/CC SCID/NN mice/NNS metastasized/VBD only/RB in/IN the/DT lung/NN ./.
P12384920A07
Blood/NN ,/, tissue/NN samples/NNS ,/, and/CC fibroblasts/NNS were/VBD assayed/VBN for/IN MMPs/NNS 1/CD ,/, 2/CD ,/, 3/CD ,/, and/CC 9/CD ,/, and/CC TIMPs/NNS 1/CD and/CC 2/CD by/IN sandwich/NN enzyme/NN immunoassay/NN ./.
P12385578A02
Overexpression/NN of/IN matrix/NN metalloproteinase/NN 3/CD (/( MMP-3/NN or/CC stromelysin/NN 1/CD )/) gene/NN has/VBZ been/VBN demonstrated/VBN in/IN various/JJ types/NNS of/IN cancers/NNS and/CC high/JJ level/NN of/IN MMP-3/NN protein/NN in/IN tumour/NN is/VBZ a/DT poor/JJ prognostic/JJ factor/NN for/IN patients/NNS ./.
P12388270A09
The/DT collagen/NN cross-linking/JJ ratio/NN (/( insoluble/JJ :/: soluble/JJ collagen/NN )/) was/VBD reduced/VBN (/( P/NN =/SYM 0.003/CD )/) as/IN the/DT left/JJ ventricle/NN dilated/VBN ./.
P12390324A01
Matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) capable/JJ of/IN degrading/NN various/JJ components/NNS of/IN connective/JJ tissue/NN matrices/NNS ,/, and/CC tissue/NN inhibitor/NN metalloproteinases/NNS (/( TIMPs/NNS )/) are/VBP considered/VBN important/JJ in/IN lung/NN parenchymal/JJ remodeling/NN and/CC repair/NN processes/NNS in/IN pulmonary/JJ diseases/NNS ./.
P12393094A04
RESULTS/NNS :/: In/IN viral/JJ infected/JJ mice/NNS ,/, both/CC mRNA/NN and/CC protein/NN abundance/NN for/IN collagen/NN type/NN I/CD remained/VBD unaltered/VBN ./.
P12399724A08
RESULTS/NNS :/: There/EX was/VBD an/DT overexpression/NN of/IN MMP-2/NN and/CC -9/CD in/IN corneal/JJ burns/NNS versus/CC control/NN corneas/NNS ./.
P12404299A04
Inhibition/NN of/IN the/DT expression/NN of/IN MMP-9/NN may/MD prevent/VBP tumor/NN development/NN ./.
P12407049A06
MMP-9/NN ,/, TIMP-1/NN and/CC TIMP-2/NN were/VBD not/RB significantly/RB different/JJ in/IN normozoospermia/NN and/CC azoospermia/NN ./.
P12426251A04
STUDY/NN OBJECTIVE/NN :/: s/NNS :/: To/TO determine/VB whether/IN severe/JJ ,/, persistent/JJ asthma/NN is/VBZ associated/VBN with/IN increased/JJ levels/NNS of/IN MMP-9/NN in/IN the/DT airway/NN compared/VBN with/IN mild/JJ asthma/NN ,/, and/CC to/TO assess/VB the/DT effect/NN of/IN both/CC allergen/NN exposure/NN and/CC steroid/NN treatment/NN on/IN MMP-9/NN and/CC TIMP-1/NN levels/NNS ./.
P12429818A10
These/DT relatively/RB rapid/JJ changes/NNS of/IN the/DT MMP-2/NN status/NN can/MD not/RB be/VBP detected/VBN by/IN gelatin/NN zymography/NN ./.
P12433840A04
By/IN binding/NN to/TO the/DT u-PA/NN receptor/NN this/DT protein/NN will/MD not/RB only/RB anchor/VBP the/DT TIMP-1/NN moiety/NN directly/RB to/TO the/DT cell/NN surface/NN ,/, it/PRP will/MD also/RB prevent/VBP the/DT local/JJ activation/NN of/IN plasminogen/NN by/IN blocking/NN the/DT binding/NN of/IN urokinase-type/NN plasminogen/NN activator/NN (/( u-PA/NN )/) to/TO its/PRP$ receptor/NN ./.
P12437648A01
Agnogenic/JJ myeloid/NN metaplasia/NN (/( AMM/NN )/) is/VBZ characterized/VBN by/IN bone/NN marrow/NN fibrosis/NN with/IN abnormal/JJ accumulation/NN of/IN extracellular/JJ matrix/NN components/NNS (/( ECM/NN )/) ,/, which/WDT is/VBZ dependent/JJ on/IN the/DT balance/NN between/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) and/CC tissue/NN inhibitors/NNS of/IN metalloproteinases/NNS (/( TIMPs/NNS )/) ./.
P12444074A10
Therefore/RB ,/, these/DT data/NNS indicate/VBP that/IN proMMP-9/NN is/VBZ produced/VBN by/IN the/DT amnion/NN but/CC not/RB the/DT chorion/NN in/IN response/NN to/TO LPS/NN ./.
P12447632A02
Total/JJ joint/NN replacement/NN results/VBZ in/IN total/JJ resection/NN of/IN cartilage/NN and/CC synovium/NN at/IN the/DT joint/NN ./.
P12449177A05
Western/NN immunoblotting/NN revealed/VBD the/DT presence/NN of/IN two/CD isoforms/NNS of/IN MMP-8/NN in/IN patient/NN samples/NNS ;/: an/DT 80/CD kD/NN form/NN representing/VBG latent/JJ enzyme/NN from/IN polymorphonuclear/JJ neutrophils/NNS and/CC a/DT 55/CD kD/NN form/NN representing/VBG the/DT fibroblast-type/NN proform/NN ./.
P12452001A07
While/IN the/DT frequency/NN of/IN the/DT serosa/NN invasion/NN and/CC lymph/NN node/NN metastasis/NN in/IN the/DT group/NN of/IN the/DT expression/NN of/IN MMP-9/NN over/IN TIMP-1/NN was/VBD significantly/RB higher/JJR than/IN those/PRP in/IN the/DT groups/NNS of/IN the/DT expression/NN of/IN TIMP-1/NN over/IN MMP-9/NN or/CC the/DT balance/NN expression/NN of/IN MMP-9/NN and/CC TIMP-1/NN ./.
P12454040A05
To/TO evaluate/VB the/DT potential/JJ role/NN of/IN PKC/NN ,/, HCM/NN cells/NNS were/VBD treated/VBN with/IN phorbol/NN 12-myrisate/NN 13-acetate/NN (/( PMA/NN )/) in/IN the/DT absence/NN or/CC presence/NN of/IN the/DT PKC/NN inhibitor/NN bisindolylmaleimide/NN I/CD (/( Bis/NN I/NN )/) or/CC the/DT PKA/NN inhibitor/NN KT5720/NN ./.
P12456342A02
The/DT chances/NNS of/IN reproductive/JJ success/NN during/IN each/DT cycle/NN depends/VBZ on/IN appropriate/JJ ,/, cell-specific/JJ responses/NNS to/TO steroids/NNS ,/, including/VBG expression/NN of/IN matrix/NN metalloproteinases/NNS (/( MMPs/NNS )/) ./.
P12464265A08
As/IN a/DT first/JJ step/NN ,/, human/NN fetal/JJ hepatocyte/NN (/( HFH/NN )/) and/CC HepG2/NN (/( HCC/NN origin/NN ,/, HBV/NN not/RB detected/VBN )/) cells/NNS were/VBD subjected/VBN to/TO infection/NN with/IN HBV/NN ,/, and/CC the/DT resulting/JJ infected/JJ cells/NNS successfully/RB established/VBD are/VBP hereafter/RB referred/VBN to/TO as/IN HFH-T2/NN and/CC HepG2-HBV/NN ./.
P12466243A13
TIMP-4/NN was/VBD not/RB released/VBN during/IN platelet/NN aggregation/NN induced/VBN by/IN HT-1080/NN cells/NNS ./.
P12468782A03
The/DT aim/NN of/IN the/DT study/NN was/VBD to/TO investigate/VB the/DT ability/NN of/IN doxycycline/NN ,/, a/DT nonspecific/JJ MMP/NN inhibitor/NN ,/, to/TO reduce/VB MMP/NN concentration/NN in/IN carotid/JJ atheroma/NN ./.
P12473546A05
Abundant/JJ MT3-MMP/NN expression/NN was/VBD noted/VBN in/IN medial/JJ smooth/JJ muscle/NN cells/NNS (/( SMCs/NNS )/) of/IN normal/JJ arteries/NNS ./.
P12475252A07
Molecular/JJ interactions/NNS of/IN TIMPs/NNS and/CC MMPs/NNS investigated/VBN by/IN IAsys/NN biosensor/NN analysis/NN highlighted/VBD different/JJ modes/NNS of/IN interaction/NN between/IN proMMP-2-TIMP-2/NN (/( or/CC TIMP-4/NN )/) and/CC active/JJ MMP-2-TIMP-2/NN (/( or/CC TIMP-4/NN )/) complexes/NNS ./.
P12479097A06
RESULTS/NNS :/: Immunohistochemical/JJ staining/NN of/IN tumor/NN cells/NNS for/IN MMP-2/NN ,/, MMP-9/NN ,/, TIMP-1/NN ,/, and/CC TIMP-2/NN were/VBD noted/VBN 82.5/CD %/SYM ,/, 70.0/CD %/SYM ,/, 62.5/CD %/SYM ,/, and/CC 97.5/CD %/SYM in/IN carcinomas/NNS ,/, 44.8/CD %/SYM ,/, 62.1/CD %/SYM ,/, 86.21/CD %/SYM ,/, and/CC 96.55/CD %/SYM in/IN CIN/NN lesions/NNS respectively/RB ,/, for/IN MMP-2/NN ,/, MMP-9/NN ,/, TIMP-1/NN in/IN 25.0/CD %/SYM normal/JJ cervices/NNS ,/, but/CC for/IN TIMP-2/NN in/IN 56.25/CD %/SYM normal/JJ cervices/NNS ./.
P12483743A03
METHODS/NNS :/: We/PRP administered/VBD human/NN TIMP-4/NN by/IN electroporation-mediated/JJ intramuscular/JJ injection/NN of/IN naked/JJ DNA/NN using/VBG the/DT rat/NN adjuvant-induced/JJ arthritis/NN (/( AIA/NN )/) model/NN ./.
P12505230A09
In/IN addition/NN ,/, a/DT concomitant/JJ increase/NN in/IN plasma/NN TIMP-1/NN levels/NNS did/VBD not/RB occur/VBP post-MI/NN ./.
P12506070A04
METHODS/NNS :/: Porcine/JJ TM/NN cells/NNS were/VBD treated/VBN with/IN TNFalpha/NN ,/, and/CC changes/NNS in/IN MMPs/NNS and/CC TIMPs/NNS were/VBD evaluated/VBN by/IN zymography/NN and/CC Western/NN immunoblot/NN assay/NN ./.
P12508295A02
Female/NN Wistar/NN rats/NNS (/( 7-8/CD months/NNS old/JJ )/) had/VBD their/PRP$ right/JJ hindlimbs/NNS immobilized/VBN by/IN an/DT external/JJ fixation/NN procedure/NN for/IN 5/CD ,/, 10/CD ,/, 21/CD ,/, and/CC 30/CD days/NNS ./.
P12514782A09
Staining/NN for/IN type/NN IV/CD collagen/NN showed/VBD focal/JJ damage/NN to/TO the/DT basement/NN membranes/NNS of/IN cardiac/JJ myocytes/NNS and/CC pulmonary/JJ alveoli/NNS near/IN the/DT granulomas/NNS ./.
P12524413A13
RT-PCR/NN demonstrated/VBD the/DT presence/NN of/IN mRNA/NN for/IN metalloproteinase/NN inhibitors/NNS TIMP1/NN and/CC TIMP2/NN in/IN PSCs/NNS while/IN reverse/JJ zymography/NN revealed/VBD the/DT presence/NN of/IN functional/JJ TIMP2/NN in/IN PSC/NN secretions/NNS ./.
P12528092A07
Interestingly/RB ,/, plasma/NN levels/NNS of/IN MMP-8/NN were/VBD decreased/VBN in/IN CHF/NN patients/NNS (/( 16/CD +/-/SYM 2/CD versus/CC 9/CD +/-/SYM 2/CD ng/NN //SYM mL/NN ,/, P/NN </SYM .05/CD )/) ./.
P12529376A05
In/IN contrast/NN ,/, MMP-7/NN and/CC TIMP-3/NN mRNAs/NNS are/VBP markedly/RB decreased/VBN in/IN obesity/NN ./.
P12538437A02
Several/JJ MMPs/NNS are/VBP overexpressed/VBN in/IN the/DT atherosclerotic/JJ plaque/NN ,/, and/CC they/PRP are/VBP believed/VBN to/TO contribute/VB to/TO the/DT expansion/NN and/CC rupture/NN of/IN the/DT lesion/NN ./.
P12540195A06
After/IN secretion/NN ,/, progelatinase/NN B/NN must/MD be/VBP activated/VBN through/IN an/DT activation/NN network/NN ./.
P12546341A11
CONCLUSIONS/NNS :/: Our/PRP$ results/NNS from/IN these/DT two/CD pilot/NN studies/NNS suggest/VBP that/IN increased/JJ MMP-9/NN and/CC decreased/JJ TIMP-1/NN at/IN night/NN in/IN NA/NN may/MD lead/VBP to/TO reduced/JJ elastin/NN density/NN ./.
P12566130A03
METHODS/NNS AND/CC RESULTS/NNS :/: Balloon/NN angioplasty/NN was/VBD performed/VBN in/IN the/DT left/JJ coronary/JJ arteries/NNS followed/VBN by/IN injection/NN of/IN adenovirus/NN vector/NN solution/NN encoding/VBG either/CC MMP-9/NN or/CC beta-galactosidase/NN (/( beta-gal/NN )/) gene/NN into/IN the/DT injured/JJ coronary/JJ arteries/NNS ./.
P12566375A11
The/DT PKC-beta/NN isoform/NN played/VBD a/DT critical/JJ role/NN in/IN the/DT expression/NN of/IN MMPs/NNS ,/, because/IN the/DT PKC-beta/NN inhibitor/NN hispidin/NN reduced/VBD ox-LDL-induced/JJ activation/NN of/IN PKC/NN and/CC the/DT expression/NN of/IN MMPs/NNS ./.
P12566376A11
These/DT effects/NNS were/VBD not/RB observed/VBN in/IN the/DT MI-only/JJ group/NN ./.
P12576963A05
INTERVENTION/NN :/: Bronchoalveolar/JJ lavages/NNS were/VBD performed/VBN on/IN day/NN 0/CD of/IN the/DT onset/NN of/IN ARDS/NN and/CC on/IN days/NNS 4/CD ,/, 8/CD ,/, and/CC 12/CD for/IN unresolving/JJ ARDS/NN ./.
P12589095A11
MMP-2/NN ,/, MMP-9/NN ,/, and/CC TGF-beta1/NN may/MD contribute/VBP to/TO eosinophil/NN and/CC mast/JJ cell/NN migrations/NNS into/IN nasal/JJ polyp/NN tissue/NN ./.
